Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SYNTHETIC TECHNIQUES AND INTERMEDIATES FOR POLYHYDROXY, DIENYLLACTONES AND MIMICS THEREOF
Document Type and Number:
WIPO Patent Application WO/1998/024429
Kind Code:
A1
Abstract:
Synthetic methods for lactone-containing compounds such as the discodermolides are provided, as are compounds which mimic the chemical and/or biological activity thereof, and methods and intermediates useful in their preparation.

Inventors:
SMITH AMOS B III
QIU YUPING
KAUFMAN MICHAEL
ARIMOTO HIROKAZA
JONES DAVID R
KOBAYASHI KAORU
Application Number:
PCT/US1997/021798
Publication Date:
June 11, 1998
Filing Date:
December 01, 1997
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV PENNSYLVANIA (US)
International Classes:
C07D303/16; A61K31/047; A61K31/12; A61K31/27; A61K31/336; A61K31/351; A61K31/366; A61K31/422; A61K31/427; A61K31/5355; A61K31/7028; A61P35/00; A61P37/06; C07C239/06; C07D263/22; C07D309/10; C07D309/30; C07D309/32; C07D319/06; C07D413/06; C07D413/12; C07D417/06; C07F7/18; C07H23/00; (IPC1-7): A61K31/35; A61K31/38; A61K31/445; B01J27/122; C07D211/44; C07D239/04; C07D265/06; C07D279/06; C07D309/04; C07D319/06; C07D327/06; C07D335/02; C07D339/08
Foreign References:
US4939168A1990-07-03
Other References:
SMITH A B, ET AL.: "TOTAL SYNTHESIS OF (-)-DISCODERMOLIDE", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, US, vol. 117, 1 January 1995 (1995-01-01), US, pages 12011/12012, XP001018841, ISSN: 0002-7863, DOI: 10.1021/ja00153a030
YANG G, MYLES D C: "THE SYNTHESIS OF THE C-9 TO C-21 SECTOR OF DISCODERMOLIDE: AN EFFICIENT ROUTE TO THE C13-13 Z-TRISUBSTITUTED ALKENE", TETRAHEDRON LETTERS, PERGAMON, GB, vol. 35, no. 16, 1 January 1994 (1994-01-01), GB, pages 2503/2504, XP001109121, ISSN: 0040-4039, DOI: 10.1016/S0040-4039(00)77155-3
See also references of EP 0969829A4
Attorney, Agent or Firm:
Elderkin, Dianne B. (46th floor One Liberty Plac, Philadelphia PA, US)
Download PDF:
Claims:
WHAT IS CLAIMED IS :
1. A process of producing a diene of the formula : comprising contacting a phosphonium salt of the formula with base and an alkylthiol of the formula : wherein : R1, R2, R3, R6, R7, R8, R11, R12 and R13 are, independently, C1ClO alkyl ; X is a halogen ; Z1 and Z2 are, independently, 0, S or NR' ; R4, R9, R14, and Ris are, independently, acid labile hydroxyl protecting groups ; R5 is C6C14 aryl ; Y is 0, S or NR' ; R'and R16 are, independently, hydrogen or ClC6 alkyl ; and Ria is C6C 4 aryl.
2. The process of claim 1 wherein : Rl, R2, R3, R6, R7, R8, R11 and R12 are methyl ; R4, Rg, R14 are tbutyldimethylsilyl ; R5 is pmethoxyphenyl ; R13 is ethyl ; R16 is hydrogen ; and Y, Z1 and Z2 are 0.
3. The process of claim 1 wherein said base is sodium hexamethyldisilazide or nbutyllithium with hexamethylphosphoramide.
4. A process for producing an alkene or the formula : comprising : (a) contacting an organometallic reagent of the formula : with a vinyl halide of the formula : or (b) contacting a vinyl halide of formula : with an organometallic compound of formula : wherein : R1, R2, R3, R6, R7 and Rg are, independently, C1ClO alkyl ; M is Li, Cu, Mg, or Zn ; X is a halogen ; Z1 and Z2 are, independently, 0, S or NR' ; R4 and R, are, independently, acid labile hydroxyl protecting groups ; Rs is C6C14 aryl ; R'is hydrogen or C1C6 alkyl ; and Ri. is an acid stable hydroxyl protecting group.
5. The process of claim 4 wherein R1, R2, R3, R6, R7 and Ra are, independently, C1C4 alkyl.
6. The process of claim 4 wherein : R1, R2, R3, R6, R7 and Rg are methyl ; X is iodide ; Z1 and Z2 are 0 ; R4 and R9 are tbutyldimethylsilyl ; R5 is pmethoxyphenyl ; and Rlo is pmethoxybenzyl.
7. The process of claim 4 wherein M is Li.
8. A process of producing a lactone of the formula : comprising : (a) contacting a diene of the formula with an organometallic compound of the formula : or (b) contacting an organometallic compound having formula : with a vinyl halide having formula : wherein : R1, R2, R3, R6, R7, R8, R11, R12 and R13 are, independently, Clcalo alkyl ; M is Li, Cu, Mg, or Zn ; X is a halogen ; Z, Z1 and Z2 are, independently, O, S or NR' ; R4, Rg, R14, and Rls are, independently, acid labile hydroxyl protecting groups ; RI is C6C14 aryl ; R'and R16 are, independently, hydrogen or C1C6 alkyl ; and R24 is hydrogen ; and R,, is hydrogen or an acid stable hydroxyl protecting group.
9. A process of producing a diene of the formula : comprising contacting a phosphonium salt of the formula : with base and an alkylthiol of the formula : wherein : R6, R7, R8, R11, R12 and R13 are, independently, C1C10 alkyl ; X is a halogen ; Z is 0, S or NR' ; R9, R14, and R1s are, independently, acid labile hydroxyl protecting groups ; Y is 0, S or NR' ; R' and R16 are, independently, hydrogen or ClC6 alkyl ; and R is C6C14 aryl.
10. A compound of the formula : wherein R1, R2 and R3 are, independently, C1C10 alkyl ; M is Li, Cu, Mg, or Zn ; X is a halogen ; Z1 and Z2 are, independently, 0, S or NR' ; R4 is an acid labile hydroxyl protecting group ; Rs is C6C14 aryl ; and R'is hydrogen or C1C6 alkyl.
11. The compound of claim 10 wherein R1, R2 and R3 are, independently, C1C4 alkyl.
12. The compound of claim 11 wherein Rl, R2 and R3 are methyl.
13. The compound of claim 10 wherein X is iodide.
14. The compound of claim 10 wherein Z1 and Z2 are O.
15. The compound of claim 10 wherein R4 is t butyldimethylsilyl.
16. The compound of claim 10 wherein R, is p methoxyphenyl.
17. The compound of claim 10 wherein : Rl, R2 and R3 are methyl ; X is iodide ; Z1 and Z2 are 0 ; R4 is tbutyldimethylsilyl ; and R, is pmethoxyphenyl.
18. A compound of the formula : wherein R6, R, and R8, are, independently, C1C10 alkyl ; M is Li, Cu, Mg, or Zn ; X is a halogen ; R9 is an acid labile hydroxyl protecting group ; and Rio is an acid stable hydroxyl protecting group.
19. The compound of claim 18 wherein R, and R, are, independently, C1C4 alkyl.
20. The compound of claim 19 wherein R, and R, are methyl.
21. The compound of claim 18 wherein X is iodide.
22. The compound of claim 18 wherein R2 is t butyldimethylsilyl.
23. The compound of claim 18 wherein R, is p methoxybenzyl.
24. The compound of claim 18 wherein : R, and R, are methyl ; X is iodide ; R2 is tbutyldimethylsilyl ; and R, is pmethoxybenzyl.
25. A compound of the formula : wherein R11, R12 and R13 are, independently, C1Cl0 alkyl ; R14 and Ri. are, independently, acid labile hydroxyl protecting groups ; Y is 0, S or NR'; and R'and R16 are, independently, hydrogen or C1C6 alkyl.
26. The compound of claim 25 wherein R11, R12 and R13 are, independently, ClC4 alkyl.
27. The compound of claim 26 wherein Rl, and R12 are methyl.
28. The compound of claim 26 wherein R13 is ethyl.
29. The compound of claim 25 wherein R14 and Ris are tbutyldimethylsilyl.
30. The compound of claim 25 wherein Y is 0 and Rl, is hydrogen.
31. The compound of claim 25 wherein : Ri. and R12 are methyl ; R13 is ethyl ; R14 and R1s are tbutyldimethylsilyl ; Y is 0 ; and R16 is hydrogen.
32. A compound of the formula : wherein R19 , R20, R21 and R22 are, independently, C1C10 alkyl ; and R23 is C7Cls aralkyl.
33. The compound of claim 32 wherein R19, R20, R21 and R22 are, independently, C1C4 alkyl.
34. The compound of claim 33 wherein R19, R20, R21 and R22 are methyl.
35. The compound of claim 32 wherein R23 is p methoxybenzyl.
36. The compound of claim 32 wherein : R19, R20, R21 and R22 are methyl ; and R. is pmethoxybenzyl.
37. A compound of the formula : wherein R6, R7, and R8 are, independently, C1C10 alkyl; X is halogen ; R9 is an acid labile hydroxyl protecting groups ; and Ri. is CC aryl.
38. A compound of the formula :.
39. wherein : R6, R"R8, Rll, R12 and R13 are, independently, C1C10 alkyl ; X is a halogen ; M is Li, Cu, Mg, or Zn ; Z is 0, S or NR' ; R9, R14, and Ris are, independently, acid labile hydroxyl protecting groups ; and R'and R16 are, independently, hydrogen or ClC6 alkyl.
40. A compound of the formula : wherein R1, R2, R3, R6, R7, R8, R11, R12 and R13 are, independently, C1C10 alkyl; Z is 0, S or NR' ; R4, R9, R14, and Rls are, independently, acid labile hydroxyl protecting groups ; R' and R16 are, independently, hydrogen or CiCg alkyl ; and R24 is hydrogen ; and R21 is an acid stable hydroxyl protecting group.
41. A compound of the formula where R30 is substituted or unsubstituted C1C1 alkyl or a moiety of one of the formulas : where A is C1C20 alkyl,CH2NH (T) or a moiety of the formula wherein T is peptide having 1 to about 10 amino acids ; R32, R40, R42, R43, R46, R47, and R48 are, independently, hydrogen or C1C6 alkyl ; R41 is a side chain of an amino acid ; W1 and W2 are, independently, OR49 or NHP1; Pi is hydrogen or an amine protecting group ; R33 and R36 are, independently, hydrogen, C1C10 alkyl, OR50, =O or together form CH2CH2; R34 and R3, are, independently, hydrogen or together formC (H) =C (H)C (H) =C (H) ; R39 isORs1 or CH2R51 ; R31 and R44 are, independently, C1C10 alkyl ; Q1 and Q2 are, independently, hydrogen, ORQ, NHR52, OC (=O) NH2 or together form0C (O)NH; RQ is hydrogen or a hydroxyl protecting group ; R51 is substituted or unsubstituted C6C14 aryl, tetrahydropyranyl, furanosyl, pyranosyl, C3C10 lactonyl or 2 pyranonyl ; R45 is ClC6 alkenyl, ClC6 alkyl, C6C14 aryl, C2C10 heterocycloalkyl, C3C10 cycloalkyl, or C7C15 aralkyl ; and R49 Rgo, and Rg, are, independently, hydrogen or C1C6 alkyl.
42. The compound of claim 40 wherein R30 is substituted or unsubstituted C1C10 alkyl.
43. The compound of claim 41 wherein said alkyl is ethyl.
44. The compound of claim 40 wherein R30 is a moiety of the formula :.
45. The compound of claim 43 wherein : R40 and R42 are hydrogen ; R43 is CiCg alkyl ; and W1 and W2 are, independently, NHP1.
46. The compound of claim 44 wherein R43 is methyl.
47. The compound of claim 40 wherein R30 is of the formula :.
48. The compound of claim 46 wherein A is C1Cl0 alkyl.
49. The compound of claim 47 wherein said alkyl is methyl.
50. The compound of claim 46 wherein A is CH2NH (T).
51. The compound of claim 46 wherein A is of the formula :.
52. The compound of claim 50 wherein R46, R47, and R48 are hydrogen.
53. The compound of claim 50 wherein at least one of R46, R47, and R48 is methyl.
54. The compound of claim 50 wherein Q1 is ORQ and Q2 is hydrogen.
55. The compound of claim 50 wherein Q1 is hydrogen and Q2 is ORQ.
56. The compound of claim 50 wherein Q1 is OC(=O)NH2.
57. The compound of claim 50 wherein Q1 and Q2 together form OC(O)NH.
58. The compound of claim 50 wherein R41 is C1C6 alkenyl.
59. The compound of claim 57 wherein said alkenyl is 1, 3butadienyl.
60. The compound of claim 57 wherein said alkenyl is 3, 4epoxy1butenyl.
61. The compound of claim 50 wherein R41 is C1C6 alkyl.
62. The compound of claim 60 wherein said alkyl is butyl.
63. The compound of claim 50 wherein R4. is C6C14 aryl.
64. The compound of claim 62 wherein said aryl is phenyl.
65. The compound of claim 50 wherein R41 is C7C15 arylalkyl.
66. The compound of claim 64 wherein said arylakyl is benzyl.
67. The compound of claim 50 wherein R,, is C2Clo heterocycloalkyl.
68. The compound of claim 66 wherein said heterocycloalkyl is oxazol2ylmethyl.
69. The compound of claim 66 wherein said heterocycloalkyl is thiazol2ylmethyl.
70. The compound of claim 50 wherein R41 is C3 C1o cycloalkyl.
71. The compound of claim 69 wherein said cycloalkyl is 2 (cyclopropyl) cyclopropyl.
72. The compound of claim 40 wherein R39 isOR where R. 1 is substituted or unsubstituted C6C14 aryl, tetrahydropyranyl, furanosyl, pyranosyl, C3C10 lactonyl or 2 pyranonyl.
73. The compound of claim 40 wherein R39 is CH2R51 where Ris is substituted or unsubstituted C6C14 aryl, tetrahydropyranyl, furanosyl, pyranosyl, C3C1o lactonyl or 2 pyranonyl.
74. The compound of claim 40 wherein R,, is substituted or unsubstituted C6C14 aryl.
75. The compound of claim 73 wherein said aryl is selected from the group consisting of pyridin2yl, pyridin 3yl, pyridin4yl, naphthal1yl, naphthal2yl, phenyl, (3 hydroxy5methoxy2, 4dimethyl) phenyl, (3methoxy2, 4 dimethyl) phenyl, (3hydroxy2, 4dimethyl) phenyl, (5methoxy 2, 4dimethyl) phenyl, (5methoxy2methyl) phenyl, (2, 4 dimethyl) phenyl, (4methyl) phenyl, (2methyl) phenyl and (5 methoxy4methyl) phenyl.
76. The compound of claim 40 wherein R,, is substituted or unsubstituted tetrahydropyranyl.
77. The compound of claim 75 wherein said tetrahydropyranyl is (4hydroxy3, 5dimethyl) tetra hydropyran2yl.
78. The compound of claim 40 wherein Rs1 is a substituted or unsubstituted furanosyl or pyranosyl.
79. The compound of claim 77 wherein said pyranosyl is selected from the group consisting of tetramethylfucosyl, tetramethylmannosyl, tetramethylgaractosyl and tetramethylglucosyl.
80. The compound of claim 40 wherein R,, is substituted or unsubstituted C3C10 lactonyl.
81. The compound of claim 79 wherein said lactonyl is substituted or unsubstituted 6valerolactonyl.
82. The compound of claim 81 wherein said b valerolactonyl is of the formula : wherein Rgo and R62 are, independently, C1ClO alkyl ; and R61 is hydrogen or C1C6 alkyl.
83. The compound of claim 81 wherein R60 and R62 are methyl and R61 is hydrogen.
84. The compound of claim 40 wherein Rs1 is substituted or unsubstituted 2pyranonyl.
85. The compound of claim 83 wherein said 2 pyranonyl is selected from the group consisting of moieties of the formula : wherein Q1 is hydrogen or ZR6s ; Z is O, NH or S ; and R63, R64, and R65 are, independently, hydrogen or C1 C6 alkyl.
86. The compound of claim 84 wherein said 2 pyranonyl is of the formula :.
87. The compound of claim 85 wherein Q1 is hydrogen.
88. The compound of claim 85 wherein Q1 is ZR65 where Z is 0 and Rgg is hydrogen.
89. The compound of claim 85 wherein at least one of R63 and R64 is methyl.
90. The compound of claim 84 wherein said 2 pyranonyl is of the formula :.
91. The compound of claim 89 wherein Q1 is hydrogen.
92. The compound of claim 89 wherein Q1 is ZR65 where Z is 0 and R65 is hydrogen.
93. The compound of claim 89 wherein at least one of R63 and R64 is methyl.
94. The compound of claim 40 wherein R44 are methyl.
95. The compound of claim 40 wherein R42is hydrogen.
96. The compound of claim 40 wherein R34 and R35 are hydrogen.
97. The compound of claim 40 wherein R34 and R3. together formC (H) =C (H)C (H) =C (H).
98. The compound of claim 40 wherein R41 is methyl.
99. The compound of claim 40 wherein R36 is hydrogen.
100. The compound of claim 40 wherein R36 is methyl.
101. The compound of claim 40 wherein R36 is OR50 where R50 is hydrogen or C1C6 alkyl.
102. The compound of claim 40 wherein R36 is =0.
103. The compound of claim 40 wherein R33 and R36 together form CH2CH2.
104. A compound of the formula : wherein R70 and R7, are, independently, Clcalo alkyl ; R71 is hydrogen or an acid labile hydroxyl protecting group ; R74 is hydrogen or an acid labile hydroxyl protecting group ; R75 is C2C10 alkenyl; Y is 0, S or NR' ; Z is 0, S or NR'; each R'is independently, hydrogen or C1C6 alkyl ;.
105. A compound of the formula : wherein R. 0 is C2C10 alkenyl ; Rugi, R83 and Ras are, independently, C1ClO alkyl ; R82 is hydrogen or an acid stable hydroxyl protecting group ; R84 is hydrogen or an acid labile hydroxyl protecting group ; R86 is C2C10 alkenyl or C6C14 aryl.
106. A method for inhibiting mammalian cell proliferation, comprising contacting mammalian cells with a compound according to claim 40.
107. A method for treating a mammal suffering from undesired cell proliferation, comprising administering to said mammal the composition of claim 40.
108. A method for inhibiting rejection of a transplanted organ in a mammal, comprising administering to a compound according to claim 40 to a mammalian organ recipient.
109. A method for treating a mammal suffering from rejection of transplanted organ, comprising administering a compound according to claim 40 to said mammal.
110. A composition comprising a compound according to claim 40 in admixture with and a pharmaceuticallyacceptable carrier or excipient. AMENDED CLAIMS [received by the International Bureau on 1 May 1998 (01. 05. 98) ; original claims 1024, 3236, 39 and 40 cancelled ; original claims 4 and 38 amended ; remaining claims unchanged (22 pages)] 1. A process of producing a diene of the formula : comprising contacting a phosphonium salt of the formula with base and an alkylthiol of the formula : wherein : Rl, R2, R3, R6, R7, R8, R1l, R12 and R13 are, independently, Clcalo alkyl ; X is a halogen ; Z1 and Z2 are, independently, O, S or NR' ; R4, R9, R14, and Ri. are, independently, acid labile hydroxyl protecting groups ; R5 is C6C14 aryl ; Y is O, S or NR' ; R' and R16 are, independently, hydrogen or C1C6 alkyl ; and Ri. is C6C14 aryl.
111. 2 The process of claim 1 wherein : Rl, Rz, R3, R6, R7, R8, Rll and R12 are methyl ; R4, R9, R14 are tbutyldimethylsilyl ; R, is pmethoxyphenyl ; R, 3 is ethyl ; R16 is hydrogen ; and Y, Z1 and Z2 are O.
112. 3 The process of claim 1 wherein said base is sodium hexamethyldisilazide or nbutyllithium with hexamethylphosphoramide.
113. 4 A process for producing an alkene of the formula : comprising : contacting a vinyl halide of formula : with an organometallic compound of formula : wherein : R1, R2, R3, R6, R and R8 are, independently, ClClo alkyl ; M is Li, Cu, Mg, or Zn ; X is a halogen ; Z1 and Z2 are, independently, O, S or NR' ; R4 and Rg are, independently, acid labile hydroxyl protecting groups ; R5 is C6C14 aryl; R'is hydrogen or C1C6 alkyl ; and Rio is an acid stable hydroxyl protecting group.
114. 5 The process of claim 4 wherein Rl, R2, R3, R6, R7 and Ra are, independently, C1C4 alkyl.
115. 6 The process of claim 4 wherein : Rl, R2, R3, R6, R7 and Rg are methyl ; X is iodide ; Z1 and Z2 are 0 ; R4 and Rg are tbutyldimethylsilyl ; R5 is pmethoxyphenyl ; and Rio is pmethoxybenzyl.
116. 7 The process of claim 4 wherein M is Li.
117. 8 A process of producing a lactone of the formula : comprising : (a) contacting a diene of the formula with an organometallic compound of the formula : or (b) contacting an organometallic compound having formula : with a vinyl halide having formula : wherein : Rl, R2, R3, R6, R7, R8, R11, R12 and R13 are, independently, ClClo alkyl ; M is Li, Cu, Mg, or Zn ; X is a halogen ; Z, Z1 and Z2 are, independently, O, S or NR' ; R4, R9, R14 and R 15are, independently, acid labile hydroxyl protecting groups ; R5 is C6C14 aryl ; R'and R16 are, independently, hydrogen or ClC6 alkyl ; and R24 is hydrogen ; and R25 is hydrogen or an acid stable hydroxyl protecting group.
118. A process of producing a diene of the formula : comprising contacting a phosphonium salt of the formula : with base and an alkylthiol of the formula : wherein : R6, R7, R8, R11, R12 and R13 are, independently, C1ClO alkyl ; X is a halogen ; Z is 0, S or NR' ; R9, R14, and R 15 are, independently, acid labile hydroxyl protecting groups ; Y is O, S or NR'; R'and R16 are, independently, hydrogen or ClC6 alkyl ; and R18 is C6C14 aryl.
119. Deleted.
120. Deleted.
121. Deleted.
122. Deleted.
123. Deleted.
124. Deleted.
125. Deleted.
126. Deleted.
127. Deleted.
128. Deleted.
129. Deleted.
130. Deleted.
131. Deleted.
132. Deleted.
133. Deleted.
134. A compound of the formula : wherein R11, R12 and R13 are, independently, C1C10 alkyl; R14 and R15 are, independently, acid labile hydroxyl protecting groups ; Y is 0, S or NR' ; and R'and R16 are, independently, hydrogen or ClC6 alkyl.
135. The compound of claim 25 wherein Rll, R12 and R13 are, independently, C1C4 alkyl.
136. The compound of claim 26 wherein R1l and R12 are methyl.
137. The compound of claim 26 wherein R13 is ethyl.
138. The compound of claim 25 wherein R14 and R15 are t butyldimethylsilyl.
139. The compound of claim 25 wherein Y is O and R16 is hydrogen.
140. The compound of claim 25 wherein : Ril and R12 are methyl ; R13 is ethyl ; R14 and Ri. are tbutyldimethylsilyl ; Y is O ; and R16 is hydrogen.
141. Deleted.
142. Deleted.
143. Deleted.
144. Deleted.
145. Deleted.
146. A compound of the formula : wherein R6, R7, and R8 are, independently, ClCl, alkyl ; X is halogen ; Rg is an acid labile hydroxyl protecting groups ; and R18 is C6Cl4 aryl.
147. A compound of the formula : wherein : R6, R7, R8, R11, R12 and R13 are, independently, ClClo alkyl ; X is a halogen ; M is Li, Cu, Mg, or Zn ; Z is 0, S or NR' ; Rg, R14, and R15 are, independently, acid labile hydroxyl protecting groups ; and R'and R16 are, independently, hydrogen or C1C6 alkyl.
148. Deleted.
149. Deleted.
150. A compound of the formula where R30 is substituted or unsubstituted C1ClO alkyl or a moiety of one of the formulas : where A is ClC20 alkyl, CH2NH (T) or a moiety of the formula wherein T is peptide having 1 to about 10 amino acids ; R32, R40, R42, R43, R46, R47, and R48 are, independently, hydrogen or ClC6 alkyl ; R41 is a side chain of an amino acid ; Wi and W2 are, independently,OR49 orNHP1 ; P1 is hydrogen or an amine protecting group ; R33 and R36 are, independently, hydrogen, C 1C 10 alkyl,OR50, =0 or together form CH2CH2; R34 and R35 are, independently, hydrogen or together formC (H) =C (H)C (H) =C (H) ; R39 is OR51 or CH2R51; R31 and R44 are, independently, ClClo alkyl ; Q1 and Q2 are, independently, hydrogen, ORQ, NHR52, OC(=O) NH2 or together form OC(O)NH; RQ is hydrogen or a hydroxyl protecting group ; R51 is substituted or unsubstituted C6C14 aryl, tetrahydropyranyl, furanosyl, pyranosyl, C3C10 lactonyl or 2pyranonyl ; R45 is ClC6 alkenyl, C1C6 alkyl, C6C14 aryl, C2ClO heterocycloalkyl, C3C10 cycloalkyl, or C7C15 aralkyl ; and R49, R50, and R52 are, independently, hydrogen or ClC6 alkyl.
151. The compound of claim 41 wherein R30 is substituted or unsubstituted C1Clo alkyl.
152. The compound of claim 42 wherein said alkyl is ethyl.
153. The compound of claim 41 wherein R30 is a moiety of the formula :.
154. The compound of claim 44 wherein : R40 and R42 are hydrogen ; R43 is ClC6 alkyl ; and Wi and W2 are, independently,NHP1.
155. The compound of claim 45 wherein R43 is methyl.
156. The compound of claim 41 wherein R30 is of the formula :.
157. The compound of claim 47 wherein A is C1Clo alkyl.
158. The compound of claim 48 wherein said alkyl is methyl.
159. The compound of claim 47 wherein A is CH2NH (T).
160. The compound of claim 47 wherein A is of the formula :.
161. The compound of claim 51 wherein R46, R47, and R48 are hydrogen.
162. The compound of claim 51 wherein at least one of R46, R47, and R48 is methyl.
163. The compound of claim 51 wherein Q1 is ORQ and Q2 is hydrogen.
164. The compound of claim 51 wherein Q1 is hydrogen and Q2 is ORQ.
165. The compound of claim 51 wherein Q1 is OC (=O) NH2.
166. The compound of claim 51 wherein Q1 and Q2 together form OC(O)NH.
167. The compound of claim 51 wherein R45 is ClC6 alkenyl.
168. The compound of claim 58 wherein said alkenyl is 1, 3butadienyl.
169. The compound of claim 58 wherein said alkenyl is 3, 4epoxylbutenyl.
170. The compound of claim 51 wherein R45 is ClC6 alkyl.
171. The compound of claim 61 wherein said alkyl is butyl.
172. The compound of claim 51 wherein R45 is C6C14 aryl.
173. The compound of claim 63 wherein said aryl is phenyl.
174. The compound of claim 51 wherein R45 is C7C15 arylalkyl. The compound of claim 65 wherein said arylakyl is benzyl. The compound of claim 51 wherein R45 is C2C10 heterocycloalkyl. The compound of claim 67 wherein said heterocycloalkyl is oxazol2ylmethyl. The compound of claim 67 wherein said heterocycloalkyl is thiazol2ylmethyl. The compound of claim 51 wherein R45 is CgCm cycloalkyl. The compound of claim 70 wherein said cycloalkyl is 2 (cyclopropyl) cyclopropyl. The compound of claim 41 wherein R39 isOR51 where R51 is substituted or unsubstituted C6 C14 aryl, tetrahydropyranyl, furanosyl, pyranosyl, C3C1O lactonyl or 2pyranonyl. The compound of claim 41 wherein R39 isCH2 R51 where R15 is substituted or unsubstituted C6C14 aryl, tetrahydropyranyl, furanosyl, pyranosyl, C3Clo lactonyl or 2pyranonyl. The compound of claim 41 wherein R51 is substituted or unsubstituted C6C14 aryl. The compound of claim 74 wherein said aryl is selected from the group consisting of pyridin2yl, pyridin3yl, pyridin4yl, naphthal1yl, naphthal2yl, phenyl, (3 hydroxy5methoxy2, 4dimethyl) phenyl, (3 methoxy2, 4dimethyl) phenyl, (3hydroxy2, 4 Amemded sheet (Article 19) dimethyl) phenyl, (5methoxy2, 4 dimethyl) phenyl, (5methoxy2methyl) phenyl, (2, 4dimethyl) phenyl, (4methyl) phenyl, (2 methyl) phenyl and (5methoxy4 methyl) phenyl.
175. 76 The compound of claim 41 wherein R51 is substituted or unsubstituted tetrahydropyranyl.
176. 77 The compound of claim 76 wherein said tetrahydropyranyl is (4hydroxy3, 5 dimethyl) tetrahydropyran2yl.
177. The compound of claim 41 wherein R51 is a substituted or unsubstituted furanosyl or pyranosyl.
178. The compound of claim 78 wherein said pyranosyl is selected from the group consisting of tetramethylfucosyl, tetramethylmannosyl, tetramethylgaractosyl and tetramethylglucosyl.
179. The compound of claim 41 wherein R51 is substituted or unsubstituted C3ClO lactonyl.
180. The compound of claim 80 wherein said lactonyl is substituted or unsubstituted b valerolactonyl.
181. The compound of claim 81 wherein said b valerolactonyl is of the formula : wherein R60 and R62 are, independently, ClClo alkyl ; and R61 is hydrogen or ClC6 alkyl.
182. The compound of claim 82 wherein R60 and R62 are methyl and R61 is hydrogen.
183. The compound of claim 41 wherein R51 is substituted or unsubstituted 2pyranonyl.
184. The compound of claim 84 wherein said 2 pyranonyl is selected from the group consisting of moieties of the formula : wherein Q1 is hydrogen or ZR65 ; Z is 0, NH or S ; and R63, R64, and R65 are, independently, hydrogen or ClC6 alkyl.
185. The compound of claim 84 wherein said 2 pyranonyl is of the formula :.
186. The compound of claim 85 wherein Q1 is hydrogen.
187. The compound of claim 85 wherein Q1 is ZR65 where Z is O and R65 is hydrogen.
188. The compound of claim 85 wherein at least one of R63 and R64 is methyl.
189. The compound of claim 84 wherein said 2 pyranonyl is of the formula :.
190. The compound of claim 89 wherein Q1 is hydrogen.
191. The compound of claim 89 wherein Q1 is ZR65 where Z is O and R65 is hydrogen.
192. The compound of claim 89 wherein at least one of R63 and R64 is methyl.
193. The compound of claim 41 wherein R44 are methyl.
194. The compound of claim 41 wherein R42 is hydrogen.
195. The compound of claim 41 wherein R34 and R35 are hydrogen.
196. The compound of claim 41 wherein R34 and R35 together formC (H) =C (H)C (H) =C (H).
197. The compound of claim 41 wherein R41 is methyl.
198. The compound of claim 41 wherein R36 is hydrogen.
199. The compound of claim 41 wherein R36 is methyl.
200. The compound of claim 41 wherein R36 isORso where Rso is hydrogen or C1C6 alkyl.
201. The compound of claim 41 wherein R36 is =O.
202. The compound of claim 41 wherein R33 and R36 together form CH2CH2.
203. A compound of the formula : wherein R70 and R72 are, independently, ClClo alkyl ; R71 is hydrogen or an acid labile hydroxyl protecting group ; R., is hydrogen or an acid labile hydroxyl protecting group ; R75 is C2C10 alkenyl ; Y is 0, S or NR' ; Z is 0, S or NR' ; each R'is independently, hydrogen or C1C6 alkyl ;.
204. A compound of the formula : wherein R80 is C2C1O alkenyl ; R81, R83 and R85 are, independently, ClCl, alkyl ; R82 is hydrogen or an acid stable hydroxyl protecting group ; R84 is hydrogen or an acid labile hydroxyl protecting group ; R86 is Clcalo alkenyl or C6C14 aryl.
205. A method for inhibiting mammalian cell proliferation, comprising contacting mammalian cells with a compound according to claim 41.
206. A method for treating a mammal suffering from undesired cell proliferation, comprising administering to said mammal the composition of claim 41.
207. A method for inhibiting rejection of a transplanted organ in a mammal, comprising administering to a compound according to claim 41 to a mammalian organ recipient.
208. A method for treating a mammal suffering from rejection of transplanted organ, comprising administering a compound according to claim 41 to said mammal.
209. A composition comprising a compound according to claim 41 in admixture with and a pharmaceuticallyacceptable carrier or excipient.
Description:
SYNTHETIC TECHNIQUES AND INTERMEDIATES FOR POLYHYDROXY, DIENYL LACTONES AND MIMICS THEREOF GOVERNMENT SUPPORT Certain of the inventors were supported by National Institutes of Health Grant GM-29028.

FIELD OF THE INVENTION This invention relates to lactone-containing compounds such as discodermolide, to compounds which mimic the chemical and/or biological activity thereof, and to methods and intermediates useful in their preparation.

BACKGROUND OF THE INVENTION In 1990, Gunasekera and co-workers at the Harbor Branch Oceanographic Institute reported the isolation of (+)-discodermolide (1), an architecturally novel metabolite of the marine sponge Discodermia dissoluta (0. 002% w/w). (See, Gunasekera, et al., J. Org. Chem. 1990, 55, 4912. Correction : J. Org. Chem. 1991, 56, 1346).

Initial studies revealed that (+)-discodermolide suppresses both the two-way mixed-lymphocyte reaction and the concanavalin A-induced mitogenesis of murine splenocytes in vitro with no associated cytotoxicity. Moreover, (+)-1 suppresses the in vivo graft-vs.-host splenomegaly response induced by injection of parental splenocytes into F1 recipient mice, with potency intermediate between those of cyclosporin A and FK506. (Longley, et al., Transplantation 1991, 52, 650 ; Longley, et al., Transplantation 1991, 52, 656 ; Longley, et al.

Ann. N. Y. Acad. Sci. 1993, 696, 94). These findings stimulated the recent discovery that (+)-1 arrests cell development at the M phase by binding and stabilizing mitotic spindle microtubules ; thus discodermolide resembles taxol in its mode of action, but the microtubule binding affinity of 1 is much higher. (ter Haar, et al., Biochemistry 1996, 35, 243 ; Hung, et al., Chemi. & Biol. 1996, 3, 287). These and other results suggest that (+)-discodermolide holds considerable promise as an anticancer agent. The scarcity of natural material however has precluded a complete evaluation of its biological profile.

The absolute configuration of discodermolide remained undefined until Schreiber et al. synthesized both antipodes of 1. (Nerenberg, et al. J. Am. Chem. Soc. 1993, 115, 12621 ; Hung, et al., Chem. & Biol. 1994, 1, 67). Interestingly, the unnatural (-) antipode also displays significant immunosuppressant activity.

There is, therefore, a need for improved synthetic methods for the preparation of polyhydroxy, dienyl lactones such as the discodermolides, as well as a need for compounds having similar chemical and/or biological activity.

OBJECTS OF THE INVENTION It is one object of the present invention to provide polyhydroxy, dienyl lactones and mimics thereof.

It is a further object to provide processes for the preparation of such compounds and their mimics.

It is another object of this invention to provide intermediates useful in such processes.

SUMMARY OF THE INVENTION These and other objects are satisfied by the present invention, which, in one aspect, provides synthetic methods for the discodermolides and other polyhydroxylactones. In preferred embodiments, such methods involve contacting a phosphonium salt of formula I : with base and an alkylthiol of formula II : to form a diene of formula III :

wherein : Ri R2, R3, R6, R7, R8, , R12 and R13 are, independently, C1-Cl0 alkyl ; X is a halogen ; Z, Z1, and Z2 are, independently, 0, S or NR' ; R4, R9, R14, and R15 are, independently, acid labile hydroxyl protecting groups ; Rs is C6-C14 aryl ; Y is 0, S or NR' ; R' and R16 are, independently, hydrogen or C1-C6 alkyl ; and R18 is C6-C14 aryl.

In another aspect, the methods of the invention involve producing an alkene of formula IV.

This can be accomplished by contacting an organometallic reagent of formula Va : with a vinyl halide of formula VIa :

wherein M is Li, Cu, Mg, or Zn and Rlo is an acid stable hydroxyl protecting group and all other variables are as defined above. Alternatively, a vinyl halide of formula Vb : can be contacted with an organometallic compound of formula VIb :

In yet another aspect, the methods of the invention involve lactones having formula VII. by contacting a diene of formula Villa :

with an organometallic compound having formula Va wherein R24 is hydrogen and R,, is hydrogen or an acid stable hydroxyl protecting group. Alternatively, an organometallic compound having formula VIIIb can be contacted with a vinyl halide having formula Vb.

The methods of the invention also involve producing dienes having formula Villa by contacting phosphonium salts having formula IX :

with base and alkylthiol compounds having formula II.

The present invention also provides synthetic intermediates which are useful in the preparation of polyhydroxylactones, including the compounds having formulas I-IX and X : wherein : R19, I R20 R21 and R22 are, independently, Cl-ClO alkyl ; and R23 is Cy-Cis aralkyl.

The present invention also provides compounds which mimic the chemical and/or biological activity of the discodermolides. In preferred embodiments, such compounds have formula XI :

where R30 is substituted or unsubstituted C1-C10 alkyl or a moiety formula XII or XIII : where A is C1-C20 alkyl, -CH2NH (T) or a moiety of formula XIV : wherein

T is peptide having 1 to about 10 amino acids ; R32, R40, R42, R43, R46, R47, and R48 are, independently, hydrogen or C1-C6 alkyl ; R41 is a side chain of an amino acid ; Wi and W2 are, independently,-OR49 or-NHP1 ; Pi is hydrogen or an amine protecting group ; R33 and R36 are, independently, hydrogen, C1-C10 alkyl, -OR50, =O or together form-CH2-CH2-; R34 and R35 are, independently, hydrogen or together form-C (H) =C (H)-C (H) =C (H)- ; R39 is-ORs1 or-CH2-R51 ; R3. and R44 are, independently, C1-Cl0 alkyl ; Q1 and Q2 are, independently, hydrogen,-ORQ,-NHRS, -OC(=O) NH2 or together form -O-C(O) -NH-; RQ is hydrogen or a hydroxyl protecting group ; R, l is substituted or unsubstituted C6-C14 aryl, tetrahydropyranyl, furanosyl, pyranosyl (e. g., tetramethylfucosyl, tetramethylmannosyl, tetramethylgaractosyl and tetramethylglucosyl), C3-C10 lactonyl or 2-pyranonyl ; R45 is Cl-C6 alkenyl, Cl-C6 alkyl, C6-C14 aryl, C2-C10 heterocycloalkyl, C3-C10 cycloalkyl, or C7-C15 aralkyl; and R49, R50, and R12 are, independently, hydrogen or Cl-C6 alkyl.

The present invention also provides methods for inhibiting mammalian cell proliferation by contacting mammalian cells with a compound according to the invention or by administering a compound according to the invention (or a pharmaceutical composition comprising such a compound) to a mammal suffering from undesired cell proliferation. Also provided are methods for inhibiting rejection of a transplanted organ in a mammal comprising administering a compound or composition according to the invention to a mammalian organ recipient.

BRIEF DESCRIPTION OF THE DRAWINGS The numerous objects and advantages of the present invention may be better understood by those skilled in the art by reference to the accompanying figures, in which : Figure 1 shows a retrosynthetic analysis for (-)- discodermolide 1.

Figure 2 shows a synthetic scheme for compound 5.

Figure 3 shows a synthetic scheme for fragment A.

Figure 4 shows a synthetic scheme for compound 22.

Figure 5 shows a synthetic scheme for compound 39.

Figure 6 shows a synthetic scheme for compounds 15 and 25.

Figure 7 shows a synthetic scheme for compound 34.

Figure 8 shows a synthetic scheme for fragment C.

Figure 9 shows a synthetic scheme for fragment B.

Figure 10 shows a synthetic scheme for compound 39.

Figure 11 shows a synthetic scheme for compound 40.

Figure 12 shows a synthetic scheme for compound 49.

Figure 13 shows a synthetic scheme for compounds 53 and 46.

Figure 14 shows a synthetic scheme for compound 56.

Figure 15 shows a synthetic scheme for compound 1.

Figure 16 shows a synthetic scheme for compound 104.

Figure 17 shows a synthetic scheme for compound 107.

Figure 18 shows a synthetic scheme for compound 206.

Figure 19 shows a synthetic scheme for compound 212.

Figure 20 shows a synthetic scheme for compound 217.

Figure 21 shows a synthetic scheme for compound 305.

Figure 22 shows a synthetic scheme for compound 309.

Figure 23 shows a synthetic scheme for compound 401.

Figure 24 shows a synthetic scheme for compound 501.

Figure 25 shows a synthetic scheme for compound 601.

Figure 26 shows a synthetic scheme for compound 701 (R = alkyl).

Figure 27 shows a synthetic scheme for compound 808.

Figure 28 shows a synthetic scheme for compound 801.

Figure 29 shows a synthetic scheme for compound 901.

Figure 30 shows a synthetic scheme for compound 1003.

Figure 31 shows a synthetic scheme for compound 1104 (Ar = 2, 4-dimethyl-3-methoxyphenyl (a), 2-methyl-5- methoxyphenyl (b), 2, 4-dimethyl-5-methoxyphenyl (c), 2, 4- dimethylphenyl (d), and 4-methylphenyl (e)).

Figure 32 shows a synthetic scheme for compound 1111.

Figures 33-36 show representative compounds of the invention.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS It has been found in accordance with the present invention that the synthesis of polyhydroxy, dienyl lactones such as the discodermolides can be achieved by highly convergent and stereocontrolled synthetic procedures.

As shown in Figure 1 for the (-)-discodermolide antipode, our analysis revealed a repeating triad of contiguous stereocenters, separated by Z-olefinic linkages at C (8, 9) and C (13, 14). Disconnections at C (8, 9), C (14, 15) and C (21, 22) generated fragments A, B and C, each deriving in turn from a common precursor (5) containing the recurring stereochemical triad.

As shown in Figure 2, precursor 5 was prepared by a synthetic procedure whereby hydroxy ester (-)-6 was protected as the p-methoxybenzyl (PMB) ether by treatment with the Bundle trichloroimidate reagent 7 under acidic conditions. Reduction with LiAlH4 provided the alcohol (-)-8 after distillation.

Swern oxidation, Evans aldol condensation, and Weinreb amide formation completed the construction of common precursor (+)-5.

This concise five-step synthesis could be routinely carried out on a 50-g scale in 59% overall yield.

In view of the polypropionate structure of the A fragment, we performed a second asymmetric aldol reaction, as shown in Figure 3. Initial formation of the p-methoxybenzylidene acetal (-)-11 from common precursor (+)-5 (78W yield) was designed to allow selective deprotection of C (21) and C (19) hydroxyls for introduction of the terminal diene and carbamate moieties. Following reduction of amide

(-)-11 to the aldehyde (80W yield), (aldol reaction with oxazolidinone (+)-9 (80% yield) provided alcohol (+)-13 which incorporated the five stereocenters of subunit A. The structure of (+)-13 was confirmed by single-crystal X-ray analysis. Protection of the secondary alcohol as the TBS ether and removal of the chiral auxiliary (LiBH4, EtOH, THF) afforded primary alcohol (-)-15 (81% yield, two steps), which could be efficiently converted either to tosylate (-)-16 or iodide (-) A.

As outlined in Figure 1, our strategy required a Z vinylic halide B for coupling with fragment A. Beginning again with the common precursor (+)-5, TBS protection (Figure 4) followed by reduction of the Weinreb amide [DIBAL (2 equiv), THF,-78 °C] (Kim, et al., Tetrahedron Lett. 1989, 30, 6697) 16 afforded aldehyde (+)-18 in 88% yield for the two steps. We adopted a stepwise approach to introduction of the vinyl halide, whereby (+)-18 was converted to the Z a-bromo unsaturated ester (-)-19 (Ph3PCBrCO2Et, PhH, reflux ; 75% yield after chromatography). Reduction to allylic alcohol (-)-20 followed by mesylation and displacement with LiBHEt3 then furnished Z vinyl bromide (-)-22 in 77% overall yield from 19.

Our preferred synthetic strategy involves selective removal of a primary PMB ether in the presence of a PMP acetal in the AB coupling product ( (-)-39, Figure 5). A 1 : 1 mixture of PMB ether (-)-22 and PMP acetal (-)-15 was exposed to DDQ (1. (Figure 6) The acetal (-)-15 largely remained intact while the debenzylated alcohol (-)-25 was formed in 83% yield.

As shown in Figure 7, we again utilized the TBS ether (+)-17 for the preparation of C from common precursor (+)-5.

Oxidative cleavage of the PMB group (DDQ, CH2Cl2, H2O) provided alcohol 26 in variable (60-860) yields, accompanied by the corresponding lactone. Debenzylation with Pearlman's catalyst afforded (+)-26 in 92% yield. Exposure of the alcohol to SO3. pyr furnished aldehyde (+)-27 (98W yield), which in turn was converted to dithiane (+)-28 (79%). In the latter step, our modification of the Evans protocol for dithiane generation

[ (TMSSCHZ) zCH2, ZnCl2, Et2O] minimized elimination of the TBS ether to form the α, (3-unsaturated amide. Following reduction to aldehyde (+)-29 with DIBAL (91W yield), dimethyl acetal formation gave (+)-30 (99%). The coupling of dithiane 30 with R- (-)-glycidyl benzyl ether [(-)-31] then afforded alcohol (-)-32 in 79% yield. Unmasking of the ketone moiety [(CF3CO2) 2IPh, 80W] and Evans stereocontrolled reduction (970) provided the anti diol (-)-34, which embodied all of the stereocenters in fragment C.

Acid-catalyzed cyclization of (-)-34 (TsOH, room temperature) provided methoxy pyran 35 in 87% yield as a 1 : 2 mixture of and ß anomers (Figure 8). Debenzylation (H2, Pd/C) of 36 afforded alcohol 37 quantitatively. Exposure to EtSH and MgBr2 in Et2O then gave a separable 6 : 1 mixture ouf 6 ethyl hemithioacetal (+)-38 and its a anomer in 83% yield. Swern oxidation of (+)-38 furnished the final fragment (+)-C in 86% yield.

Synthesis of the desired B segment (-)-B preferably was achieved by direct olefination of aldehyde (+)-18 (41t, 6 : 1 Z/E) (Figure 9), followed by chromatographic removal of the undesired E cross coupling product. Reaction of (-)-B with the organozinc derivative of (-)-A (Figure 10) was achieved by premixing iodide A with dried solid ZnCl2 (ether,-78 °C) before addition of t-BuLi. It is believed that three equivalents of t-BuLi are required for complete consumption of (-)-A, probably because the first equivalent reacts with ZnCl2.

This modification increased the yield to 66% after flash chromatography.

Conversion of the Z trisubstituted olefin (-)-39 to the phosphonium iodide (-)-49 began with selective removal of the PMB group, as in our model study (DDQ, CH2Cl2, H2O), furnishing (-)-40 in 87% yield (Figure 11). As shown in Figure 12, alcohol (-)-40 furnished the requisite iodide 42 almost exclusively, as indicated by NMR examination of the crude material. The very sensitive iodide was used without purification. Thorough mixing of iodide 42 with i-Pr2NEt (3 equiv) followed by exposure to excess PPh3 (15 equiv) without

solvent at 80 °C generated (-)-49 in 37% yield for the two steps. The major by-product was characterized as (-)-50 (35% yield). The unsaturated model alcohol (+)-44 similarly afforded the Wittig salt (+)-46 in low yield (Figure 13), whereas the saturated derivative (+)-51 gave phosphonium iodide (+)-53 almost quantitatively.

As shown in Figure 14, assembly of the discodermolide backbone entailed Wittig coupling of aldehyde C with the ylide derived from AB phosphonium salt (-)-49 to install the C (8, 9) Z alkene in (-)-54 (>49 : 1 Z/E, 76% yield). DIBAL reduction (88% yield) followed by oxidation of the resultant primary alcohol (-)-55 then produced aldehyde (-)-56 (960). The terminal Z diene (-)-57 was elaborated via the Yamamoto protocol in 70% yield with excellent selectivity (16 : 1 Z/E).

After flash chromatography, hydrolysis of the hemithio acetal and mild DMSO/Ac2O oxidation provided lactone (-)-58 in 82% yield for the two steps. Removal of the PMB group (DDQ, CH2Cl2, H2O, 95k yield) and carbamate formation (C13CONCO, CH2Cl2, neutral Al203, 830) afforded tris (TBS ether) (-)-60.

Final deprotection with 48% HF/CH3CN (1 : 9) furnished (-)-discodermolide, identical with an authentic sample (Figure 15).

Preferred processes according to the invention involve contacting a phosphonium salt of formula I with base and an alkylthiol of formula II : to form a diene of formula III :

wherein : R1, R2, R3, R6, R7, R8, R11, R12 and R13 are, independently, C1-C10 alkyl ; X is a halogen ; Z, Z1, and Z2 are, independently, 0, S or NR' ; R4, Rg, R14, and R15 are, independently, acid labile hydroxyl protecting groups ; Rs is C6-C14 aryl ; Y is 0, S or NR' ; R'and R16 are, independently, hydrogen or Cl-C6 alkyl ; and RI, is C6-C14 aryl.

Such procedures preferably are run in solvents such as tetrahydrofuran at-78 °C-0 °C. Suitable bases for such procedures include sodium hexamethyldisilazide, potassium hexamethyldisilazide, and n-butyllithium with hexamethylphosphoramide.

Alkyl groups according to the invention include but are not limited to straight chain and branched chain hydrocarbons such as methyl, ethyl, propyl, pentyl, isopropyl, 2-butyl, isobutyl, 2-methylbutyl, and isopentyl moieties having 1 to about 10 carbon atoms, preferably 1 to about 6 carbon atoms. Cycloalkyl groups are cyclic hydrocarbons having 3 to about 10 carbon atoms such as cyclopentyl and cyclohexyl groups. Heterocycloalkyl groups are cycloalkyl groups which include at least one heteroatom (i. e., an atom which is not carbon, such as 0, S, or N) in their cyclic backbone. Alkenyl groups according to the invention are straight chain or branched chain hydrocarbons that include one or more carbon- carbon double bonds. Preferred alkenyl groups are those having 2 to about 10 carbon atoms. Alkyl, cycloalkyl, heterocycloalkyl, and alkenyl groups according to the invention optionally can be unsubtituted or can bear one or more substituents such as, for example, halogen hydroxyl, amine, and epoxy groups.

Aryl groups according to the invention are aromatic and heteroaromatic groups having 6 to about 14 carbon atoms, preferably from 6 to about 10 carbon atoms, including, for example, naphthyl, phenyl, indolyl, and xylyl groups and substituted derivatives thereof, particularly those substituted with amino, nitro, hydroxy, methyl, methoxy, thiomethyl, trifluoromethyl, mercaptyl, and carboxy groups. Alkaryl groups are groups that contain alkyl and aryl portions and are covalently bound to other groups through the alkyl portion, as in a benzyl group.

Protecting groups are known per se as chemical functional groups that can be selectively appended to and removed from functionality, such as hydroxyl and amine groups, present in a chemical compound to render such functionality

inert to certain chemical reaction conditions to which the compound is expose. See, e. g., Greene and Wuts, Protective Groups in Organic Synthesis, 2d edition, John Wiley & Sons, New York, 1991. Numerous hyroxyl protecting groups are known in the art, including the acid-labile t-butyldimethylsilyl, diethylisopropylsilyl, and triethylsilyl groups and the acid- stable aralkyl (e. g., benzyl), triisopropylsilyl, and t- butyldiphenylsilyl groups. Useful amine protecting groups include the allyloxycarbonyl (Alloc), benzyloxycarbonyl (CBz), chlorobenzyloxycarbonyl, t-butyloxycarbonyl (Boc), fluorenylmethoxycarbonyl (Fmoc), isonicotinyloxycarbonyl (i-Noc) groups.

The methods of the invention involve also are directed to the synthesis of alkenes of formula IV : by contacting organometallic reagents of formula Va : with vinyl halides of formula VIa :

wherein M is Li, Cu, Mg, or Zn, and R1o is an acid stable hydroxyl protecting group. Alternatively, a vinyl halide of formula Vb : is contacted with an organometallic compound of formula VIb :

Such reactions preferably are performed in the presence of a palladium-containing catalyst such as Pd (PPh3) 4, Pd (Cl2) (PPh3) 2 g Pd(Cl2) (dppf)2.

In yet another aspect, the synthetic methods of the invention are directed to the preparation of lactones having formula VII : by contacting a diene of formula Villa :

with an organometallic compound having formula Va wherein R24 is hydrogen and R25 is hydrogen or an acid stable hydroxyl protecting group. Alternatively, an organometallic compound having formula VIIIb is contacted with a vinyl halide having formula Vb.

The reaction of compounds having formulas V and VIII preferably is performed in ether in the presence of a palladium-or nickel-containing catalyst.

The methods of the invention also involve producing dienes having formula Villa by contacting phosphonium salts having formula IX :

with a base such as sodium hexamethyl disilazide and an alkylthiol compound having formula II. Such procedures preferably are run in solvents such as tetrahydrofuran at-78 °C-0 °C. Suitable bases for such procedures include sodium hexamethyldisilazide, potassium hexamethyldisilazide, and n- butyllithium with hexamethylphosphoramide.

Although preferred synthetic methods are those directed to (+)-discodermolide and compounds having like stereochemistry, those skilled in the art will recognize that the methods disclosed herein can be readily adapted to the synthesis of antipodal compounds such as, for example, (-)- discodermolide, and vice versa. All such synthetic methods are within the scope of the present invention.

The present invention provides compounds which mimic the chemical and/or biological activity of the discodermolides.

In preferred embodiments, such compounds have formula XI : where R30 is substituted or unsubstituted C,-C,,, alkyl or a moiety formula XII or XIII : where A is C1-C20 alkyl, -CH2NH (T) or a moiety of formula XIV :

wherein T is peptide having 1 to about 10 amino acids ; R32, R40, R42, R43, R46, R47, and R48 are, independently, hydrogen or C1-C6 alkyl ; R41 is a side chain of an amino acid ; Wi and W2 are, independently, -OR49 or-NHP1 ; P1 is hydrogen or an amine protecting group ; R33 and R36 are, independently, hydrogen, C1-Cl0 alkyl, -OR50, =O or together form -CH2-CH2- ; R34 and R3s are, independently, hydrogen or together form-C (H) =C (H)-C (H) =C (H)- ; R39 is-ORs1 or -CH2-R51 ; R31 and R44 are, independently, C1-C10 alkyl ; Q1 and Q2 are, independently, hydrogen,-ORQ,-NHRsz, -OC(=O) NH2 or together form -O-C(O) -NH- ; RQ is hydrogen or a hydroxyl protecting group ; Rs1 is substituted or unsubstituted C6-C14 aryl, tetrahydropyranyl, furanosyl, pyranosyl, C3-C10 lactonyl or 2- pyranonyl ; R45 is C1-C6 alkenyl, C1-C6 alkyl, C6-C14 aryl, C2-C10 heterocycloalkyl, C3-C10 cycloalkyl, or C7-C15 aralkyl ; and

R49, R50, and Rs2 are, independently, hydrogen or C1-C6 alkyl.

Some preferred compounds having formula XI are shown in Figures 33-36.

The term amino acid as used herein is intended to include all naturally-occurring and synthetic amino acids known in the art. In general, amino acids have structure H2N-CH (Rc) - C (O) OH where Ré is the amino acid side chain. Representative, naturally-occurring side chains are shown in Table 1.

TABLE 1 <BR> <BR> CH3-CH3-CH2-S-CH2-CH2-<BR> HO-CH,-HO-CH2-CH2- C6H5-CH2- CH3-CH2(OH) - HO-C6H5-CH,-HO2C-CH2-NH, C (0)-CH2- CH3-CH2-CH(CH3) - HS-CH,-CH,-CH,-CH,-CH,- HO2C-CH(NH2)-CH2-S-S-CH2- H2N-CH2-CH2-CH2-CH2- CH3-CH2- CH3-S-CH2-CH2- Hydrophobic amino acid side chains are preferred, including the CH3-, C6H,-CH2-, CH3-CH2-, CH3-S-CH2-CH2-, (CH3) 2-CH-, (CH3) 2-CH- CH2-, CH3-CH2-CH (CH3)-, and CH3-CH2-CH2-CH2-side chains.

Peptides according to the invention are linear, branched, or

cyclic chemical structures containing at least 2 covalently bound amino acids.

Certain compounds of the invention contain amino groups and, therefore, are capable of forming salts with various inorganic and organic acids. Such salts are also within the scope of this invention. Representative salts include acetate, adipate, benzoate, benzenesulfonate, bisulfate, butyrate, citrate, camphorate, camphorsulfonate, ethanesulfonate, fumarate, hemisulfate, heptanoate, hexanoate, hydrochloride, hydrobromide, hydroiodide, methanesulfonate, lactate, maleate, methanesulfonate, 2-naphthalenesulfonate, nitrate, oxalate, pamoate, persulfate, picrate, pivalate, propionate, succinate, sulfate, tartrate, tosylate, and undecanoate. The salts can be formed by conventional means, such as by reacting the free base form of the product with one or more equivalents of the appropriate acid in a solvent or medium in which the salt is insoluble, or in a solvent such as water which is later removed in vacuo or by freeze drying. The salts also can be formed by exchanging the anions of an existing salt for another anion on a suitable ion exchange resin.

The compounds of the invention can be admixed with carriers, excipients, and/or diluents to form novel compositions. Such compositions can be used in prophylactic, diagnostic, and/or therapeutic techniques. By administering an effective amount of such a composition, prophylactic or therapeutic responses can be produced in a human or some other type mammal. It will be appreciated that the production of prophylactic or therapeutic responses includes the initiation or enhancement of desirable responses, as well as the mitigation, cessation, or suppression of undesirable responses.

The compositions of the invention are expected to find use, for example, in the inhibition of undesired cell proliferation (e. g., cancer) and in the inhibition of rejection in organ transplantation procedures. (See, e. g., Longley, et al., Transplantation 1991, 52, 650 and 656).

Compositions of the invention can be prepared by any of the methods well known in the pharmaceutical art, for example, as described in Remington's Pharmaceutical Sciences (Mack Pub. Co., Easton, PA, 1980). The compositions can include a compound of the invention as an active ingredient in admixture with an organic or inorganic carrier or excipient suitable, for example, for oral administration. Other suitable modes of administration will be apparent to those skilled in the art. The compound of the invention can be compounded, for example, with the usual non-toxic, pharmaceutically acceptable carriers for tablets, pellets, capsules, solutions, suppositories, suspensions, and any other form suitable for use. The carriers which can be used are water, glucose, lactose, gum acacia, gelatin, mannitol, starch paste, magnesium trisilicate, talc, corn starch, keratin, colloidal silica, potato starch, urea and other carriers suitable for use in manufacturing preparations, in solid, semisolid, or liquid form, and in addition auxiliary, stabilizing, thickening and coloring agents and perfumes may be used. The compound of the invention is included in the pharmaceutical composition in an amount sufficient to produce the desired effect upon the process or condition of diseases.

For oral administration, tablets containing various excipients such as microcrystalline cellulose, sodium citrate, calcium carbonate, dicalcium phosphate and glycine may be employed along with various disintegrants such as starch and preferably corn, potato or tapioca starch, alginic acid and certain complex silicates, together with granulation binders like polyvinylpyrrolidone, sucrose, gelatin and acacia.

Additionally, lubricating agents such as magnesium stearate, sodium lauryl sulfate and talc are often very useful for tableting purposes. Solid compositions of a similar type may also be employed as fillers in appropriately soluble (e. g., gelatin) capsules ; preferred materials in this connection also include lactose or milk sugar as well as high molecular weight polyethylene glycols.

When aqueous suspensions and/or elixirs are desired for oral administration, the active ingredient may be combined with various sweetening or flavoring agents, coloring matter or dyes, and, if so desired, emulsifying and/or suspending agents as well, together with such diluents as water, ethanol, glycerin and various like combinations thereof.

For parenteral administration, suspensions containing a compound of the invention in, for example, aqueous propylene glycol can be employed. The suspensions should be suitably buffered (preferably pH>8) if necessary and the liquid diluent first rendered isotonic. The aqueous suspensions are suitable for intravenous injection purposes. The preparation of such suspensions under sterile conditions is readily accomplished by standard pharmaceutical techniques well-known to those skilled in the art. Additionally, it is possible to administer the compounds of the invention topically and this may preferably be done by way of creams, jellies, gels, pastes, ointments and the like, in accordance with standard pharmaceutical practice.

The compounds of the invention can be employed as the sole active agent in a pharmaceutical composition or can be used in combination with other active ingredients, e. g., other agents useful in diseases or disorders.

The amount of active ingredient that is to be combined with the carrier materials to produce a single dosage form will vary depending upon the host treated and the particular mode of administration. The specific dose level for any particular patient will depend on a variety of factors including the activity of the specific compound employed, the age, body weight, general health, sex, diet, time of administration, route of administration, rate of excretion, drug combination, and the severity of the particular disease undergoing therapy.

In some instances, dosage levels below the lower limit of the aforesaid range may be more than adequate, while in other cases still larger doses may be employed without causing any harmful side effects provided that such higher dose levels are first divided into several small doses for administration throughout the day. The concentrations of the active ingredient in

therapeutic compositions will vary depending upon a number of factors, including the dosage of the drug to be administered, the chemical characteristics (e. g., hydrophobicity) of the active ingredient, and the route of administration. Typical dose ranges are from about 285 Ug/kg of body weight per day in three divided doses ; a preferred dose range is from about 42 ßg/kg to about 171 yg/kg of body weight per day. The preferred dosage to be administered is likely to depend on such variables as the type and extent of progression of the disease or disorder, the overall health status of the particular patient, the relative biological efficacy of the compound selected, and formulation of the compound excipient, and its route of administration, as well as other factors, including bioavailability, which is in turn influenced by several factors well known to those skilled in the art.

Additional objects, advantages, and novel features of this invention will become apparent to those skilled in the art upon examination of the following examples thereof, which are not intended to be limiting.

All reactions were carried out in oven-dried or flame-dried glassware under an argon atmosphere, unless otherwise noted. All solvents were reagent grade. Diethyl ether and tetrahydrofuran (THF) were freshly distilled from sodium/benzophenone under argon before use. Dichloromethane, benzene and diisopropyl amine were freshly distilled from calcium hydride before use. Triethylamine and diisopropylethylamine were distilled from calcium hydride and stored over potassium hydroxide. Hexamethylphosphoramide was freshly distilled from calcium hydride. Anhydrous pyridine, dimethylformamide and dimethyl sulfoxide were purchased from Aldrich and used without purification. n-Butyllithium and t-butyllithium were purchased from Aldrich and standardized by titration with diphenylacetic acid.

Unless stated otherwise all reactions were magnetically stirred and monitored by thin layer chromatography using 0. 25 mm E. Merck pre-coated silica gel plates. Flash column chromatography was performed with the indicated solvents

using silica gel-60 (particle size 0. 040-0. 062 mm) supplied by E. Merck. Yields refer to chromatographically and spectroscopically pure compounds, unless otherwise stated.

All melting points were determined on a Bristoline heated-stage microscope or a Thomas-Hoover apparatus and are corrected. The IR and NMR were obtained for CHCl3 and CDC13 solutions respectively unless otherwise noted. Infrared spectra were recorded with a Perkin-Elmer Model 283B spectrometer using polystyrene as an external standard. Proton NMR spectra were recorded on a Bruker AM-500 spectrometer.

Carbon-13 NMR spectra were recorded on a Bruker AM-500 or AM-250 spectrometer. Chemical shifts are reported relative to internal tetramethylsilane (d 0. 00) for proton and chloroform 6 77. 0) or benzene (6 128. 0) for carbon-13. Optical rotations were obtained with a Perkin-Elmer model 241 polarimeter in the solvent indicated. High-resolution mass spectra were obtained at the University of Pennsylvania Mass Spectrometry Service Center on either a VG micromass 70/70H high resolution double-focusing electron impact/chemical ionization spectrometer or a VG ZAB-E spectrometer. Microanalyses were performed by Robertson Laboratories, Madison, New Jersey.

Single-crystal X-ray diffraction structure determination were performed at the University of Pennsylvania using an Enraf Nonius CAD-4 automated diffractometer. High performance liquid chromatography (HPLC) was performed using a Ranin component analytical/semi-prep system.

EXAMPLE 1 Alcohol (-)-8. p-Methoxybenzyl alcohol (200 g, 1. 45 mol) was added to a suspension of NaH (60W in mineral oil ; 5. 82 g, 0. 146 mol) in anhydrous ether (450 mL) over 1 h at room temperature. The mixture was stirred for 1 h and cooled to 0 °C.

Trichloroacetonitrile (158 mL, 1. 58 mol) was then introduced over 80 min. After 1. 5 h the solution was concentrated with the water bath temperature maintained below 40 °C. The residue was treated with a mixture of pentane (1. 5 L) and MeOH (5. 6 mL),

stirred at room temperature for 30 min, and filtered through a short Celite column. Concentration gave the trichloroimidate (394. 3 g) as a red oil which was used without further purification.

A solution of (R)- (-)-Roche ester (124. 7 g, 1. 06 mol) in CH2Cl2/cyclohexane (1 : 2, 1. 5 L) was cooled to 0 °C and treated with trichloroimidate (364. 3 g) and PPTS (13. 3 g, 52. 9 mmol). After 3 h, the mixture was warmed to room temperature, stirred for 40 h, and concentrated. Filtration through a short silica column (20%-methyl acetate/hexane) afforded the ester (303. 5 g) as a slight yellow oil.

The ester (303. 5 g) was divided into three portions for the next reaction. In each preparation, solution of crude ester (112. 8 g) in anhydrous THF (1. 0 L) was cooled to 0 °C and LiAlH4 (1. 0 M in THF, 560 mL, 0. 560 mol) was added over 1 h.

The mixture was warmed gradually to room temperature and stirred for 24 h. After dilution with ether (1. 0 L) the mixture was cooled to 0 °C and quenched carefully with saturated aqueous Rochelle's salt (20 mL). The resultant mixture was then transferred to a 4-L flask, diluted with ether (1. 0 L), and treated with additional Rochelle's solution (ca.

300 mL) with shaking untill a solid precipitated. The solution was filtered, concentrated, and the residue (including the aqueous layer) was diluted with ether (700 mL), dried over Na2SO4, filtered and concentrated. The crude products of the three reactions were combined and distilled under vacuum, furnishing (-)-8 (142. 7 g, 74% yield for two steps) as a colorless oil : lul 22 D-16. 9* (c 1. 28, CHC13) ; IR (CHC13) 3510 (m), 3015 (s), 2965 (s), 2940 (s), 2920 (s), 2870 (s), 2840 (m), 1618 (s), 1590 (m), 1517 (s), 1470 (s), 1445 (m), 1423 (m), 1365 (m), 1305 (s), 1250 (s), 1178 (s), 1092 (s), 1037 (s), 826 (m), 814 (m), 718 (w), 710 (w) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 23 (d, J = 8. 6 Hz, 2 H), 6. 86 (d, J = 8. 6 Hz, 2 H), 4. 43 (ABq, J = 11. 7 Hz, A6,, = 13. 2 Hz, 2 H), 3. 78 (s, 3 H), 3. 61-3. 54 (m, 2 H), 3. 53 (ddd, J = 9. 1, 4. 7, 0. 8 Hz, 1 H), 3. 38 (dd, J = 9. 1, 7. 9 Hz, 1 H), 2. 60 (br s, 1 H), 2. 08-1. 98 (m, 1 H), 0. 90 (d, J = 7. 0 Hz, 3 H) ; 13C NMR (125 MHZ, CDC13) d 159. 2,

130. 2, 129. 2, 113. 8, 75. 0, 73. 0, 67. 7, 55. 2, 35. 6, 13. 4 ; high resolution mass spectrum (CI, NH3) m/z 210. 1252 [M+ ; calcd for C12Hl803 : 210. 1256].

Anal. Calcd for C12Hl803 : C, 68. 54 ; H, 8. 63. Found : C, 68. 41 ; H, 8. 60.

EXAMPLE 2 Aldol (+)-10.

A solution of DMSO (40. 0 mL, 564 mmol) in CHZCl2 (1. 0 L) was cooled to-78 °C and oxalyl chloride (23. 0 mL, 263 mmol) was added over 1 h. After an additional 15 min, a cooled (-78 °C) solution of alcohol (-)-8 (38. 0 g, 181 mmol) in CH2Cl2 (50 mL) was introduced via a cannula over 15 min (20 mL rinse) and the resultant milky mixture was stirred 0. 5 h further at-78 °C. i-Pr2NEt (150 mL, 861 mmol) was then added over 15 min.

The mixture was stirred for 30 min, slowly warmed to room temperature (70 min), and quenched with aqueous NaHSO4 (1. 0 M, 1. 0 L). The organic phase was concentrated, diluted with ether (500 mL), washed with water (6 x 500 mL), dried over MgSO4, filtered and concentrated to give the corresponding aldehyde (38. 0 g) as a colorless oil.

A solution of oxazolidinone (+)-9 (44. 3 g, 190 mmol) in CH2Cl2 (500 mL) was cooled to 0 C. n-Bu2BOTf (1. 0 M in CH2Cl2 199. 0 mL, 199 mmol) was introduced over 0. 5 h, followed by addition of NEt3 (30. 2 mL, 217 mmol) over 10 min. The mixture was stirred at 0 °C for 0. 5 h and cooled to-78 °C. A precooled (-78 °C) solution of the above aldehyde in CH2C12 (lOOmL) was then added via a cannula over 30 min (2 x 20mL rinse). After 2 h at-78 °C and 2 h at 0 °C, the reaction was quenched with pH 7 phosphate buffer (200 mL). The mixture was slowly treated with a solution of 30% H202 in MeOH (1 : 2, 600 mL) at 0 °C, stirred overnight at room temperature, and concentrated. The residue was extracted with ethyl acetate (3 x 250 mL) and the combined extracts were washed with saturated aqueous NaHCO3 and water (500 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (30% ethyl acetate/hexane) provided (+)-10 (70. 9 g, 89% yield from 8) as

a colorless oil : [a] 23D +278 (c 0. 49, CHC13) ; IR (CHC1,) 3470 (w, br), 3020 (m), 2980 (m), 2940 (m), 2920 (m), 2880 (m), 1790 (s), 1705 (m), 1620 (m), 1590 (w), 1520 (m), 1485 (w), 1460 (m), 1390 (m), 1360 (m), 1305 (w), 1230 (br, s), 1110 (m), 1080 (m), 1035 (m), 985 (m), 970 (m), 820 (w), 695 (w) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 33-7. 30 (m, 2 H), 7. 27-7. 19 (m, 5 H), 6. 85 (d, J = 8. 7 Hz, 2 H), 4. 67-4. 63 (m, 1 H), 4. 42 (apparent s, 2 H), 4. 14 (apparent d, J = 5. 0 Hz, 2 H), 3. 93 (qd, J = 6. 9, 3. 4 Hz, 1 H), 3. 85 (ddd, J = 8. 2, 3. 1, 3. 1 Hz, 1 H), 3. 78 (s, 3 H), 3. 69 (d, J = 2. 8 Hz, 1 H), 3. 54 (apparent t, J = 9. 3 Hz, 1 H), 3. 54 (dd, J = 21. 1, 9. 2 Hz, 1 H), 3. 28 (dd, J = 13. 4, 3. 2 Hz, 1 H), 2. 76 (dd, J = 13. 4, 9. 6 Hz, 1 H), 1. 98-1. 93 (m, 1 H), 1. 25 (d, J = 6. 9 Hz, 3 H), 0. 94 (d, J = 7. 0 Hz, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 176. 1, 159. 2, 153. 0, 135. 3, 129. 9, 129. 3, 129. 2, 128. 8, 127. 2, 113. 7, 75. 3, 74. 5, 73. 1, 66. 0, 55. 5, 55. 2, 40. 6, 37. 7, 35. 9, 13. 5, 9. 7 ; high resolution mass spectrum (CI, NH3) m/z 442. 2243 [(M+H)+ ; calcd for C2sH32NO6 : 442. 2229].

Anal. Calcd for CzSH3INOs : C, 68. 01 ; H, 7. 08. Found : C, 67. 81 ; H, 7. 26.

EXAMPLE 3 Common Precursor (+)-5.

A suspension of N, O-Dimethylhydroxylamine hydrochloride (46. 9 g, 481 mmol) in THF (250 mL) was cooled to 0 °C and AlMe3 (2. 0 M in hexane, 240 mL, 480 mmol) was added over 30 min. The resultant solution was warmed to room temperature, stirred for 0. 5 h and then cooled to-30 °C. A solution of oxazolidinone (+)-10 (70. 9 g, 161 mmol) in THF (150 mL) was introduced over 20 min via cannula (20 mL rinse).

After 3 h, the solution was poured slowly into a mixture of aqueous HC1 (1. 0 N, 1. 2 L) and CH2C12 (1. 0 L) at 0 °C and the mixture was shaken vigorously for 1 h. The aqueous phase was extracted with CH2Cl2 (2 x 500 mL) and the combined organic extracts were washed with water (3 x 1. 0 L), dried over MgSO4, filtered and concentrated. The crude material was taken up in ethyl acetate/hexane (1 : 3, 150 mL) with vigorous stirring to precipitate most of the chiral auxiliary. Filtration,

concentration and flash chromatography (20W acetone/hexane) afforded (+)-5 (46. 2 g, 88t yield) as a colorless oil : [a] 23D +144° (c 0. 41, CHCl3) ; IR (CHCl3) 3470 (m, br), 3010 (s), 2975 (s), 2945 (s), 2915 (s), 2870 (s), 2845 (m), 1680 (s), 1590 (w), 1515 (s), 1465 (s), 1425 (m), 1390 (m), 1365 (m), 1310 (m), 1250 (s), 1180 (s), 1150 (m), 1090 (s), 1040 (s), 1000 (s), 825 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 25 (d, J = 8. 6 Hz, 2 H), 6. 86 (d, J = 8. 7 Hz, 2 H), 4. 44 (ABq, JAT3 = 11. 6 Hz, ##AB = 17.1 Hz, Hz, H), H), 95 (d, (d, J = 2. 8 Hz, 1 H), 3. 79 (s, 3 H), 3. 70 (ddd, J = 8. 2, 3. 2, 3. 2 Hz, 1 H), 3. 66 (s, 3 H), 3. 62 (dd, J = 9. 0, 4. 0 Hz, 1 H), 3. 53 (dd, J = 9. 1, 5. 9 Hz, 1 H), 3.17 (s, 3 H), 3. 04 (m, 1 H), 1. 91-1. 84 (m, 1 H), 1. 17 (d, J = 7. 0 Hz, 3 H), 0. 98 (d, J = 6. 9 Hz, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 178. 0, 159. 0, 130. 6, 129. 1, 113. 7, 113. 6, 73. 8, 72. 8, 72. 6, 61. 3, 55. 1, 36. 5, 36. 0, 14. 2, 10. 4 ; high resolution mass spectrum (CI, NH3) m/z 326. 1962 [ (M+H) + ; calcd for C17H28NOs : 326. 1967].

Anal. Calcd for C17H27NOs : C, 62. 74 ; H, 8. 36. Found : C, 62. 74 ; H, 8. 24.

EXAMPLE 4 Weinreb Amide (-)-11.

A mixture of common precursor (+)-5 (337. 3 mg, 1. 04 mmol), 4 A molecular sieves (344 mg), and CH2C12 (10 mL) was cooled to 0 °C and treated with DDQ (310. 3 mg, 1. 37 mmol).

After 1. 5 h, the mixture was filtered through a short Celite column (50% ethyl acetate/hexane). The filtrate was washed with saturated aqueous NaHCO, and water (100 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (30% ethyl acetate/hexane) provided (-)-11 (255. 6 mg, 760 yield) as a colorless oil : [a] 23D-339° (c 0. 520, CHCl3) ; IR (CHCl3) 3010 (s), 2970 (s), 2940 (m), 2880 (m), 2840 (m), 1663 (s), 1620 (s), 1592 (w), 1520 (s), 1466 (s), 1447 (m), 1425 (m), 1393 (s), 1375 (s), 1307 (m), 1253 (s), 1178 (s), 1120 (s), 1083 (s), 1035 (s), 1015 (m), 1000 (s), 930 (w), 830 (m), 700 (w), 660 (w), 620 (w) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 41 (d, J = 8. 8 Hz, 2 H), 6. 87 (d, J = 8. 8 Hz, 2 H), 5. 46 (s, 1 H),

4. 04 (dd, J = 11. 3, 4. 7 Hz, 1 H), 3. 82 (dd, J = 9. 8, 6. 5 Hz, 1 H), 3. 79 (s, 3 H), 3. 71 (s, 3 H), 3. 51 (apparent t, J = 11. 2 Hz, 1 H), 3. 19 (s, 3 H), 3. 21-3. 14 (m, 1 H), 1. 98-1. 92 (m, 1 H), 1. 27 (d, J = 7. 0 Hz, 3 H), 0. 75 (d, J = 6. 8 Hz, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 175. 8, 159. 8, 131. 2, 127. 2, 113. 5, 100. 7, 82. 8, 72. 8, 61. 3, 55. 3, 39. 0, 33. 8, 32. 6, 13. 1, 12. 4 ; high resolution mass spectrum (CI, NH3) m/z 323. 1736 [M+ ; calcd for C17H2sNOs : 323. 1732].

Anal. Calcd for Ci7H2sNOs : C, 63. 14 ; H, 7. 79. Found : C, 63. 18 ; H, 7. 74.

EXAMPLE 5 Aldehyde (-)-12.

A solution of amide (-)-11 (2. 07 g, 6. 40 mmol) in THF (70 mL) was cooled to-78 °C and LiAlH4 (1. 0 M in THF, 3. 40 mL, 3. 40 mmol) was added over 15 min. After 10 min at-78 °C and 10 min at 0 °C, the mixture was quenched with MeOH (1. 0 mL), and partitioned between ethyl acetate and saturated aqueous Rochelle's salt (100 mL each). The organic phase was washed with brine (100 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (15% ethyl acetate/hexane) gave (-)-12 (1. 38 g, 80% yield) as a colorless oil : lux 23D -7. 8 (c 0. 46, CHC13) ; IR (CHC13) 3015 (m), 2970 (m), 2940 (m), 2840 (m), 1735 (s), 1725 (s), 1615 (m), 1590 (w), 1520 (s), 1460 (s), 1390 (m), 1370 (m), 1305 (m), 1250 (s), 1170 (s), 1115 (s), 1085 (s), 1035 (s), 990 (m), 960 (m), 830 (m) cm-1; 'H NMR (500 MHZ, CDCl3) d 9. 74 (apparent s, 1 H), 7. 32 (d, J = 8. 8 Hz, 2 H), 6. 84 (d, J = 8. 7 Hz, 2 H), 5. 46 (s, 1 H), 4. 13 (dd, J = 11. 5, 4. 8 Hz, 1 H), 4. 05 (dd, J = 10. 4, 2. 6 Hz, 1 H), 3. 77 (s, 3 H), 3. 56 (apparent t, J = 11. 1 Hz, 1 H), 2. 56 (qd, J = 7. 1, 2. 6 Hz, 1 H), 2. 15-2. 03 (m, 1 H), 1. 23 (d, J = 7. 1 Hz, 3 H), 0. 80 (d, J = 6. 7 Hz, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 204. 0, 159. 9, 130. 7, 127. 2, 113. 5, 100. 9, 81. 6, 72. 8, 55. 2, 47. 4, 30. 3, 11. 9, 7. 1 ; high resolution mass spectrum (CI, NH3) m/z 265. 1432 [ (M+H) + ; calcd for C15H21O4 265. 1439].

EXAMPLE 6 Aldol (+)-13.

A solution of oxazolidinone (+)-9 (21. 6 g, 92. 7 mmol) in CH2Cl2 (200 mL) was cooled to 0 °C and n-Bu2BOTf (1. 0 M in CH2Cl2, 86. 1 mL, 86. 1 mmol) was added over 0. 5 h, followed by addition of NEt3 (15. 7 mL, 112. 5 mmol) over 10 min. The mixture was stirred at 0 °C for 1 h and cooled to-78 °C. A solution of aldehyde (-)-12 (17. 5 g, 66. 2 mmol) in CH2Cl2 (50 mL) was added over 10 min. After additional 20 min at-78 °C and 1 h at 0 °C, the reaction was quenched with pH 7 phosphate buffer (100 mL) and MeOH (300 mL), then slowly treated with a solution of 30% H202 in MeOH (1 : 1, 100 mL) at 0 °C. After 1 h, saturated aqueous Na2S203 (100 mL) was added. The mixture was concentrated and the residue was extracted with ethyl acetate (3 x 250 mL). The combined extracts were washed with saturated aqueous Na2S203, aqueous NaHCO3 (10%), brine (200 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (10% ethyl acetate/hexane) provided (+)-13 (26. 3 g, 80% yield) as white crystals : mp 98-100 C ; [a] 23D +13. 5 (c 1. 19, CHC13) ; IR (CHC13) 3690 (w), 3520 (w, br), 3020 (m), 2980 (m), 2940 (m), 2880 (w), 2850 (m), 1790 (s), 1695 (m), 1620 (m), 1595 (w), 1525 (m), 1505 (w), 1490 (w), 1465 (m), 1390 (s), 1365 (m), 1310 (m), 1260-1210 (m, br), 1175 (m), 1120 (s), 1085 (m), 1040 (m), 1020 (m), 985 (m), 970 (m), 930 (w), 830 (m), 700 (m) cm'' ;'H NMR (500 MHZ, CDC13) d 7. 35 (d, J = 8. 7 Hz, 2 H), 7. 31 (d, J = 7. 6 Hz, 2 H), 7. 27 (d, J = 7. 2 Hz, 1 H), 7. 19 (d, J = 7. 7 Hz, 2 H), 6. 84 (d, J = 8. 7 Hz, 2 H), 5. 45 (s, 1 H), 4. 67-4. 62 (m, 1 H), 4. 14 (apparent d, J = 5. 3 Hz, 2 H), 4. 08 (dd, J = 11. 4, 4. 8 Hz, 1 H), 4. 07 (apparent t, J = 4. 1 Hz, 1 H), 4. 04-3. 99 (m, 1 H), 3. 76 (s, 3 H), 3. 61 (dd, J = 9. 9, 2. 2 Hz, 1 H), 3. 51 (apparent t, J = 11. 1 Hz, 1 H), 3. 33 (d, J = 1. 3 Hz, 1 H), 3. 21 (dd, J = 13. 4, 3. 4 Hz, 1 H), 2. 76 (dd, J = 13. 4, 9. 4 Hz, 1 H), 2. 12-2. 06 (m, 1 H), 1. 92-1. 86 (m, 1 H), 1. 31 (d, J = 6. 9 Hz, 3 H), 1. 07 (d, J = 7. 0 Hz, 3 H), 0. 74 (d, J = 6. 7 Hz, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 177. 1, 160. 0, 152. 7, 135. 0, 131. 0, 129. 4, 128. 9, 127. 40, 127. 39, 113. 6, 101. 2, 85. 8, 74. 5, 73. 0, 66. 0, 55. 2, 54. 9, 39. 8, 37. 7, 35. 7, 30. 4, 12. 8, 11. 7,

7. 8 ; high resolution mass spectrum (CI, NH3) m/z 497. 2410 [M+ ; calcd for C2aH3sNO7 : 497. 2413].

Anal. Calcd for CZgH35NO, : C, 67. 58 ; H, 7. 09. Found : C, 67. 42 ; H, 7. 02.

EXAMPLE 7 Acetal (+)-14.

A solution of alcohol (+)-13 (26. 3 g, 52. 9 mmol) and 2, 6-lutidine (11. 1 mL, 95. 3 mmol) in CH2C12 (150 mL) was cooled to -20°C and TBSOTf (20. 5 mL, 79. 3 mmol) was added over 30 min.

After additional 2 h at 0 °C, the mixture was diluted with ether (300 mL), washed with aqueous NaHSO4 (1. 0 M, 200 mL), brine (200 mL), dried over MgSO4, filtered and concentrated.

Flash chromatography (gradient elution, 5% -> 10%-ethyl acetate/hexane) afforded (+)-14 (32. 4 g, 100E yield) as a colorless oil : [a] 23D +20. 3 ° (c 1. 32, CHCl3) ; IR (CHCl3) 3025 (m), 2970 (m), 2940 (m), 2864 (m), 1788 (s), 1705 (m), 1620 (m), 1597 (w), 1524 (m), 1503 (w), 1470 (m), 1447 (w), 1430 (w), 1395 (s), 1358 (m), 1307 (m), 1255 (s), 1135 (m), 1120 (s), 1075 (m), 1030 (m), 985 (m), 976 (m), 930 (m), 865 (m), 838 (s), 813 (m), 790 (m), 700 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 38 (d, J = 8. 7 Hz, 2 H), 7. 30-7. 12 (m, 5 H), 6. 82 (d, J = 8. 7 Hz, 2 H), 5. 44 (s, 1 H), 4. 30 (dddd, J = 13. 4, 7. 3, 5. 1, 5. 1 Hz, 1 H), 4. 11 (dd, J = 7. 1, 4. 0 Hz, 1 H), 4. 02 (dd, J = 11. 2, 4. 7 Hz, 1 H), 3. 97 (dq, J = 7. 0, 7. 0 Hz, 1 H), 3. 80 (dd, J = 8. 9, 2. 3 Hz, 1 H), 3. 740 (apparent t, J = 4. 9 Hz, 1 H), 3. 738 (s, 3 H), 3. 48 (apparent t, J = 11. 1 Hz, 1 H), 3. 27 (apparent t, J = 8. 2 Hz, 1 H), 3. 15 (dd, J = 13. 4, 3. 2 Hz, 1 H), 2. 59 (dd, J = 13. 4, 9. 8 Hz, 1 H), 2. 05 (apparent qd, J = 7. 4, 4. 2 Hz, 1 H), 2. 02-1. 94 (m, 1 H), 1. 19 (d, J = 6. 9 Hz, 1 H), 1. 04 (d, J = 7. 5 Hz, 3 H), 0. 92 (s, 9 H), 0. 73 (d, J = 6. 7 Hz, 3 H), 0. 05 (s, 3 H), 0. 04 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 175. 6, 159. 9, 152. 4, 135. 5, 132. 0, 129. 4, 128. 8, 127. 8, 127. 2, 113. 4, 100. 7, 80. 7, 74. 6, 73. 1, 65. 3, 55. 3, 55. 2, 41. 4, 40. 9, 37. 4, 30. 6, 26. 0, 18. 1, 15. 0, 12. 7, 11. 5,-4. 0,-4. 6 ; high resolution mass spectrum (CI, NH3) m/z 612. 3340 [(M+H)+ ; calcd for C34HsoNO7Si : 612. 3356].

Anal. Calcd for C34H49NO7Si : C, 66. 74 ; H, 8. 07. Found : C, 66. 69 ; H, 7. 98.

EXAMPLE 8 Alcohol (-)-15.

A solution of acetal (+)-14 (32. 0 g, 52. 3 mmol) in THF (600 mL) was cooled to-30 °C and EtOH (6. 14 mL, 105 mmol) was added, followed by addition of LiBH4 (2. 0 M in THF, 52. 3 mL, 105 mmol) over 15 min. After additional 1 h at 0 °C and 12 h at room temperature, the mixture was diluted with ether (1. 0 L), quenched carefully with aqueous NaOH (1. 0 N, 200 mL) and stirred for 2 h at room temperature. The layers were separated and the organic phase was washed with brine (500 mL), dried over Na2SO4, filtered and concentrated. Flash chromatography (20-06 ethyl acetate/hexane) provided (-)-15 (18. 7 g, 81% yield) as a colorless oil : [O !] 23D-36. 1 (c 1. 15, CHCl3) ; IR (CHCl3) 3630 (w), 3480 (w, br), 3010 (m), 2960 (s), 2940 (s), 2885 (m), 2860 (s), 1620 (m), 1594 (w), 1523 (s), 1468 (s), 1445 (w), 1430 (w), 1395 (m), 1365 (m), 1307 (m), 1255 (s), 1175 (m), 1165 (m), 1150 (m), 1120 (s), 1080 (s), 1030 (s), 990 (m), 968 (m), 910 (s), 860 (m), 833 (s), 700 (m), 645 (m) cmm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 36 (d, J = 8. 7 Hz, 2 H), 6. 85 (d, J = 8. 8 Hz, 2 H), 5. 38 (s, 1 H), 4. 08 (dd, J = 11. 2, 4. 7 Hz, 1 H), 3. 84 (dd, J = 6. 7, 1. 9 Hz, 1 H), 3. 77 (s, 3 H), 3. 53 (dd, J = 9. 9, 1. 8 Hz, 1 H), 3. 55-3. 52 (m, 1 H), 3. 47 (apparent t, J = 11. 1 Hz, 1 H), 3. 44 (dd, J = 10. 3, 6. 2 Hz, 1 H), 2. 08-1. 97 (m, 2 H), 1. 94 (dqd, J = 7. 1, 7. 1, 1. 7 Hz, 1 H), 1. 76 (br s, 1 H), 1. 02 (d, J = 7. 1, 3 H), 0. 88 (s, 9 H), 0. 84 (d, J = 6. 9 Hz, 3 H), 0. 73 (d, J = 6. 7 Hz, 3 H), 0. 03 (s, 3 H), 0. 00 (s, 3 H) ; 13C NMR (125 MHZ, CDC13) d 159. 8, 131. 4, 127. 3, 113. 5, 101. 0, 82. 9, 74. 3, 73. 3, 66. 3, 55. 2, 38. 7, 37. 8, 30. 7, 26. 1, 18. 3, 12. 2, 11. 1, 10. 7,-4. 0,-4. 2 ; high resolution mass spectrum (CI, NH3) m/z 439. 2889 [(M+H)+ ; calcd for C24H410IS' : 439. 2879].

Anal. Calcd for C24H420sSi : C, 65. 71 ; H, 9. 65. Found : C, 65. 51 ; H 9. 54.

EXAMPLE 9 Tosylate (-)-16.

A solution of alcohol (-)-15 (5. 00 g, 11. 4 mmol) in anhydrous pyridine (30 mL) was cooled to 0 °C and treated with TsCl (3. 91 g, 20. 5 mmol). After 30 min at 0 °C and 5 h at room temperature, the reaction was quenched with saturated aqueous NaHCO3 (20 mL). The mixture was diluted with ether (200 mL), washed with aqueous NaHSO4 (1. 0 M), aqueous NaHCO3 (10%-), brine (200 mL each), dried over MgSO4, filtered and concentrated.

Flash chromatography (100i ethyl acetate/hexane) provided (-)-15 (6. 76 g, 100% yield) as white solid : mp 71-72 °C ; [aJ23D-23. 2° (c 1. 42, CHCl3) ; IR (CHC13) 3020 (m), 3000 (m), 2960 (s), 2935 (s), 2880 (m), 2855 (s), 1617 (m), 1600 (m), 1590 (m), 1518 (m), 1495 (w), 1462 (s), 1390 (m), 1360 (s), 1302 (m), 1250 (s), 1190 (s), 1178 (s), 1120 (s), 1098 (s), 1085 (s), 1070 (s, 1032 (s), 963 (s), 900 (m), 830 (s), 810 (s), 653 (m) ; 1H NMR (500 MHZ, CDCl3) d 7. 70 (d, J = 8. 3 Hz, 2 H), 7. 34 (d, J = 8. 7 Hz, 2 H), 7. 25 (d, J = 8. 8 Hz, 2 H), 6. 86 (d, J = 8. 7 Hz, 2 H), 5. 36 (s, 3 H), 4. 07 (dd, J = 11. 2, 4. 7 Hz, 1 H), 3. 85 (dd, J = 7. 3, 2. 7 Hz, 1 H), 3. 79 (s, 3 H), 3. 71 (dd, J = 7. 1, 1. 7 Hz, 1 H), 3. 48 (dd, J = 9. 9, 1. 4 Hz, 1 H), 3. 45 (apparent t, J = 11. 1 Hz, 1 H), 2. 40 (s, 3 H), 2. 15 (dqd, J = 13. 9, 7. 0, 1. 7 Hz, 1 H), 2. 05-1. 96 (m, 1 H), 1. 83 (dqd, J = 7. 1, 7. 1, 1. 6 Hz, 1 H), 0. 94 (d, J = 7. 1 Hz, 3 H), 0. 82 (s, 9 H), 0. 81 (d, J = 7. 7 Hz, 3 H), 0. 69 (d, J = 6. 7 Hz, 3 H),-0. 04 (s, 3 H),-0. 11 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 159. 8, 144. 6, 133. 2, 131. 3, 129. 7, 127. 9, 127. 3, 113. 5, 100. 9, 82. 0, 73. 7, 73. 2, 73. 0, 55. 2, 38. 4, 35. 5, 30. 6, 26. 0, 21. 6, 18. 3, 12. 2, 10. 6, 10. 3, -3. 9,-4. 3 ; high resolution mass spectrum (FAB, NBA) m/z 593. 2955 [ (M+H) + ; calcd for C31H4907SSi : 593. 2968].

EXAMPLE 10 Fragment (-)-A.

From Tosylate (-)-16 : A solution of Tosylate (-)-16 (6. 76 g, 11. 4 mmol) in anhydrous DMF (50 mL) was treated with NaI (17. 1 g, 114. 0 mmol), heated at 60 °C for 1. 5 h, and cooled to room temperature. The mixture was diluted with ether (200

mL), washed with water (200 mL), saturated aqueous Nazis203 (100 mL), brine (200 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (3W ethyl acetate/hexane) provided (-)-A (5. 87 g, 94 W yield) as a colorless oil.

From Alcohol (-)-15 : A solution of alcohol (-)-15 (4. 70 g, 10. 7 mmol), PPh3 (4. 21 g, 16. 1 mmol) and imidazole (1. 09 g, 16. 1 mmol) in benzene/ether (1 : 2, 75 mL) was treated with I2 (4. 08 g, 16. 1 mmol) under vigorous stirring. The mixture was stirred 1 h then diluted with ether (200 mL), washed with saturated Na2S203, brine (100 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (2%- ethyl acetate/hexane) furnished (-)-A (5. 56 g, 95% yield) as a colorless oil : [u] 23 D-3 9. 3 * (c 2. 01, CHC13) ; IR (CHC1 3015 (m), 2960 (s), 2940 (s), 2860 (m), 1620 (w), 1520 (m), 1465 (m), 1430 (w), 1390 (m), 1305 (w), 1255 (s), 1230 (m), 1215 (m), 1205 (m), 1170 (m), 1120 (m), 1070 (m), 1035 (m), 990 (w), 970 (w), 930 (w), 830 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 39 (d, J = 8. 7 Hz, 2 H), 6. 86 (d, J = 8. 8 Hz, 2 H), 5. 40 (s, 1 H), 4. 09 (dd, J = 11. 2, 4. 7 Hz, 1 H), 3. 85 (dd, J = 7. 1, 1. 9 Hz, 1 H), 3. 79 (s, 3 H), 3. 48 (dd, J = 8. 2, 1. 5 Hz, 1 H), 3. 47 (apparent t, J = 11. 1 Hz, 1 H), 3. 18-3. 12 (m, 2 H), 2. 11-2. 00 (m, 2 H), 1. 84 (ddq, J = 7. 1, 7. 1, 1. 6 Hz, 1 H), 1. 02 (d, J = 7. 1 Hz, 3 H), 0. 98 (d, J = 6. 7 Hz, 3 H), 0. 89 (s, 9 H), 0. 72 (d, J = 6. 7 Hz, 3 H), 0. 06 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 159. 8, 131. 4, 127. 4, 113. 4, 100. 9, 82. 4, 75. 5, 73. 2, 55. 3, 39. 6, 38. 7, 30. 7, 26. 2, 18. 4, 14. 7, 14. 5, 12. 2, 10. 7,-3. 7, -3. 8 ; high resolution mass spectrum (CI, NH3) m/z 548. 1833 [ (M) + ; calcd for C24H41IO4Si : 548. 1819].

Anal. Calcd for C24H4104ISi : C, 52. 55 ; H, 7. 53. Found : C, 52. 77 ; H, 7. 68.

EXAMPLE 11 Amide (+)-17 A solution of common precursor (+)-5 (12. 1 g, 37. 2 mmol) and 2, 6-lutidine (7. 80 mL, 70. 0 mmol) in CH2Cl2 (90 mL) was cooled to 0°C and tert-Butyldimethylsilyl trifluoromethanesulfonate (12. 8 mL, 55. 8 mmol) was added over

10 min. After 1. 5 h, the mixture was diluted with Et2O (100 mL), washed with aqueous NaHSO4 (1. 0 M), brine (200 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (10% ethyl acetate/hexanes) provided (+)-17 (16. 4 g, 100% yield) as a colorless oil : [α] +9. 49° (c 1. 47, CHCl3) ; IR (CHCl3) 3018 (s), 2970 (s), 2945 (s), 2900 (m), 2870 (s), 1658 (s), 1620 (m), 1592 (w), 1520 (s), 1470 (s), 1448 (m), 1425 (m), 1393 (m), 1367 (m), 1308 (m), 1255 (s), 1213 (s), 1185 (m), 1178 (m), 1115 (s), 1084 (s), 1042 (s), 1000 (s), 940 (w), 928 (w), 871 (s), 839 (s), 770 (s), 726 (s), 664 (m) cm-1; 1H NMR (500 MHZ, CDCl3) d 7. 21 (d, J = 8. 7 Hz, 2 H), 6. 83 (d, J = 8. 7, 2 H), 4. 36 (ABq, JM3 = 11. 6 Hz, AdE3 = 17. 3 Hz, 2 H), 3. 92 (dd, J = 8. 2, 3. 0 Hz, 1 H), 3. 77 (s, 3 H), 3. 55 (s, 3 H), 3. 54 (dd, J = 9. 2, 2. 5 Hz, 1 H), 3. 13 (dd, J = 9. 2, 7. 8 Hz, 1 H), 3. 09 (s, 3 H), 3. 15-3. 09 (m, 1 H), 1. 92-1. 87 (m, 1 H), 1. 09 (d, J = 7. 0 Hz, 3 H), 0. 98 (d, J = 7. 0 Hz, 3 H), 0. 88 (s, 9 H), 0. 04 (apparent s, 6 H) ; 13C NMR (125 MHZ, CDC13) d 176. 8, 159. 1, 130. 9, 129. 2, 113. 7, 76. 0, 72. 7, 71. 9, 61. 1, 55. 2, 39. 3, 38. 9, 26. 1, 18. 4, 15. 3, 15. 0,-3. 87,-3. 93 ; high resolution mass spectrum (CI, NH3) m/z 440. 2823 [ (M+H) + ; calcd for CHNOgSi : 440. 2832].

Anal. Calcd for C23H41NOSSi : C, 62. 83 ; H, 9. 40. Found : C, 63. 05 ; H, 9. 32.

EXAMPLE 12 Aldehyde (+)-18.

A solution of amide (+)-17 (9. 19 g, 20. 9 mmol) in THF (350 mL) was cooled to-78 °C and DIBAL (1. 0 M in hexane, 44. 0 mL, 44. 0 mmol) was added over 30 min. After 0. 5 h at-78 °C, the reaction was quenched with MeOH (10 mL). The mixture was diluted with ether (500 mL), washed with saturated aqueous Rochelle's salt, brine (300 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (100-. ethyl acetate/hexane) gave (+)-18 (7. 05 g, 89% yield) as a colorless oil : [a] 23D +23. 2° (c 1. 49, CHCl3) ; IR (CHC13) 2960 (s), 2930 (s), 2860 (s), 1730 (s), 1610 (m), 1583 (w), 1510 (m), 1460 (m), 1373 (m), 1360 (w), 1300 (m), 1245 (s), 1170 (m), 1085

(m), 1033 (s), 933 (w), 835 (s) cm'' ; 1H NMR (500 MHZ, CDCl3) d 9. 67 (d, J = 0. 9 Hz, 1 H), 7. 22 (d, J = 8. 7 Hz, 2 H), 6. 86 (d, J = 8. 7 Hz, 2 H), 4. 37 (ABq, JAB = 11. 6 Hz, ##AB = 23. 6 Hz, 2 H), 4. 18 (dd, J = 6. 1, 3. 7 Hz, 1 H), 3. 78 (s, 3 H), 3. 41 (dd, J = 9. 2, 5. 7 Hz, 1 H), 3. 31 (dd, J = 9. 2, 6. 0 Hz, 1 H), 2. 47 (qdd, J = 7. 1, 3. 7, 0. 9 Hz, 1 H), 2. 03-1. 95 (m, 1 H), 1. 08 (d, J = 7. 0 Hz, 3 H), 0. 94 (d, J = 7. 0 Hz, 3 H), 0. 84 (s, 9 H), 0. 04 (s, 3 H),-0. 03 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 204. 8, 159. 2, 130. 5, 129. 2, 113. 8, 72. 7, 72. 4, 71. 7, 55. 3, 50. 0, 38. 3, 25. 9, 18. 2, 14. 3, 8. 4,-4. 1,-4. 4 ; high resolution mass spectrum (FAB, NBA) m/z 403. 2304 (M+Na) calcd for C21H3604SiNa : 403. 2280].

EXAMPLE 13 Bromo Ester 19.

A solution of aldehyde (+)-18 (822. 1 mg, 2. 16 mmol) in benzene (20 mL) was treated with Ph3P=CBrCO2Et (2. 28 g, 5. 34 mmol), heated at reflux for 40 h and cooled to room temperature. The mixture was filtered through a short silica column (20W ethyl acetate/hexane) and concentrated. Flash chromatography (3t ethyl acetate/hexane) afforded Z-Bromo ester (-)-19 (861. 4 mg, 75% yield) and E-Bromo Ester (+)-19 (101. 0 mg, 8. 8% yield).

Z-Bromo Ester (-)-19 : Colorless oil ; [a] z3p-6. 38° (c 1. 85, CHCl3) ; IR (CHCl3) 2960 (s), 2940 (s), 2860 (s), 1725 (s), 1618 (m), 1590 (w), 1515 (s), 1468 (m), 1390 (m), 1370 (m), 1303 (m), 1250 (s, br), 1176 (m), 1090 (s), 1037 (s), 1008 (m), 950 (m), 940 (m), 840 (s) cm-1; H1 NMR (500 MHZ, C6D6) d 7. 45 (d, J = 9. 7 Hz, 1 H), 7. 26 (d, J = 8. 6 Hz, 2 H), 6. 80 (d, J = 8. 7 Hz, 2 H), 4. 37 (ABq, JA, = 11. 6 Hz, AdAi3 = 19. 3 Hz, 2 H), 3. 99, (dq, J = 10. 8, 7. 1 Hz, 1 H), 3. 94 (dq, J = 10. 8, 7. 1 Hz, 1 H), 3. 82 (apparent t, J = 5. 4 Hz, 1 H), 3. 41 (dd, J = 9. 1, 6. 3 Hz, 1 H), 3. 31 (s, 3 H), 3. 30 (dd, J = 9. 2, 6. 5 Hz, 1 H), 3. 13-3. 06 (m, 1 H), 2. 05 (apparent septet, J = 6. 9 Hz, 1 H), 1. 013 (d, J = 7. 0 Hz, 3 H), 1. 006 (d, J = 6. 8 Hz, 3 H), 0. 97 (s, 9 H), 0. 92 (apparent t, J = 7. 1 Hz, 3 H), 0. 06 (s, 3 H), 0. 05 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 162. 5, 159. 1, 149. 6, 130. 8, 129. 0,

114. 9, 113. 7, 75. 5, 72. 6, 72. 2, 62. 4, 55. 3, 40. 2, 38. 9, 26. 0, 18. 3, 14. 2, 14. 1, 13. 7,-4. 0,-4. 2 ; high resolution mass spectrum (CI, NH3) m/z 546. 2270 [(M+NH) 4+ ; calcd for CHNOgBrSi : 546. 2251].

Anal. Calcd for C25H41O5BrSi. C, 56. 70 ; H, 7. 80.

Found : C, 56. 96 ; H, 7. 86.

E-Bromo Ester (+)-19. Colorless oil ; [a] 23D +3. 2° (c 1. 65, CHCl3) ; IR (CHCl3) 2965 (s), 2940 (s), 2905 (m), 2890 (m), 2865 (s), 1720 (s), 1617 (m), 1590 (w), 1518 (s), 1468 (s), 1375 (s), 1350 (m), 1305 (m), 1250 (s, br), 1177 (m), 1090 (s), 1035 (s), 1007 (m), 950 (m), 840 (s), 675 (w) cm'' ;'H NMR (500 MHZ, CDCl3) d 7. 23 (d, J = 8. 6 Hz, 2 H), 6. 86 (d, J = 8. 7 Hz, 2 H), 6. 56 (d, J = 10. 6 Hz, 1 H), 4. 39 (apparent s, 2 H), 4. 24 (dq, J = 10. 8, 7. 1 Hz, 1 H), 4. 22 (dq, J = 10. 8, 7. 1 Hz, 1 H), 3. 79 (s, 3 H), 3. 61 (dd, J = 5. 5, 5. 0 Hz, 1 H), 3. 43 (dd, J = 9. 2, 5. 5 Hz, 1 H), 3. 39-3. 32 (m, 1 H), 3. 24 (dd, J = 9. 1, 7. 2 Hz, 1 H), 1. 98-1. 90 (m, 1 H), 1. 30 (apparent t, J = 7. 1 Hz, 1 H), 1. 00 (d, J = 6. 7 Hz, 3 H), 0. 94 (d, J = 7. 0 Hz, 3 H), 0. 89 (s, 9 H), 0. 05 (s, 3 H), 0. 03 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 162. 8, 159. 1, 151. 9, 130. 8, 129. 1, 113. 7, 110. 2, 76. 3, 72. 6, 72. 2, 62. 1, 55. 2, 38. 8, 26. 1, 18. 3, 14. 7, 14. 1, 13. 9,-4. 06, -4. 10 ; high resolution mass spectrum (CI, NH3) m/z 529. 1982 [(M+H) + ; calcd for C25 H42BrOsSi : 529. 1985].

Anal. Calcd for CHOBrSi : C, 56. 70 ; H, 7. 80.

Found : C, 56. 83 ; H, 7. 99.

EXAMPLE 14 Allylic Alcohol (-)-20.

A solution of ester (-)-19 (858. 4 mg, 1. 62 mmol) in CH2Cl2 (16 mL) was cooled to-78 C and DIBAL (1. 0 M in hexane, 3. 60 mL, 3. 60 mmol) was added over 10 min. After 5 min at-78 °C and 10 min at room temperature, the reaction was quenched with MeOH (200 mL), followed by addition of saturated aqueous Rochelle's salt dropwise with stirring until a solid precipitated. The solution was separated by decanting (3 x 30 mL rinse, ethyl acetate) and the combined organic solutions were dried over MgSO4, and concentrated. Flash chromatography

(100-. ethyl acetate/hexane) provided (-)-20 (674. 5 mg, 85% yield) as a colorless oil : [a] 23D-15. 5° (c 2. 51, CHCl3) ; IR (CHCl3) 3600 (w), 3420 (w, br), 3010 (m), 2960 (s), 2940 (s), 2890 (m), 2860 (s), 1618 (m), 1590 (w), 1520 (s), 1470 (m), 1380 (m), 1315 (m), 1307 (m), 1255 (s), 1178 (m), 1085 (s), 1039 (s), 1010 (m), 972 (m), 940 (m), 840 (s), 675 (m), 660 (m) cm-i 1; 1H NMR (500 MHZ, CDCl3) d 7. 24 (d, J = 8. 7 Hz, 2 H), 6. 87 (d, J = 8. 7 Hz, 2 H), 5. 88 (br d, J = 9. 3 Hz, 1 H), 4. 39 (ABq, JAB = 11. 6 Hz, A6AW3 = 18. 3 Hz, 2 H), 4. 16 (apparent d, J = 5. 6 Hz, 2 H), 3. 79 (s, 3 H), 3. 59 (apparent t, J = 5. 3 Hz, 1 H), 3. 48 (dd, J = 9. 2, 5. 3 Hz, 1 H), 3. 23 (dd, J = 9. 2, 7. 7 Hz, 1 H), 2. 82-2. 76 (m, 1 H), 2. 00-1. 92 (m, 1 H), 0. 98 (d, J = 6. 9 Hz, 3 H), 0. 97 (d, J = 6. 8 Hz, 3 H), 0. 88 (s, 9 H), 0. 024 (s, 3 H), 0. 016 (s, 3 H) ; 13C NMR (125 MHZ, CDC1,) d 159. 1, 134. 1, 130. 9, 129. 1, 125. 1, 113. 7, 76. 5, 72. 6, 72. 3, 68. 4, 55. 3, 39. 1, 38. 7, 26. 1, 18. 4, 14. 9, 14. 3,-3. 9,-4. 0 ; high resolution mass spectrum (CI, NH3) m/z 487. 1873 [ (M+H) + ; calcd for C23H4o04BrSi : 487. 1879].

Anal. Calcd for C23H3904BrSi : C, 56. 66 ; H, 8. 06.

Found : C, 56. 72 ; H, 8. 07.

EXAMPLE 15 Mesylate (-)-21.

A solution of alcohol (-)-20 (6. 85 g, 14. 1 mmol) in CH2Cl2 (150 mL) was cooled to 0 °C and MsCl (2. 20 mL, 28. 4 mmol) was added over 2 min. After 10 min, the reaction was quenched with aqueous NaHSO4 (1. 0 M, 100 mL). The organic phase was washed with water (100 mL), dried over MgSO4, and concentrated.

Flash chromatography (100-. ethyl acetate/hexane) afforded (-)-21 (7. 85 g, 99% yield) as a colorless oil : [a] 23D-14. 6° (c 1. 40, CHCl3) ; IR (CHCl3) 3020 (m), 2960 (s), 2940 (s), 2880 (m), 2860 (s), 1730 (w), 1610 (m), 1583 (m), 1510 (s), 1460 (m), 1410 (m), 1362 (s), 1300 (m), 1250 (s), 1220 (s), 1175 (s), 1080 (s), 1032 (s), 1002 (m), 960 (m), 937 (s), 835 (s) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 23 (d, J = 8. 6 Hz, 2 H), 6. 86 (d, J = 8. 6 Hz, 2 H), 6. 07 (d, J = 9. 4 Hz, 1 H), 4. 74 (d, J = 0. 4 Hz, 2 H), 4. 38 (ABq, JAB = 11. 7 Hz, A6A3 = 25. 5 Hz, 2 H), 3. 79 (s, 3 H),

3. 61 (apparent t, J = 5. 2 Hz, 1 H), 3. 44 (dd, J = 9. 2, 5. 7 Hz, 1 H), 3. 22 (dd, J = 9. 2, 7. 3 Hz, 1 H), 3. 01 (s, 3 H), 2. 84-2. 77 (m, 1 H), 1. 99-1. 91 (m, 1 H), 0. 98 (d, J = 6. 8 Hz, 3 H), 0. 96 (d, J = 7. 0 Hz, 3 H), 0. 88 (s, 9 H), 0. 03 (s, 3 H), 0. 02 (s, 3 H) ; 13C NMR (125 MHZ, CDC13) d 159. 1, 140. 9, 130. 8, 129. 1, 116. 7, 113. 8, 76. 1, 74. 2, 72. 6, 72. 1, 55. 3, 39. 6, 38. 8, 38. 5, 26. 0, 18. 3, 14. 7, 14. 3,-3. 9,-4. 0 ; high resolution mass spectrum (CI, NH3) m/z 582. 1911 [(M+NH4) + ; calcd for C24H4sNO6BrSSi : 582. 1920].

EXAMPLE 16 Vinyl Bromide (-)-22.

A solution of mesylate (-)-21 (6. 43 g, 11. 4 mmol) in benzene (120 mL) was treated with LiBHEt3 (1. 0 M in THF, 25. 0 mL, 25. 0 mmol) at room temperature. After 0. 5 h, the reaction was quenched with aqueous NaOH (1. 0 N, 50 mL). The mixture was diluted with ethyl acetate (200 mL), washed with brine (2 x 200 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (5% ethyl acetate/hexane) provided (-)-22 (4. 86 g, 91%) as a colorless oil : [oil 23D-16. 9° (c 1. 69, CHC13) ; IR (CHCl3) 3005 (m), 2965 (s), 2935 (s), 2860 (s), 1660 (w), 1610 (m), 1585 (w), 1510 (m), 1460 (m), 1425 (w), 1377 (m), 1360 (m), 1300 (m), 1250 (s), 1180 (m), 1170 (m), 1075 (s), 1030 (m), 860 (m), 835 (s), 805 (m), 660 (w) cm-1; 1H NMR (500 MHZ, CDCl3) d 7. 24 (d, J = 8. 6 Hz, 2 H), 6. 86 (d, J = 8. 6 Hz, 2 H), 5. 47 (apparent dd, J = 9. 0, 1. 2 Hz, 1 H), 4. 39 (ABq, JE3 = 11. 7 Hz, dX3 = 15. 8 Hz, 2 H), 3. 79 (s, 3 H), 3. 56 (apparent t, J = 5. 4 Hz, 1 H), 3. 50 (dd, J = 9. 1, 5. 1 Hz, 1 H), 3. 22 (dd, J = 8. 8, 8. 1 Hz, 1 H), 2. 74-2. 67 (m, 1 H), 2. 21 (d, J = 1. 1 Hz, 3 H), 1. 99-1. 91 (m, 1 H), 0. 98 (d, J = 6. 9 Hz, 3 H), 0. 94 (d, J = 6. 8 Hz, 3 H), 0. 88 (s, 9 H), 0. 01 (s, 3 H), 0. 00 (s, 3 H) ; 13C NMR (125 MHZ, CDCL3) d 159. 1, 133. 4, 131. 0, 129. 1, 120. 6, 113. 7, 76. 7, 72. 6, 72. 5, 55. 3, 39. 7, 38. 7, 28. 8, 26. 1, 18. 4, 14. 8, 14. 4,-3. 96,-4. 01 ; high resolution mass spectrum (FAB, NBA) m/z 493. 1763 [ (M+Na) + ; calcd for C23H3903BrSiNa : 493. 1750].

EXAMPLE 17 Vinyl Silane (-)-23.

A solution of vinyl bromide (-)-22 (83. 2 mg, 0. 177 mmol) in THF (2. 0 mL) was cooled to-78 °C and n-BuLi (1. 6 M in hexane, 260 ml, 416 mmol) was added over 10 min. After 1 h at -78 oC and 15 min at room temperature, the reaction was quenched with H20 (200 mL). The mixture was concentrated and dissolved in ethyl acetate (30 mL), washed with water (30 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (5% ethyl acetate/hexane) provided (-)-23 (47. 9 mg, 69% yield) as a colorless oil : [a] 23D-61. 5° (c 0. 615, CHC1,) ; IR (CHCl3) 3680 (w), 3470 (m, br), 1614 (m), 1588 (w), 1513 (s), 1465 (m), 1442 (m), 1415 (m), 1360 (m), 1302 (m), 1250 (s), 1176 (m), 1120 (m), 1077 (m), 1032 (m), 992 (m), 830 (s), 820 (s), 805 (s) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 22 (d, J = 8. 7 Hz, 2 H), 6. 85 (d, J = 8. 7 Hz, 2 H), 6. 22 (dq, J = 10. 5, 1. 6 Hz, 1 H), 4. 42 (ABq, J = 11. 4 Hz, A6AP3 = 18. 8 Hz, 2 H), 3. 78 (s, 3 H), 3. 65 (br s, 1 H), 3. 56 (dd, J = 9. 1, 4. 0 Hz, 1 H), 3. 44 (dd, J = 8. 8, 2. 9 Hz, 1 H), 3. 42 (apparent t, J = 8. 8 Hz, 1 H), 2. 45 (dqd, J = 10. 3, 6. 6, 2. 7 Hz, 1 H), 1. 95-1. 87 (m, 1 H), 1. 78 (d, J = 1. 6 Hz, 3 H), 0. 91 (d, J = 6. 7 Hz, 3 H), 0. 87 (s, 9 H), 0. 80 (d, J = 7. 0 Hz, 3 H), 0. 09 (s, 3 H), 0. 08 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 159. 4, 147. 7, 130. 8, 129. 7, 129. 4, 113. 9, 79. 9, 76. 4, 73. 3, 55. 3, 38. 1, 36. 3, 27. 1, 26. 6, 17. 8, 13. 4, 13. 1,-3. 4,-3. 7 ; high resolution mass spectrum (CI, NH3) m/z 393. 2821 [M+H)+ ; calcd for CHO. Si : 393. 2824].

Anal. Calcd for C23H4003Si. C, 70. 36 ; H, 10. 27. Found : C, 70. 58 ; H, 10. 57.

EXAMPLE 18 trans Olefin (+)-24.

A solution of vinyl bromide (-)-22 (27. 8 mg, 0. 0591 mmol) in ether (600 UL) was cooled to-78 °C, and t-BuLi (1. 7 M in pentane, 103 HL, 0. 175 mmol) was added over 2 min. After 10 min at-78 °C and 5 min at room temperature, the reaction was quenched with MeOH (100 mL). The mixture was filtered through a short silica plug, and concentrated. Flash

chromatography (1*-. ethyl acetate/hexane) provided (+)-24 (21. 9 mg, 94% yield) as a colorless oil ; [a] 23D +19. 3° (c 1. 10, CHCl3) ; IR (CHCl3) 3000 (m), 2960 (s), 2935 (s), 2880 (m), 2860 (s), 1612 (m), 1587 (w), 1510 (s), 1462 (m), 1440 (m), 1405 (w), 1375 (m), 1360 (m), 1300 (m), 1250 (s), 1170 (m), 1090 (s), 1034 (s), 1002 (m), 970 (m), 934 (w), 850 (m), 832 (s), 720 (m) cm-1 ;'H NMR (500 MHZ, C6D6) d 7. 24 (d, J = 8. 7 Hz, 2 H), 6. 80 (d, J = 8. 6 Hz, 2 H), 5. 43 (ddq, J = 15. 3, 7. 8, 1. 4 Hz, 1 H), 5. 34 (dqd, J = 15. 4, 6. 3, 0. 7 Hz, 1 H), 4. 38 (ABq, JA, 3 = 11. 7 Hz, A6,, = 30. 7 Hz, 2 H), 3. 58 (apparent t, J = 5. 2 Hz, 1 H), 3. 57 (dd, J = 9. 0, 5. 1 Hz, 1 H), 3. 36 (dd, J = 9. 0, 7. 2 Hz, 1 H), 3. 30 (s, 3 H), 2. 39 (ddq, J = 6. 8, 6. 8, 6. 8 Hz, 1 H), 2. 17-2. 10 (m, 1 H), 1. 58 (apparent d, J = 6. 1 Hz, 3 H), 1. 07 (d, J = 7. 2 Hz, 3 H), 1. 05 (d, J = 6. 9 Hz, 3 H), 1. 00 (s, 9 H), 0. 10 (s, 3 H), 0. 08 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 159. 0, 135. 6, 131. 1, 129. 1, 123. 9, 113. 7, 78. 4, 72. 6, 72. 5, 55. 3, 40. 4, 37. 9, 26. 2, 26. 1, 18. 4, 18. 0, 15. 9, 15. 1,-3. 8,-4. 1 ; high resolution mass spectrum (CI, NH3) m/z 393. 2836 [(M+H) + ; calcd for C23H4103Si : 393. 2824].

EXAMPLE 19 Alcohol (-)-25.

A solution of PMB ether (-)-22 (50. 0 mg, 0. 106 mmol) and PMB acetal (-)-15 (46. 5 mg, 0. 106 mmol) in CH2Cl2 (2. 0 mL) was cooled to 0 °C, then treated with H20 (100 mL) and DDQ (26. 5 mg, 0. 117 mmol). After 30 min, the mixture was diluted with ether (60 mL), washed with saturated aqueous NaHCO3 (60 mL), brine (3 X 60 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (gradient elution, 5% -> 10% ethyl acetate/hexane) afforded (-)-25 (31. 0 mg, 83% yield) and recovered (-)-15 (40. 0 mg, 86% recovery).

(-)-25 : [a] 23D-13-3 (c 0. 99, CHCl3) ; IR (CHCl3) 3640 (w), 3520 (m), 3000 (m), 2960 (s), 2940 (s), 2890 (m), 2860 (s), 1660 (w), 1472 (m), 1465 (m), 1440 (m), 1407 (m), 1390 (m), 1380 (m), 1360 (m), 1258 (s), 1072 (s), 1023 (s), 1005 (s), 980 (m), 937 (m), 847 (s) cm'' ;'H NMR (500 MHZ, CDC13) d 5. 50 (apparent dd, J = 9. 0, 1. 1 Hz, 1 H), 3. 65 (dd, J = 11. 0,

4. 8 Hz, 1 H), 3. 59 (dd, J = 11. 0, 5. 7 Hz, 1 H), 3. 56 (apparent t, J = 5. 2 Hz, 1 H), 2. 80- 2. 72 (m, l H), 2. 25 (d, J = 1. 0 Hz, 3 H), 2. 20 (br s, 1 H), 1. 86-1. 78 (m, 1 H), 0. 99 (d, J = 7. 1 Hz, 3 H), 0. 98 (d, J = 6. 9 Hz, 3 H), 0. 90 (s, 9 H), 0. 09 (s, 3 H), 0. 05 (s, 3 H) ; 13C NMR (125 MHZ, CDC13) d 132. 6, 121. 7, 79. 7, 65. 6, 40. 9, 38. 8, 28. 9, 26. 1, 18. 3, 15. 5, 15. 0,-3. 9,-4. 0 ; high resolution mass spectrum (CI, NH3) m/z 351. 1087 [M+ ; calcd for CisHOBrSi : 351. 1093].

EXAMPLE 20 Alcohol (+)-26.

A solution of amide (+)-17 (323. 5 mg, 0. 738 mmol) in EtOH (8. 0 mL) was stirred for 5 h under H2 atmosphere in the presence of Pearlman's catalyst (20W Pd (OH) 2/C, 104. 1 mg), then filtered and concentrated. Flash chromatography (10 mL silica, 20% ethyl acetate/hexane) provided (+)-26 (216. 7 mg, 92W yield) as a colorless oil : [a] 23D +16. 1 (c 2. 60, CHCl3) ; IR (CHC13) 3480 (m, br), 3000 (s), 2958 (s), 2935 (s), 2880 (s), 2860 (s), 1635 (s), 1460 (s), 1415 (m), 1390 (s), 1360 (m), 1285 (w), 1255 (s), 1174 (m), 1148 (m), 1093 (s), 1070 (s), 1047 (s), 1033 (s), 990 (s), 935 (m), 905 (w), 860 (s), 830 (s) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 4. 05 (dd, J = 9. 1, 3. 1 Hz, 1 H), 3. 69 (s, 3 H), 3. 55-3. 50 (m, 1 H), 3. 23 (ddd, J = 10. 1, 10. 1, 2. 8 Hz, 1 H), 3. 13 (s, 3 H), 3. 09 (br m, 1 H), 2. 81 (br m, 1 H), 1. 91-1. 83 (m, 1 H), 1. 14 (d, J = 7. 0 Hz, 3 H), 0. 879 (d, J = 7. 0 Hz, 3 H), 0. 879 (s, 9 H), 0. 08 (s, 3 H), 0. 06 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 177. 3, 75. 2, 64. 9, 61. 5, 40. 8, 38. 2, 32. 2, 26. 0, 18. 2, 15. 9, 12. 8,-4. 1,-4. 3 ; high resolution mass spectrum (CI, NH3) m/z 320. 2265 [ (M+H) + ; calcd for C1sH34N04Si : 320. 2256].

EXAMPLE 21 Aldehyde (+)-27.

A solution of alcohol (+)-26 (8. 80 g, 27. 5 mmol) and NEt3 (15. 3 mL, 110 mmol) in CH2Cl2 (50 mL) was cooled to-10 °C and treated with SO3. pyr (13. 1 g, 82. 6 mmol) in DMSO (100 mL).

After 20 min at room temperature, the mixture was diluted with

ether (300 mL), washed with aqueous NaHSO4 (1. 0 M, 200 mL), brine (4 x 200 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (20W ethyl acetate/hexane) afforded (+)-27 (8. 55 g, 98% yield) as a colorless oil : [a] 23D +51. 2° (c 1. 00, CHC13) ; IR (CHC13) 3010 (m), 2960 (s), 2940 (s), 2895 (m), 2865 (m), 1750 (m), 1720 (s), 1647 (s), 1460 (s), 1420 (m), 1390 (s), 1360 (m), 1255 (s), 1180 (m), 1105 (m), 1077 (m), 1040 (s), 995 (s), 936 (m), 853 (s), 837 (s), 710 (m), 657 (m) cm'' ; 1H NMR (500 MHZ, CDCl3) d 9. 68 (d, J = 1. 6 Hz, 1 H), 4. 22 (dd, J = 8. 9, 2. 6 Hz, 1 H), 3. 68 (s, 3 H), 3. 10 (apparent s, 4 H), 2. 46 (qdd, J = 7. 1, 2. 6, 1. 5 Hz, 1 H), 1. 16 (d, J = 6. 9 Hz, 3 H), 1. 10 (d, J = 7. 0 Hz, 3 H), 0. 88 (s, 9 H), 0. 092 (s, 3 H), 0. 088 (s, 3 H) ; 13C NMR (125 MHZ, CDCl2) d 203. 2, 175. 6, 75. 1, 61. 5, 52. 1, 39. 6, 32. 1, 25. 9, 18. 2, 15. 4, 10. 2,-4. 07,-4. 11 ; high resolution mass spectrum (CI, NH3) m/z 318. 2096 [(M+H)+ ; Cl, H32No4S' : 318. 2100].

EXAMPLE 22 Dithiane (+)-28.

A solution of ZnCl2 (dried at 140 °C for 1 h under vacuum, 170. 5 mg, 1. 25 mmol) in ether (6. 0 mL) was cooled to 0 °C and (TMSSCH2) 2CH2 (175. 0 yL, 0. 628 mmol) was added. The resultant white milky suspension was treated with aldehyde (+)-27 (180. 0 mg, 0. 567 mmol) in ether (6. 0 mL). The mixture was stirred for 4. 5 h at 0 °C and 1. 5 h at room temperature, then partitioned between ethyl acetate (50 mL) and aqueous ammonia (30 mL). The organic phase was washed with brine (2 x 30 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (100-. ethyl acetate/hexane) provided (+)-28 (182. 9 mg, 79% yield) as a white solid : mp 55-57 °C ; [a] 23D +18. 5° (c 1. 44, CHCl3) ; IR (CHC13) 3015 (m), 2970 (s), 2945 (s), 2910 (m), 2870 (m), 1665 (s), 1475 (m), 1470 (m), 1437 (m), 1430 (m), 1420 (m), 1390 (m), 1365 (m), 1320 (w), 1280 (m), 1260 (m), 1120 (m), 1115 (m), 1097 (m), 1080 (m), 1065 (m), 1040 (m), 1000 (m), 940 (w), 925 (w), 910 (w), 877 (m), 838 (s), 815 (m), 800 (m), 700 (w), 675 (w), 660 (w) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 4. 33 (d, J = 4. 2 Hz, 1 H), 4. 23 (dd, J =

7. 1, 3. 6 Hz, 1 H), 3. 68 (s, 3 H), 3. 15 (s, 3 H), 2. 98 (dq, J = 6. 8, 3. 7 Hz, 1 H), 2. 90 (ddd, J = 14. 1, 12. 2, 2. 5 Hz, 1 H), 2. 83-2. 77 (m, 3 H), 2. 09-2. 03 (m, 1 H), 1. 94 (ddq, J = 7. 2, 7. 2, 4. 3 Hz, 1 H), 1. 88-1. 76 (m, 1 H), 1. 08 (d, J = 7. 2 Hz, 3 H), 1. 07 (d, J = 6. 9 Hz, 3 H), 0. 90 (s, 9 H), 0. 13 (s, 3 H), 0. 02 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 176. 2, 73. 2, 61. 0, 50. 8, 44. 2, 38. 6, 31. 3, 30. 3, 26. 2, 18. 4, 12. 9, 11. 0,-4. 1, -4. 2 ; high resolution mass spectrum (CI, NH3) m/z 408. 2081 [ (M+H) + ; calcd for Cl8H38NO3S2Si : 408. 2062].

Anal. Calcd. for Cl8H37NO3S2Si : C, 53. 03 ; H, 9. 15.

Found : C, 53. 06 ; H, 9. 31.

EXAMPLE 23 Aldehyde (+)-29.

A solution of dithiane (+)-28 (1. 05 g, 2. 58 mmol) in THF (40 mL) was cooled to-78"C and DIBAL (1. 0 M in hexane, 5. 15 mL, 5. 15 mmol) was added over 15 min. After 10 min at-78 °C, the mixture was quenched with MeOH (2. 0 mL) and partitioned between ether and saturated aqueous Rochelle's salt (50 mL each). The organic phase was washed with brine (30 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (10% ethyl acetate/hexane) provided (+)-29 (822 mg, 91% yield) as white solid : mp 54-55 °C ; [OI] 23D +50. 8 (c 1. 19, CHCl3) ; IR (CHC13) 2965 (s), 2940 (s), 2910 (s), 2865 (s), 2720 (w), 1730 (s), 1475 (m), 1467 (m), 1428 (m), 1418 (m), 1390 (m), 1365 (m), 1280 (m), 1260 (s), 1190 (m), 1150 (m), 1104 (s), 1070 (m), 1030 (s), 1007 (m), 953 (m), 940 (m), 910 (m), 835 (s), 810 (m), 675 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 9. 70 (s, 1 H), 4. 44 (dd, J = 8. 3, 2. 2 Hz, 1 H), 4. 38 (d, J = 3. 7 Hz, 1 H), 2. 93 (ddd, J = 14. 1, 12. 3, 2. 6 Hz, 1 H), 2. 84-2. 80 (m, 3 H), 2. 43 (qd, J = 7. 1, 2. 2 Hz, 1 H), 2. 13-2. 07 (m, 1 H), 2. 02 (dqd, J = 8. 2, 7. 1, 3. 7 Hz, 1 H), 1. 88-1. 79 (m, 1 H), 1. 10 (d, J = 6. 9 Hz, 3 H), 1. 05 (d, J = 7. 1 Hz, 3 H), 0. 87 (s, 9 H), 0. 16 (s, 3 H),-0. 01 (s, 3 H) 13C NMR (125 MHZ, CDCl3) d 204. 6, 71. 1, 51. 0, 49. 7, 43. 5, 31. 3, 30. 3, 26. 2, 26. 0, 18. 4, 12. 9, 6. 8,-3. 9,-4. 3 ; high resolution mass spectrum (CI, NH3) m/z 349. 1678 [(M+H) + ; calcd for Cl6H3302S2Si : 349. 1691].

Anal. Calcd for Cl6H3202S2Si : C, 55. 12 ; H, 9. 25. Found : C, 55. 08 ; H, 9. 28.

EXAMPLE 24 Dimethoxy Acetal (+)-30.

A solution of aldehyde (+)-29 (792 mg, 2. 27mmol) in HC (OMe) 3/MeOH (48 mL, 1 : 5) was treated with TsOH'HQ (8. 6 mg, 0. 045 mmol) at room temperature. After 30 min, NEt3 (1. 0 mL) was added and the mixture was concentrated. Flash chromatography (10% ethyl acetate/hexane) provided (+)-30 (886 mg, 99% yield) as a white solid : mp 58-59 °C ; [a] 23D +27. 1° (c 2. 85, CHCl3) IR (CHCl3) 2960 (s), 2940 (s), 2905 (s), 2860 (m), 2835 (m), 1473 (m), 1463 (m), 1432 (m), 1425 (m), 1415 (m), 1387 (m), 1362 (m), 1340 (w), 1278 (m), 1252 (s), 1190 (m), 1158 (m), 1104 (s), 1070 (m), 1050 (m), 1030 (s), 1005 (m), 963 (m), 938 (m), 908 (m), 873 (m), 834 (s), 810 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 4. 41 (d, J = 3. 1 Hz, 1 H), 4. 23 (d, J = 8. 6 Hz, 1 H), 4. 02 (dd, J = 8. 6, 1. 3 Hz, 1 H), 3. 29 (s, 3 H), 3. 26 (s, 3 H), 2. 93 (ddd, J = 14. 0, 12. 4, 2. 5 Hz, 1 H), 2. 85-2. 78 (m, 3 H), 2. 11-2. 05 (m, 1 H), 1. 93-1. 77 (m, 3 H), 1. 00 (d, J = 7. 2 Hz, 3 H), 0. 91 (s, 9 H), 0. 85 (d, J = 6. 9 Hz, 3 H), 0. 17 (s, 3 H), 0. 09 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 105. 0, 71. 5, 53. 0, 51. 5, 51. 2, 43. 8, 37. 4, 31. 3, 30. 2, 26. 3, 18. 8, 12. 9, 8. 1,-3. 8,-4. 3 ; high resolution mass spectrum (FAB, NBA) m/z 417. 1934 [ (M+Na) + ; calcd for Cl8H3803S2SiNa : 417. 1930].

Anal. Calcd for Cl8H3803S2Si : C, 54. 78 ; H, 9. 70. Found : C, 54. 80 ; H, 9. 66.

EXAMPLE 25 Hydroxy Acetal (-)-32.

A solution of dithiane (+)-30 (3. 60 g, 9. 12 mmol) in 10% HMPA/THF (60 mL) was cooled to-78 °C and treated with t-BuLi (1. 7 M in pentane, 5. 63 mL, 9. 58 mmol) dropwise over 15 min. The mixture was stirred 1 h at-78 °C and 1 h at-42 °C, then recooled to-78 °C. A solution of benzyl R- (-)-glycidyl ether (1. 65 g, 10. 0 mmol) in 10% HMPA/THF (12 mL) was added via cannula. After 0. 5 h, the reaction mixture was warmed to-42

°C for 0. 5 h and quenched with saturated aqueous NH4C1 (20 mL).

The mixture was diluted with ether (200 mL), washed with water, brine (200 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (100-. ethyl acetate/hexane) afforded (-)-32 (4. 04 g, 79W yield) as a colorless oil : lul 23D -5. 9° (c 2. 1, CHCl3) ; IR CHCl3) 3450 (w, br), 3020 (m), 2960 (s), 2940 (s), 2910 (m), 2860 (m), 2840 (m), 1605 (w), 1500 (w), 1475 (m), 1468 (m), 1458 (m), 1440 (m), 1430 (m), 1393 (m), 1387 (m), 1365 (m), 1280 (w), 1255 (m), 1233 (m), 1203 (m), 1167 (w), 1153 (w), 1110 (s), 1060 (m), 1045 (m), 1030 (m), 1010 (m), 980 (w), 940 (m), 910 (w), 860 (m), 837 (s), 800 (m), 695 (m), 670 (m), 660 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 35-7. 25 (m, 5 H), 4. 64 (dd, J = 4. 0, 1. 1 Hz, 1 H), 4. 57 (ABq, J = 12. 1 Hz, AdX3 = 17. 8 Hz, 2 H), 4. 21 (d, J = 7. 7 Hz, 1 H), 4. 14-4. 09 (m, 1 H), 3. 48 (dd, J = 9. 5, 6. 0 Hz, 1 H), 3. 47 (dd, J = 9. 6, 5. 0 Hz, 1 H), 3. 37 (d, J = 0. 7 Hz, 1 H), 3. 36 (s, 3 H), 3. 29 (s, 3 H), 3. 08 (ddd, J = 14. 4, 11. 4, 2. 9 Hz, 1 H), 2. 95 (ddd, J = 14. 4, 11. 3, 3. 1 Hz, 1 H), 2. 71-2. 64 (m, 2 H), 2. 59 (dqd, J = 6. 7, 6. 7, 0. 9 Hz, 1 H), 2. 49 (dd, J = 15. 6, 7. 9 Hz, 1 H), 2. 30 (dq, J = 4. 0, 7. 3 Hz, 1 H), 2. 27 (dd, J = 15. 6, 2. 3 Hz, 1 H), 2. 04-2. 00 (m, 1 H), 1. 86-1. 78 (m, 1 H), 1. 18 (d, J = 7. 4 Hz, 3 H), 0. 94 (d, J = 6. 8 Hz, 3 H), 0. 90 (s, 9 H), 0. 08 (s, 3 H), 0. 07 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 138. 2, 128. 4, 127. 6, 106. 9, 74. 4, 73. 3, 70. 0, 67. 9, 55. 7, 53. 6, 52. 6, 47. 2, 39. 4, 38. 5, 26. 3, 26. 1, 26. 0, 25. 0, 18. 3, 9. 8, 9. 5,-3. 9, -4. 9 ; high resolution mass spectrum (FAB, NBA) m/z 581. 2763 [(M+Na) + ; calcd for CH,. OsS, SiNa : 581. 2767].

EXAMPLE 26 Ketone (+)-33.

A solution of hydroxy acetal (-)-32 (3. 94 g, 7. 05 mmol) in H2O/MeOH (1 : 9, 75 mL) was treated with (CF CQ) iPt (4. 55 g, 10. 6 mmol) at 0 °C. After 5 min, the mixture was quenched with saturated NaHCO3 (20 mL) and extracted with ether (200 mL). The organic phase was washed with brine (200 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (20k ethyl acetate/hexane) furnished (+)-33

(2. 66 g, 80W yield) as a colorless oil. [a] 23D +36° (c 0. 36, CHCl3) ; IR (CHCl3) 3580 (w, br), 3005 (m), 2960 (s), 2930 (s), 2900 (m), 2860 (m), 1710 (m), 1463 (m), 1455 (m), 1387 (m), 1362 (m), 1253 (m), 1220 (m), 1105 (s), 1070 (s), 1053 (s), 1030 (s), 1002 (m), 938 (m), 866 (m), 830 (s), 808 (m), 690 (m), 660 (m) cm'' ; 1H NMR (500 MHZ, CDCl3) d 7. 34-7. 25 (m, 5 H), 4. 54 (apparent s, 2 H), 4. 40-4. 25 (m, 1 H), 4. 23 (dd, J = 7. 6, 1. 9 Hz, 1 H), 4. 19 (d, J = 8. 0 Hz, 1 H), 3. 46 (dd, J = 9. 7, 4. 9 Hz, 1 H), 3. 43 (dd, J = 9. 7, 5. 9 Hz, 1 H), 3. 27 (s, 3 H), 3. 25 (s, 3 H), 3. 01 (d, J = 3. 8 Hz, 1 H), 2. 76 (dd, J = 18. 0, 8. 7 Hz, 1 H), 2. 74 (dq, J = 7. 1, 7. 1 Hz, 1 H), 2. 62 (dd, J = 17. 9, 3. 2 Hz, 1 H), 1. 83 (dqd, J = 8. 0, 7. 0, 1. 9 Hz, 1 H), 0. 97 (d, J = 7. 1 Hz, 3 H), 0. 88 (d, J = 6. 9 Hz, 3 H), 0. 83 (s, 9 H), 0. 06 (s, 3 H),-0. 05 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 213. 0, 138. 0, 128. 4, 127. 71, 127. 68, 105. 0, 73. 4, 73. 3, 71. 8, 66. 5, 52. 9, 52. 6, 52. 3, 46. 5, 37. 9, 26. 1, 18. 4, 12. 7, 8. 8,-4. 1, -4. 8 ; high resolution mass spectrum (FAB, NBA) m/z 491. 2821 [(M+Na) + ; calcd for C2, H4406SiNa : 491. 2805].

EXAMPLE 27 Diol (-)-34.

A solution of Me4NBH (OAc) 3 (1. 80 g, 6. 84 mmol) in HOAc/CH3CN (1 : 1, 10. 0 mL) was cooled to-40 C and ketone (+)-33 (536 mg, 1. 14 mmol) in CH3CN (5 mL) was added. After 12 h at-20 °C, the mixture was treated with saturated aqueous Rochelle's salt (20 mL) and extracted with CH2Cl2 (3 x 50 mL).

The combined organic extracts were washed with saturated NaHC03, brine (100 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (1 : 1 : 1, CH2Cl2/ether/hexane) provided (-)-34 (519 mg, 97% yield) as a colorless oil : [a] 23D -7. 78° (c 0. 900, CHCl3) ; IR (CHC1,) 3680 (w), 3460 (m, br), 3015 (m), 2960 (s), 2940 (s), 2900 (m), 2865 (s), 1470 (m), 1460 (m), 1390 (m), 1365 (m), 1260 (m), 1230 (m), 1208 (m), 1112 (s), 1065 (s), 1030 (m), 1010 (m), 942 (m), 865 (m), 838 (m), 698 (m) cm~1 ; 1H NMR (500 MHZ, CDCl3) d 7. 33-7. 30 (m, 4 H), 7. 29-7. 25 (m, 1 H), 4. 55 (ABq, J = 12. 0 Hz, Abc = 15. 7 Hz, 2 H), 4. 16-4. 11 (m, 1 H), 4. 13 (d, J = 7. 8 Hz, 1 H), 4. 07 (dd, J

= 4. 8, 1. 6 Hz, 1 H), 3. 73 (br s, 1 H), 3. 68 (dddd, J = 9. 3, 9. 3, 2. 4, 2. 4 Hz, 1H), 3. 50 (dd, J = 9. 6, 4. 5 Hz, 1 H), 3. 42 (dd, J = 9. 4, 7. 0 Hz, 1 H), 3. 38 (s, 3 H), 3. 29 (s, 3 H), 3. 09 (d, J = 4. 0 Hz, 1 H), 1. 90 (dqd, J = 7. 0, 7. 0, 1. 5 Hz, 1 H), 1. 76 (br dd, J = 13. 6, 8. 5 Hz, 1 H), 1. 68 (dqd, J = 9. 6, 6. 9, 5. 0 Hz, 1 H), 1. 49 (ddd, J = 14. 3, 9. 0, 2. 9 Hz, 1 H), 0. 894 (d, J = 7. 9 Hz, 3 H), 0. 886 (s, 9 H), 0. 80 (d, J = 7. 0 Hz, 3 H), 0. 055 (s, 3 H), 0. 048 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 138. 2, 128. 4, 127. 7, 127. 6, 107. 3, 74. 5, 73. 3, 71. 0, 70. 9, 67. 8, 55. 2, 52. 1, 45. 9, 37. 3, 36. 9, 25. 9, 18. 2, 11. 6, 10. 6, -4. 3,-4. 7 ; high resolution mass spectrum (FAB, NBA) m/z 493. 2951 [ (M+Na) + ; calcd for CzSH4606SiNa : 493. 2962].

EXAMPLE 28 Alcohol (-)-35.

A solution of (-)-34 (123. 3 mg, 0. 262 mmol) in benzene (10 mL) was treated with TsOH H2O (2. 0 mg, 0. 0105 mmol) at room temperature. After 20 min, the mixture was quenched with NEt3 (1. 0 mL) and concentrated. Flash chromatography (2h ether/CH2Cl2) afforded 35 (100. 1 mg, ß/a = 2 : 1, 87W yield) as a colorless oil.

ß Anomer (35) : [a] 2'D-3. 3 ° (c 2. 25, CHCl3) ; IR (CHCl3) 3680 (w), 3580 (w), 3490 (w), 3010 (m), 2960 (s), 2930 (s), 2880 (m), 2860 (s), 1603 (w), 1525 (w), 1515 (w), 1493 (m), 1470 (m), 1460 (m), 1450 (m), 1387 (m), 1360 (m), 1347 (m), 1330 (m), 1253 (s), 1225 (m), 1200 (m), 1143 (m), 1110 (s), 1070 (s), 1045 (s), 1020 (s), 1015 (m), 1003 (m), 985 (m), 950 (m), 870 (m), 853 (m), 833 (s), 807 (m), 800 (m), 790 (m), 690 (m), 670 (m), 657 (m) cm-' ; 1H NMR (500 MHZ, CDCl3) d 7. 34-7. 25 (m, 5 H), 4. 69 (d, J = 2. 4 Hz, 1 H), 4. 55 (ABq, JX3 = 12. 0 Hz, AdX3 = 14. 6 Hz, 2 H), 4. 17-4. 12 (m, 1 H), 3. 78 (ddd, J = 9. 7, 9. 7, 2. 5 Hz, 1 H), 3. 60 (apparent t, J = 2. 7 Hz, 1 H), 3. 51 (dd, J = 9. 5, 4. 1 Hz, 1 H), 3. 42 (s, 3 H), 3. 39 (dd, J = 9. 5, 7. 0 Hz, 1 H), 2. 86 (d, J = 3. 8 Hz, 1 H), 1. 88 (apparent qt, J = 7. 1, 2. 7 Hz, 1 H), 1. 76 (ddd, J = 14. 4, 8. 9, 2. 6 Hz, 1 H), 1. 72-1. 65 (m, 1 H), 1. 53 (ddd, J = 14. 4, 9. 3, 2. 9 Hz, 1 H), 0. 90 (d, J = 8. 2 Hz, 3 H), 0. 89 (s, 9 H), 0. 78 (d, J = 6. 8 Hz,

3 H), 0. 04 (s, 3 H), 0. 02 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 138. 2, 128. 4, 127. 7, 101. 2, 76. 7, 74. 7, 73. 3, 73. 0, 67. 4, 56. 6, 41. 1, 36. 0, 34. 7, 25. 9, 18. 1, 13. 7, 9. 7,-4. 6,-4. 9 ; high resolution mass spectrum (FAB, NBA) m/z 461. 2693 [(M+Na)+ ; calcd for C22H42O5SiNa : 461. 2699]. a Anomer (35) : [α]23D +48° (c 0. 54, CHCl3) ; IR (CHC1,) 3670 (w), 3570 (w), 3480 (w, br), 3005 (m), 2960 (s), 2930 (s), 2880 (m), 2855 (s), 1600 (w), 1527 (w), 1515 (w), 1495 (w), 1460 (m), 1360 (m), 1253 (s), 1225 (m), 1212 (m), 1200 (m), 1170 (m), 1148 (m), 1106 (s), 1087 (s), 1048 (s), 1030 (s), 963 (m), 872 (m), 833 (s), 788 (m), 690 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 34-7. 24 (m, 5 H), 4. 55 (ABq, JX3 = 12. 1 Hz, A6 AB= 14. 4 Hz, 2 H), 4. 30 (d, J = 2. 9 Hz, 1 H), 4. 12-4. 07 (m, 1 H), 4. 01 (ddd, J = 9. 2, 9. 2, 2. 7 Hz, 1 H), 3. 51 (apparent t, J = 4. 4 Hz, 1 H), 3. 50 (dd, J = 9. 5, 4. 2 Hz, 1 H), 3. 39 (dd, J = 9. 5, 7. 1 Hz, 1 H), 3. 28 (s, 3 H), 2. 86 (d, J = 3. 2 Hz, 1 H), 1. 85 (qdd, J = 7. 3, 5. 2, 2. 9 Hz, 1 H), 1. 76 (dqd, J = 9. 3, 6. 9, 4. 0 Hz, 1 H), 1. 71 (ddd, J = 14. 5, 9. 0, 2. 8 Hz, 1 H), 1. 55 (ddd, J = 14. 4, 9. 2, 2. 9 Hz, 1 H), 0. 96 (d, J = 7. 3 Hz, 3 H), 0. 88 (s, 9 H), 0. 81 (d, J = 6. 8 Hz, 3 H), 0. 03 (s, 3 H),-0. 01 (s, 3 H) ; 13C NMR d 138. 2, 128. 4, 127. 7, 101. 2, 76. 7, 74. 7, 73. 3, 73. 0, 67. 4, 56. 7, 41. 1, 36. 0, 34. 7, 25. 9, 18. 1, 13. 7, 9. 7,-4. 6,-4. 9 ; high resolution mass spectrum (FAB, NBA) m/z 461. 2715 [ (M+Na) + ; calcd for C2, H420ISiNa : 461. 2699].

EXAMPLE 29 Methyl Pyranoside 36.

A solution of 35 (281. 2 mg, /a = 2 : 1, 0. 642 mmol) and 2, 6-lutidine (224. 0 µL, 1. 92 mmol) in CH2Cl2 (6. 0 mL) was cooled to 0 °C and TBSOTf (295. 0 µL, 1. 28 mmol) was added over 5 min.

After 1 h at 0 °C the mixture was diluted with ethyl acetate (100 mL), washed with aqueous NaHSO4 (1. 0 M, 50 mL), brine (100 mL), dried over MgSOR, filtered and concentrated. Flash chromatography (50-. ethyl acetate/hexane) provided 36 (344. 6 mg, j6/o'= 2 : 1, 97% yield) as a colorless oil. a anomer : [α]23D +50.0° (C 1. 44, CHC1 IR (CHC1 2960 (s), 2935 (s), 2885 (s), 2860 (s), 1490 (w), 1460 (m),

1388 (m), 1378 (m), 1360 (m), 1250 (s), 1190 (m), 1145 (m), 1105 (s), 1085 (s), 1050 (s), 1025 (s), 1002 (s), 963 (m), 934 (m), 867 (m), 833 (s), 690 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 32-7. 25 (m, 5 H), 4. 51 (ABq, J, = 12. 1 Hz, ##AB = 19. 7 Hz, 2 H), 4. 23 (d, J = 4. 8 Hz, 1 H), 4. 03 (dddd, J = 8. 0, 5. 3, 5. 3, 2. 5 Hz, 1 H), 3. 87 (ddd, J = 9. 9, 7. 8, 1. 8 Hz, 1 H), 3. 53 (dd, J = 7. 2, 4. 8 Hz, 1 H), 3. 39 (dd, J = 9. 8, 5. 6 Hz, 1 H), 3. 37 (dd, J= 10. 0, 5. 2 Hz, 1 H), 3. 33 (s, 3 H), 1. 79 (dqd, J = 7. 1, 7. 1, 4. 9 Hz, 1 H), 1. 71-1. 64 (m, 2 H), 1. 53 (ddd, J = 14. 4, 8. 8, 1. 9 Hz, 1 H), 0. 94 (d, J = 7. 0 Hz, 3 H), 0. 89 (s, 9 H), 0. 865 (s, 9 H), 0. 862 (d, J = 6. 9 Hz, 3 H), 0. 07 (s, 3 H), 0. 04 (s, 3 H), 0. 03 (s, 3 H), 0. 005 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 138. 5, 128. 3, 127. 6, 127. 5, 103. 8, 75. 5, 73. 2, 72. 8, 69. 8, 69. 1, 55. 7, 38. 9, 38. 5, 37. 6, 26. 0, 25. 8, 18. 18, 18. 16, 15. 1, 12. 9,-3. 9,-4. 6,-4. 7,-4. 8 ; high resolution mass spectrum (FAB, NBA) m/z 575. 3552 [(M+Na) + ; calcd for C3oHssOsSi2Na : 575. 3564]. anomer : [a] 23D +13. 3 (c 1. 38, CHCl3); IR (CHCl3) 3003 (m), 2960 (s), 2935 (s), 2880 (s), 2860 (s), 1495 (w), 1470 (m), 1464 (m), 1390 (m), 1360 (m), 1350 (m), 1330 (w), 1253 (s), 1155 (s), 1140 (s), 1120 (s), 1090 (s), 1045 (s), 1022 (s), 1002 (s), 953 (m), 933 (m), 850 (s), 830 (s), 690 (m), 658 (m) cm~1 ; 1H NMR (500 MHZ, CDCl3) d 7. 32-7. 22 (m, 5 H), 4. 74 (d, J = 2. 4 Hz, 1 H), 4. 50 (ABq, J = 13. 2 Hz, A6A, = 17. 8 Hz, 2 H), 4. 23-4. 18 (m, 1 H), 3. 74 (ddd, J = 10. 6, 10. 6, 1. 3 Hz, 1 H), 3. 60 (apparent t, J = 2. 7 Hz, 1 H), 3. 48 (s, 3 H), 3. 38 (dd, J = 9. 8, 4. 5 Hz, 1 H), 3. 35 (dd, J = 9. 8, 5. 7 Hz, 1 H), 1. 88 (qdd, J = 7. 1, 2. 7, 2. 7 Hz, 1 H), 1. 66 (ddd, J = 14. 0, 10. 1, 1. 6 Hz, 1 H), 1. 63-1. 55 (m, 1 H), 1. 49 (ddd, J = 14. 0, 10. 8, 1. 8 Hz, 1 H), 0. 91 (d, J = 7. 1 Hz, 3 H), 0. 89 (s, 9 H), 0. 88 (s, 9 H), 0. 785 (d, J = 6. 8 Hz, 3 H), 0. 07 (s, 3 H), 0. 045 (s, 3 H), 0. 040 (s, 3 H), 0. 02 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 138. 5, 128. 2, 127. 6, 127. 4, 100. 6, 76. 9, 75. 8, 73. 2, 71. 7, 67. 9, 56. 7, 41. 1, 38. 4, 35. 0, 26. 1, 25. 8, 18. 2, 18. 1, 14. 0, 9. 7,-3. 9,-4. 5,-5. 0 ; high resolution mass spectrum (FAB, NBA) m/z 575. 3560 [ (M+Na) + ; calcd for C3, H Q6Si Na :, 575. 3564].

EXAMPLE 30 Primary Alcohol 37.

A solution of 36 (331. 6 mg, 0. 600 mmol) in EtOH/EtOAc (1 : 8, 9 mL) was treated with Pd/C (10t wet, E101 NE/W, 51. 2 mg) under H2 atmosphere for 3 h, then filtered and concentrated.

Flash chromatography (10o ethyl acetate/hexane) provided 37 (276. 6 mg, glu = 2 : 1, 99% yield) as a colorless oil.

ß anomer : [a]' +16. 9° (c 2. 52, CHCl3) ; IR (CHC1,) 3680 (w), 3590 (w, br), 3450 (w, br), 3000 (m), 2960 (s), 2925 (s), 2880 (m), 2855 (s), 1470 (m), 1462 (m), 1388 (m), 1360 (m), 1253 (s), 1222 (m), 1200 (m), 1150 (m), 1130 (m), 1110 (s), 1098 (m), 1065 (s), 1046 (s), 1023 (s), 1002 (m), 980 (m), 952 (m), 894 (m), 865 (m), 850 (m), 830 (s), 663 (m), 657 (m) cm-1 ; 'H NMR (500 MHZ, CDCl3) d 4. 73 (d, J = 2. 5 Hz, 1 H), 4. 09-4. 05 (m, 1 H), 3. 64 (ddd, J = 10. 5, 10. 5, 1. 3 Hz, 1 H), 3. 60 (apparent t, J = 2. 5 Hz, 1 H), 3. 62-3. 59 (m, 1 H), 3. 47 (s, 3 H), 3. 47-3. 42 (m, 1 H), 1. 95-1. 85 (m, 2 H), 1. 82 (ddd, J = 14. 3, 9. 2, 1. 5 Hz, 1 H), 1. 60 (dqd, J = 10. 2, 6. 8, 2. 5 Hz, 1 H), 1. 45 (ddd, J = 14. 3, 10. 7, 2. 6 Hz, 1 H), 0. 895 (d, J = 7. 5 Hz, 3 H), 0. 887 (apparent s, 18 H), 0. 785 (d, J = 6. 8 Hz, 3 H), 0. 09 (s, 3 H), 0. 08 (s, 3 H), 0. 04 (s, 3 H), 0. 02 (s, 3 H) ; 13C NMR (125 MHZ, CDC13) d 100. 8, 76. 8, 72. 2, 69. 5, 67. 6, 56. 8, 41. 0, 38. 2, 34. 9, 25. 9, 25. 8, 18. 1, 14. 0, 9. 7,-4. 2,-4. 6, -4. 7,-5. 0 ; high resolution mass spectrum (FAB, NBA) m/z 485. 3080 [(M+Na) + ; calcd for C23HsOOsSiNa : 485. 3094]. a anomer : [a] +54. 9° (c 1. 20, CHCl3) ; IR (CHCl3) 3670 (w), 3590 (w) 3440 (w, br), 3000 (m), 2960 (s), 2925 (s), 2880 (m), 2855 (s), 1463 (m), 1390 (m), 1360 (m), 1255 (s), 1225 (m), 1192 (m), 1168 (m), 1143 (m), 1102 (s), 1083 (s), 1045 (s), 1030 (m), 1002 (m), 963 (m), 932 (m), 862 (m), 833 (s) cm~1 ; 1H NMR (500 MHZ, CDCl3) d 4. 25 (d, J = 4. 2 Hz, 1 H), 3. 89 (dddd, J = 6. 5, 4. 6, 4. 6, 4. 6 Hz, 1 H), 3. 80 (ddd, J = 9. 1, 9. 1, 2. 3 Hz, 1 H), 3. 61 (br dd, J = 10. 9, 3. 4 Hz, 1 H), 3. 51 (dd, J = 6. 5, 4. 6 Hz, 1 H), 3. 52-3. 48 (m, 1 H), 3. 33 (s, 3 H), 2. 15 (s, br, 1 H), 1. 81 (dqd, J = 6. 9, 6. 9, 4. 2 Hz, 1 H), 1. 72-1. 60 (m, 3 H), 0. 94 (d, J = 7. 1 Hz, 3 H), 0. 882 (s, 9 H), 0. 879 (s, 9 H), 0. 845 (d, J = 6. 8 Hz, 3 H), 0. 09 (s, 3 H), 0. 08

(s, 3 H), 0. 02 (s, 3 H), 0. 00 (s, 3 H) ; 13C NMR (125 MHz, CDCl3) d 104. 0, 72. 7, 71. 3, 70. 0, 67. 6, 55. 7, 38. 7, 38. 5, 37. 3, 25. 8, 18. 13, 18. 08, 15. 2, 13. 1,-4. 4,-4. 6,-4. 7 ; high resolution mass spectrum (FAB, NBA) m/z 485. 3081 [ (M+Na) + ; calcd for CHOsSi. Na : 485. 3094].

EXAMPLE 31 Alcohol 38.

A solution of 37 (276. 6 mg, 0. 598 mmol) in Et20 (40 mL) was treated with EtSH (8. 90 mL, 120 mmol) and MgBr2. Et2O (1. 54 g, 5. 96 mmol) at room temperature. After 60 h, the mixture was diluted with ethyl acetate (50 mL), washed with brine (2 x 100 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (3% acetone/hexane) provided 38 a (34. 4 mg, 12% yield) and 38 ß (211. 3 mg, 71% yield).

ß anomer : colorless oil ; [a] 23D +16. 6° (c 1. 18, CHCl3) ; IR (CHCl3) 3595 (m), 3400 (m, br), 3000 (m), 2960 (s), 2930 (s), 2855 (s), 1655 (w), 1612 (s), 1588 (m), 1510 (s), 1462 (s), 1375 (m), 1360 (m), 1300 (m), 1250 (s, br), 1170 (m), 1080 (s, br), 1030 (s), 1002 (m), 967 (m), 835 (s) cm'' ; 1H NMR (500 MHZ, CDCl3) d 5. 08 (d, J = 2. 3 Hz, 1 H), 4. 04-4. 00 (m, 1H), 3. 62 (ddd, J = 10. 4, 10. 4, 1. 0 Hz, 1 H), 3. 60 (ddd, J = 11. 1, 11. 1, 4. 2 Hz, 1 H), 3. 56 (apparent t, J = 2. 7 Hz, 1 H), 3. 43 (ddd, J = 11. 7, 7. 9, 4. 1 Hz, 1 H), 2. 70 (dq, J = 12. 7, 7. 4 Hz, 1 H), 2. 67 (dq, J = 12. 8, 7. 5 Hz, 1 H), 1. 95 (dd, J = 7. 9, 4. 8 Hz, 1 H), 1. 86 (qdd, J = 7. 1, 2. 7, 2. 7 Hz, 1 H), 1. 79 (ddd, J = 14. 4, 9. 0, 1. 4 Hz, 1 H), 1. 66-1. 59 (m, 1 H), 1. 57 (s, 3 H), 1. 45 (ddd, J = 14. 4, 10. 5, 2. 7 Hz, 1 H), 1. 27 (apparent t, J = 7. 4 Hz, 1 H), 0. 99 (d, J = 7. 1 Hz, 3 H), 0. 90 (s, 9 H), 0. 89 (s, 9 H), 0. 79 (d, J = 6. 8 Hz, 3 H), 0. 083 (s, 3 H), 0. 075 (s, 3 H), 0. 04 (s, 3 H), 0. 03 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 81. 0, 76. 2, 75. 0, 69. 8, 67. 6, 41. 9, 38. 3, 34. 5, 25. 9, 25. 8, 25. 2, 18. 1, 15. 2, 14. 4, 11. 5,-4. 2,-4. 56,-4. 63,-4. 9 ; high resolution mass spectrum (FAB, NBA) m/z 515. 3037 [(M+Na) ; calcd for C24Hs204SSi2Na : 515. 3023].

a anomer : colorless oil ; [a] 23D +94. 5° (c 0. 33, CHCl3) ; IR (CHCl3) 3680 (w), 3580 (w), 3440 (w, br), 3010 (m), 2960 (s), 2930 (s), 2880 (m), 2860 (s), 1513 (w), 1470 (m), 1462 (m), 1390 (m), 1380 (m), 1360 (m), 1257 (s), 1225 (m), 1200 (m), 1114 (m), 1070 (s), 1047 (s), 1022 (m), 1002 (m), 957 (m), 860 (m), 833 (s), 705 (s), 660 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 4. 76 (d, J = 3. 1 Hz, 1 H), 4. 04 (ddd, J = 9. 8, 9. 8, 1. 8 Hz, 1 H), 3. 84 (dddd, J = 5. 0, 5. 0, 5. 0, 5. 0 Hz, 1 H), 3. 57 (dd, J = 11. 0, 4. 2 Hz, 1 H), 3. 53 (apparent t, J = 4. 0 Hz, 1 H), 3. 47 (dd, J = 11. 0, 4. 7 Hz, 1 H), 2. 57 dq, J = 12. 8, 7. 5 Hz, 1 H), 2. 54 (dq, J = 12. 8, 7. 5 Hz, 1 H), 1. 97-1. 91 (m, 1 H), 1. 75 (ddd, J = 14. 7, 6. 1 Hz, 2. 0, 1 H), 1. 72-1. 65 (m, 1 H), 1. 60 (ddd, J = 14. 9, 10. 0, 5. 1 Hz, 1 H), 1. 60-1. 50 (br, 1 H), 1. 23 (apparent t, J = 7. 4 Hz, 3 H), 1. 06 (d, J = 7. 1 Hz, 3 H), 0. 92 (s, 9 H), 0. 89 (s, 9 H), 0. 85 (d, J = 6. 9 Hz, 3 H), 0. 12 (s, 3 H), 0. 08 (s, 3 H), 0. 05 (s, 3 H), 0. 02 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 85. 3, 73. 8, 71. 5, 69. 2, 67. 5, 40. 6, 38. 2, 36. 4, 26. 4, 26. 1, 25. 9, 18. 2, 18. 1, 17. 5, 14. 7, 13. 9,-4. 2, -4. 4,-4. 8 ; high resolution mass spectrum (FAB, NBA) m/z 515. 3045 [(M+Na) + ; calcd for C24H5204SSi2Na : 515. 3023].

EXAMPLE 32 Fragment (+)-C.

A solution of DMSO (100 yL, 1. 42 mmol) in CH2Cl2 (2. 0 mL) was cooled to-78 °C and oxalyl chloride (55. 0 µl, 0. 630 mmol) was introduced dropwise. After 15 min. a cooled (-78 °C) solution of 38 a (104. 8 mg, 0. 213 mmol) in CH2C12 (1. 0 mL) was introduced via cannula (2 x 500 ßL rinse). The resultant milky solution was stirred for 15 min at-78 °C and i-Pr2NEt (370 yl, 2. 12 mmol) was added dropwise. The reaction mixture was stirred for 0. 5 h, slowly warmed to room temperature (15 min), and quenched with aqueous NaHSO4 (1. 0 M, 4. 0 mL). The organic phase was diluted with ether (30 mL), washed with brine (3 x 30 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (2W ethyl acetate/hexane) furnished (+)-C (88. 8 mg, 86% yield) as a colorless oil : [a] 23D +11. 2° (c 1. 42, CHCl3) ; IR (CHCl3) 2960 (s), 2935 (s), 2880 (s), 2860 (s), 1735

(s), 1470 (m), 1460 (m), 1380 (m), 1360 (m), 1320 (m), 1295 (w), 1265 (s), 1153 (m), 1120 (m), 1080 (m), 1060 (s), 1043 (s), 1025 (s), 1003 (s), 970 (m), 950 (m), 935 (m), 903 (m), 865 (m), 835 (s), 800 (m), 690 (m) cm-1 ;'H NMR (500 MHZ, CDC13) d 9. 56 (d, J = 0. 9 Hz, 1 H), 5. 07 (d, J = 2. 3 Hz, 1 H), 4. 35 (ddd, J = 7. 9, 2. 2, 0. 6 Hz, 1 H), 3. 70 (ddd, J = 10. 3, 10. 3, 1. 5 Hz, 1 H), 3. 57 (apparent t, J = 2. 7 Hz, 1 H), 2. 71-2. 60 (m, 2 H), 1. 86 (apparent qt, J = 7. 1, 2. 7 Hz, 1 H), 1. 78 (ddd, J = 14. 1, 10. 4, 7. 8 Hz, 1 H), 1. 72-1. 66 (m, 1 H), 1. 67 (ddd, J = 10. 3, 3. 9, 1. 8 Hz, 1 H), 1. 25 (apparent t, J = 7. 4 Hz, 3 H), 1. 00 (d, J = 7. 2 Hz, 3 H), 0. 90 (s, 9 H), 0. 89 (s, 9 H), 0. 78 (d, J = 6. 8 Hz, 3 H), 0. 10 (s, 3 H), 0. 04 (s, 6 H), 0. 03 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 202. 6, 81. 2, 76. 1, 74. 9, 73. 7, 41. 9, 35. 8, 34. 4, 25. 82, 25. 79, 25. 2, 18. 2, 18. 1, 15. 3, 14. 3, 11. 5,-4. 2,-4. 5,-4. 9,-5. 2 ; high resolution mass spectrum (CI, NH3) m/z 491. 3058 [(M+H)+ ; calcd for CHOSSi : 491. 3046].

EXAMPLE 33 Fragment (-)-B.

From vinyl bromide (-)-22 : A solution of (-)-22 (3. 78 g, 8. 04 mmol) in HMPA/DMF (2 : 1, 6 mL) was added to a mixture of KI (4. 15 g, 250 mmol), NiBr2 (34. 9 mg, 0. 160 mmol), and Zn powder (23. 2 mg, 0. 355 mmol). The mixture was stirred at room temperature for 15 min then heated to 90 °C. The green color mixture turned black-brown after 5 min and dark green after 1 h. After additional 1 h at 90 °C, the mixture was cooled to room temperature, diluted with ethyl acetate (200 mL), washed with brine (4 x 200 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (2W ethyl acetate/hexane) provided B (3. 59 g, containing 13% unreacted vinyl bromide) as a colorless oil.

From aldehyde (+)-18 : A suspension of EtPh3P+I- (15. 1 g, 36. 1 mmol) in THF (200 mL) was treated with n-BuLi (1. 6 M in hexane, 23. 0 mL, 36. 8 mmol) at room temperature over 10 min.

After an additional 10 min, the resultant red solution was added via cannula to a cooled (-78°C) solution of I2 (8. 02 g, 31. 6 mmol) in THF (300 mL) over 15 min. The yellow slurry

formed was stirred at-78 °C for 5 min and at-23 °C for 10 min. NaHMDS (1. 0 M in THF, 31. 0 mL, 31. 0 mmol) was added over 8 min and the mixture stirred 15 min further. A solution of aldehyde (+)-18 (6. 96 g, 18. 3 mmol) in THF (50 mL) was introduced via cannula (lOmL rinse), and the reaction mixture was stirred at-23 °C for 10 min, warmed to room temperature, stirred for 3 h, and then quenched with MeOH (10 mL).

Following concentration and filtration through a silica column (50% ethyl acetate/hexane), the filtrate was washed with saturated aqueous Na2S203, brine (300 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (5W ethyl acetate/hexane) furnished B (6 : 1 Z/E, 3. 94 g, 41% yield) as a colorless oil.

An analytical sample of (-)-B was obtained by reversed-phase HPLC (gradient elution, 90% CHCN/HO-> 100% CH3CN) : [a] 23D-23 (c 0. 30, CHCl3) ; IR (CHCl3) 3000 (m), 2960 (s), 2930 (s), 2880 (m), 2855 (s), 1610 (m), 1588 (w), 1510 (s), 1463 (m), 1453 (m), 1428 (m), 1405 (w), 1390 (m), 1377 (m), 1360 (m), 1303 (m), 1250 (s), 1180 (m), 1172 (m), 1080 (s, br), 1033 (s), 1002 (m), 948 (m), 935 (m), 922 (m), 833 (s), 803 (m), 760 (m, br), 720 (m), 658 (m) cm~1 ; 1H NMR (500 MHZ, CDC13) d 7. 25 (d, J = 8. 6 Hz, 2 H), 6. 87 (d, J = 8. 7 Hz, 2 H), 5. 28 (apparent dd, J = 8. 9, 1. 4 Hz, 1 H), 4. 41 (ABq, J = 7. 0 Hz, ##AB = 10.2 Hz, 2 H), 3. 80 (s, 3 H), 3. 60 (apparent t, J = 5. 3 Hz, 1 H), 3. 51 (dd, J = 9. 1, 5. 1 Hz, 1 H), 3. 23 (dd, J = 9. 0, 8. 0 Hz, 1 H), 2. 54-2. 47 (m, 1 H), 2. 44 (d, J = 1. 4 Hz, 3 H), 2. 00-1. 92 (m, 1 H), 1. 00 (d, J = 6. 9 Hz, 3 H), 0. 95 (d, J = 6. 7 Hz, 3 H), 0. 89 (s, 9 H), 0. 02 (s, 3 H), 0. 01 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 159. 1, 139. 6, 131. 0, 129. 1, 113. 7, 98. 9, 76. 5, 72. 6, 72. 5, 55. 3, 44. 5, 38. 7, 33. 5, 26. 1, 18. 4, 14. 7, 14. 5,-3. 95,-3. 99 ; high resolution mass spectrum (FAB, NBA) m/z 541. 1626 [(M+Na) + ; calcd for C23H3903ISiNa : 541. 1611].

EXAMPLE 34 Olefin (-)-39.

ZnCl2 (1. 32 g, 9. 69 mmol) was dried at 160 °C under vacuum overnight and then treated with a solution of (-)-A

(5. 25 g, 9. 59 mmol) in dry Et2O (50 mL) via a cannula (2 x 25 mL rinse). The mixture was stirred at room temperature until most of the ZnCl2 dissolved and cooled to-78 °C. t-BuLi (1. 7 M in pentane, 17. 0 mL) was added over 30 min, and the resultant solution was stirred 15 min further, warmed to room temperature, and stirred for 1 h. The solution was added by cannula to a mixture of B (3. 21 g, 6. 19 mmol ; 6 : 1 Z/E) and Pd (PPh3) 4 (364. 0 mg, 0. 315 mmol). The mixture was covered with aluminum foil, stirred overnight, and then diluted with ethyl acetate (100 mL), washed with brine (2 x 100 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (50-,, ethyl acetate/hexane) gave (-)-39 (3. 32 g, 66% yield) as a white semisolid : [a]'-28. 6° (c 1. 53, CHCl3) IR (CHC1,) 3010 (m), 2970 (s), 2940 (s), 2865 (s), 1620 (m), 1590 (w), 1520 (s), 1465 (s), 1445 (m), 1390 (m), 1380 (m), 1360 (m), 1305 (m), 1250 (s), 1175 (m), 1115 (s), 1080 (s), 1040 (s), 970 (m), 940 (w), 860 (m), 835 (s) cm-1 ; 1H NMR (500 MHZ, CDC13) d 7. 36 (d, J = 8. 7 Hz, 2 H), 7. 22 (d, J = 8. 6 Hz, 2 H), 6. 86 (d, J = 9. 0 Hz, 2 H), 6. 84 (d, J = 8. 9 Hz, 2 H), 5. 37 (s, 1 H), 5. 00 (d, J = 10. 2 Hz, 1 H), 4. 36 (ABq, JA3 = 11. 6 Hz, A6A3 = 17. 4 Hz, 2 H), 4. 08 (dd, J = 11. 2, 4. 7 Hz, 1 H), 3. 78 (s, 3 H), 3. 77 (s, 3 H), 3. 61 (dd, J = 7. 1, 1. 8 Hz, 1 H), 3. 51 (dd, J = 9. 9, 1. 7 Hz, 1 H), 3. 47 (apparent t, J = 11. 0 Hz, 1 H), 3. 46 (dd, J = 9. 1, 5. 0 Hz, 1 H), 3. 38 (dd, J = 6. 0, 4. 8 Hz, 1 H), 3. 19 (apparent t, J = 8. 8 Hz, 1 H), 2. 51 (ddq, J = 10. 1, 6. 5, 6. 5 Hz, 1 H), 2. 32 (apparent t, J = 12. 2 Hz, 1 H), 2. 08-2. 02 (m, 1 H), 1. 99-1. 93 (m, 2 H), 1. 88 (dqd, J = 7. 1, 7. 1, 1. 8 Hz, 1 H), 1. 67 (br d, J = 11. 1 Hz, 1 H), 1. 55 (d, J = 0. 5 Hz, 3 H), 1. 01 (d, J = 7. 1 Hz, 3 H), 0. 94 (d, J = 6. 9 Hz, 3 H), 0. 90 (s, 9 H), 0. 89 (d, J = 6. 7 Hz, 3 H), 0. 87 (s, 9 H), 0. 74 (d, J = 6. 3 Hz, 3 H), 0. 73 (d, J = 6. 4 Hz, 3 H), 0. 03 (s, 3 H), 0. 013 (s, 3 H), 0. 008 (s, 3 H), 0. 003 (s, 3 H) ; 13C NMR (125 MHZ, CDC13) d 159. 8, 159. 0, 132. 0, 131. 5, 131. 2, 131. 1, 129. 0, 127. 3, 113. 7, 113. 5, 101. 1, 83. 4, 78. 49, 78. 46, 73. 3, 72. 6, 72. 5, 55. 3, 38. 8, 38. 2, 37. 5, 35. 6, 33. 7, 30. 8, 26. 27, 26. 25, 23. 1, 18. 42, 18. 40, 17. 0, 14. 6, 12. 6, 12. 1, 10. 9,-3. 5,-3. 7,-3. 8,-3. 9 ; high

resolution mass spectrum (FAB, NBA) m/z 835. 5315 [(M+Na) + ; calcd for C47H8007Si2Na : 835. 5341].

Anal. Calcd for C47H8007Si2 : C, 69. 41 ; H, 9. 91. Found : C, 69. 52 ; H, 10. 10.

EXAMPLE 35 Alcohol (-)-40.

A solution of olefin (-)-39 (2. 65 g, 3. 26 mmol) in CH2C12 (32 mL) was cooled to 0 °C and treated with H20 (1. 50 mL) and DDQ (774 mg, 3. 41 mmol). After 4 h, the mixture was diluted with CH2Cl2 (20 mL), dried over MgSO4, and filtered through a silica column (50% ethyl acetate/hexane). Following concentration, the residue was dissolved in EtOH (50 mL) and treated with NaBH4 (500 mg, excess) at room temperature to reduce the contaminated p-methoxybenzyl aldehyde. After 0. 5 h, the mixture was quenched with saturated aqueous NH4Cl (50 mL) at 0 °C then concentrated. The residue was partitioned between CH2Cl2 (200 mL) and water (100 mL). The organic phase was washed with water (100 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (10% ethyl acetate/hexane) provided (-)-40 (2. 06 g, 91% yield) as a white solid. mp 99-100 °C ; [cx] 23D-25. 4° (c 1. 35, CHC13) ; IR (CHC13) 3520 (w), 3010 (m), 2960 (s), 2940 (s), 2880 (m), 2860 (m), 1620 (m), 1593 (w), 1520 (m), 1565 (m), 1390 (m), 1360 (m), 1255 (s), 1175 (m), 1165 (m), 1117 (m), 1075 (s), 1037 (s), 1025 (s), 1005 (m), 982 (m), 965 (m), 930 (w), 835 (s), 800 (m), 705 (w), 675 (w), 660 (w) cm'' ; 1H NMR (500 MHZ, CDCl3) d 7. 36 (d, J = 8. 7 Hz, 2 H), 6. 86 (d, J = 8. 8 Hz, 2 H), 5. 37 (s, 1 H), 5. 01 (d, J = 10. 1 Hz, 1 H), 4. 09 (dd, J = 11. 2, 4. 7 Hz, 1 H), 3. 79 (s, 3 H), 3. 65 (dd, J = 10. 4, 4. 7 Hz, 1 H), 3. 63 (dd, J = 7. 0, 1. 8 Hz, 1 H), 3. 54-3. 50 (m, 1 H), 3. 51 (dd, J = 10. 0, 2. 0 Hz, 1 H), 3. 47 (apparent t, J = 11. 2 Hz, 1 H), 3. 41 (dd, J = 6. 6, 4. 0 Hz, 1 H), 2. 59 (ddq, J = 13. 2, 6. 7, 6. 7 Hz, 1 H), 2. 33 (apparent t, J = 12. 2 Hz, 1 H), 2. 24 (apparent t, J = 5. 5 Hz, 1 H), 2. 09-1. 95 (m, 2 H), 1. 89 (dqd, J = 7. 0, 7. 0, 1. 7 Hz, 1 H), 1. 84-1. 77 (m, 1 H), 1. 72 (br d J = 11. 0 Hz, 1 H), 1. 58 (d, J = 0. 8 Hz, 3 H), 1. 01 (d, J = 7. 1 Hz, 3 H), 0. 98 (d, J = 7. 1

Hz, 3 H), 0. 94 (d, J = 6. 7 Hz, 3 H), 0. 910 (s, 9 H), 0. 905 (s, 9 H), 0. 75 (d, J = 7. 1 Hz, 3 H), 0. 74 (d, J = 7. 1 Hz, 3 H), 0. 09 (s, 3 H), 0. 07 (s, 3 H), 0. 05 (s, 3 H), 0. 01 (s, 3 H) ; 13C NMR (125 MHZ, CDC13) d 159. 8, 133. 0, 131. 5, 130. 5, 127. 3, 113. 4, 101. 0, 83. 3, 81. 6, 78. 4, 73. 3, 65. 4, 55. 3, 38. 5, 38. 2, 37. 6, 37. 0, 33. 7, 30. 8, 26. 17, 26. 16, 23. 2, 18. 4, 18. 3, 17. 4, 15. 7, 12. 6, 12. 1, 10. 9,-3. 57,-3. 61,-3. 66,-3. 9 ; high resolution mass spectrum (CI, NH3) m/z 693. 4918 [(M+H) + ; calcd for C39H7306Si2 : 693. 4945].

Anal. Calcd for C39H7206Si2 : C, 67. 58 ; H, 10. 47.

Found : C, 67. 30 ; H, 10. 54.

EXAMPLE 36 Phosphonium Salt (-)-49.

A solution of alcohol (-)-40 (402. 8 mg, 0. 577 mmol) in PhH/Et2O (1 : 2, 45 mL) was treated with PPh3 (532 mg, 2. 03 mmol) and imidazole (158 mg, 2. 32 mmol). After the imidazole dissolved, I2 (437 mg, 1. 72 mmol) was added under vigorous stirring. The mixture was stirred 2 h and then treated with NEt3 (2 mL). The resultant yellow suspension was diluted with CH2Cl2 (50 mL) and washed with saturated aqueous Na2S203 (100 mL), saturated aqueous NaHCO3 (100 mL), and brine (2 x 100 mL).

The organic phase was dried over MgSO4, filtered and concentrated. Filtration through a short silica column (NEt3/ethyl acetate/hexane, 2 : 10 : 90) removed triphenylphosphine oxide, affording the impure iodide 42. Preparative TLC (500 mm silica gel plate, 4% acetone/hexane) furnished an analytical sample as an unstable white solid : 1H NMR (500 MHZ, CDC1,) d 7. 35 (d, J = 8. 8 Hz, 2 H), 6. 85 (d, J = 8. 7 Hz, 2 H), 5. 37 (s, 1 H), 5. 02 (d, J = 10. 2 Hz, 1 H), 4. 08 (dd, J = 11. 2, 4. 7 Hz, 1 H), 3. 78 (s, 3 H), 3. 62 (dd, J = 7. 0, 1. 8 Hz, 1 H), 3. 51 (dd, J = 9. 9, 1. 7 Hz, 1 H), 3. 47 (apparent t, J = 11. 1 Hz, 1 H), 3. 37 (dd, J = 6. 3, 4. 3 Hz, 1 H), 3. 32 (dd, J = 9. 6, 4. 5 Hz, 1 H), 2. 99 (dd, J = 9. 5, 8. 6 Hz, 1 H), 2. 50 (ddq, J = 10. 2, 6. 5, 6. 5 Hz, 1 H), 2. 31 (apparent t, J = 12. 2 Hz, 1 H), 2. 08-1. 95 (m, 2 H), 1. 88 (dqd, J = 7. 1, 7. 1, 1. 7 Hz, 1 H), 1. 85-1. 78 (m, 1 H), 1. 74 (br d, J = 11. 7 Hz, 1 H), 1. 57 (apparent s, 3 H),

1. 01 (apparent d, J = 7. 0 Hz, 6 H), 0. 91-0. 89 (m, 3 H), 0. 90 (s, 9 H), 0. 89 (s, 9 H), 0. 74 (d, J = 6. 8 Hz, 3 H), 0. 73 (d, J = 6. 7 Hz, 3 H), 0. 06 (s, 3 H), 0. 05 (s, 3 H), 0. 01 (s, 3 H), -0. 02 (s, 3 H) ; 13C NMR (125 MHZ, CDC13/1% pyridine-ds, 20 mg sample) d 159. 8, 132. 9, 131. 5, 130. 4, 127. 3, 113. 5, 101. 1, 83. 3, 79. 6, 78. 5, 73. 3, 55. 3, 41. 4, 38. 3, 37. 6, 36. 0, 33. 7, 30. 8, 26. 20, 26. 17, 23. 2, 18. 4, 17. 7, 17. 3, 13. 5, 12. 6, 12. 2, 10. 9,-3. 5,-3. 6,-4. 0 ; high resolution mass spectrum (FAB, NBA) m/z 803. 3935 [(M+H)+ ; calcd for C39H., zO5ISi2 : 803. 3963].

The very sensitive impure iodide (obtained by filtration through silica) was quickly mixed with i-Pr2NEt (300 yL, 1. 72 mmol) and PPh3 (2. 47 g, 9. 42 mmol). The mixture was heated at 80 °C for 24 h, then cooled to room temperature and extracted with hexane (2 x 30 mL). The residue was purified by flash chromatography (2t MeOH/CHCl3) furnishing (-)-49 (224. 9 mg, 37% yield from (-)-39) as a pale yellow foam. The hexane extract was concentrated and purified by flash chromatography (2*-. ethyl acetate/hexane) affording a mixture of cyclization products (200 mg). Further purification by normal phase HPLC (1. 5t ethyl acetate/hexane) provided (-)-50 as the major cyclization product.

Wittig reagent (-)-49 : [α] 23D-25. 3 (c 1. 48, CHC13) ; IR (CHCl3) 2960 (s), 2930 (s), 2860 (m), 1615 (m), 1590 (w), 1515 (m), 1485 (w), 1460 (m), 1440 (m), 1385 (m), 1360 (m), 1300 (m), 1250 (s), 1215 (m, br), 1180 (m), 1110 (s), 1080 (m), 1025 (m), 1005 (m), 965 (m), 945 (w), 860 (m), 830 (s), 732 (m), 725 (m), 710 (m), 680 (m), 653 (m) cm-1 ; 1H NMR (500 MHZ, CDC13 ; concentration dependent) d 7. 82-7. 76 (m, 15 H), 7. 35 (d, J = 8. 8 Hz, 2 H), 6. 84 (d, J = 8. 8 Hz, 2 H), 5. 35 (s, 1 H), 5. 30 (d, J = 10. 5 Hz, 1 H), 4. 07 (dd, J = 11. 2, 4. 7 Hz, 1 H), 3. 77 (s, 3 H), 3. 73-3. 67 (m, 2 H), 3. 56 (dd, J = 7. 0, 1. 8 Hz, 1 H), 3. 48 (dd, J = 9. 8, 1. 7 Hz, 1 H), 3. 46 (apparent t, J = 11. 1 Hz, 1 H), 3. 31 (ddd, J = 15. 6, 11. 2, 11. 2 Hz, 1 H), 2. 49 (ddq, J = 10. 5, 6. 4, 6. 4 Hz, 1 H), 2. 25 (apparent t, J = 12. 1 Hz, 1 H), 2. 10-1. 92 (m, 3 H), 1. 85 (dqd, J = 7. 1, 7. 1, 1. 8 Hz, 1 H), 1. 57-1. 52 (m, 1 H), 1. 56 (s, 3 H), 0. 98 (d, J = 7. 1 Hz, 3 H), 0. 89 (d, J = 6. 6 Hz, 3 H), 0. 852 (s, 9 H), 0. 849 (s, 9

H), 0. 72-0. 71 (m, 3 H), 0. 71 (d, J = 6. 6 Hz, 3 H), 0. 69 (d, J = 6. 9 Hz, 3 H), 0. 10 (s, 3 H),-0. 02 (s, 3 H),-0. 03 (s, 3 H), -0. 07 (s, 3 H) 13C NMR (125 MHZ, CDCl3) d 159. 8, 135. 2 (J-p = 2. 6 Hz), 133. 5 (JCP = 10. 0 Hz), 132. 9, 131. 4, 130. 6 (JCP = 12. 6 Hz), 130. 3, 127. 3, 118. 4 (Jcp = 85. 5 Hz), 113. 4, 101. 0, 83. 2, 80. 1 (Jp = 14. 0 Hz), 78. 3, 73. 2, 55. 3, 38. 1, 37. 4, 36. 0, 33. 7 (Jcp = 4. 4 Hz), 33. 6, 30. 7, 26. 1, 25. 5 (JCP = 49. 7 Hz), 22. 9, 18. 33, 18. 29, 17. 2, 17. 1, 12. 5, 12. 1, 10. 9,-3. 2,-3. 6,-3. 7, -4. 0 ; high resolution mass spectrum (FAB, NBA) m/z 937. 5708 [ (M-I) + ; calcd for C57H86O5PSi2 : 937. 5751].

Olefin (-) 50 : white solid ; mp 80-82 °C ; [a] 23D-18 (c 0. 48, CHCl3) ; IR (CHCl3) 2955 (s), 2920 (s), 2880 (m), 2850 (s), 1640 (w), 1613 (m), 1588 (w), 1517 (m), 1460 (m), 1387 (m), 1360 (m), 1300 (m), 1250 (s), 1178 (m), 1170 (m), 1160 (m), 1115 (m), 1080 (m), 1023 (s), 1000 (m), 980 (m), 960 (m), 930 (w), 887 (m), 855 (m), 830 (m), 715 (m) cm-1 ; 1H NMR (500 MHZ, C6D6) d 7. 62 (d, J = 8. 7 Hz, 2 H), 6. 83 (d, J = 8. 7 Hz, 2 H), 5. 46 (s, 1 H), 5. 00 (s, 1 H), 4. 95 (s, 1 H), 3. 93 (dd, J = 11. 1, 4. 7 Hz, 1 H), 3. 89 (dd, J = 7. 2, 1. 5 Hz, 1 H), 3. 55 (dd, J = 9. 9, 1. 9 Hz, 1 H), 3. 51 (apparent t, J = 5. 9 Hz, 1 H), 3. 27 (s, 3 H), 3. 22 (apparent t, J = 11. 0 Hz, 1 H), 2. 32 (dd, J = 13. 6, 3. 5 Hz, 1 H), 2. 27-2. 20 (m, 1 H), 2. 16 (dd, J = 13. 7, 9. 5 Hz, 1 H), 2. 07-1. 92 (m, 4 H), 1. 87-1. 80 (m, 1 H), 1. 50-1. 42 (m, 1 H), 1. 18 (d, J = 7. 1 Hz, 3 H), 1. 10 (d, J = 6. 6 Hz, 3 H), 1. 06 (d, J = 6. 6 Hz, 3 H), 1. 04 (s, 9 H), 1. 02 (d, J = 7. 0 Hz, 3 H), 1. 00 (s, 9 H), 0. 41 (d, J = 6. 7 Hz, 3 H), 0. 13 (s, 3 H), 0. 09 (s, 3 H), 0. 08 (s, 3 H), 0. 06 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 159. 8 (q), 150. 7 (q), 131. 5 (q), 127. 3, 113. 4, 108. 3 (CH2), 101. 0, 83. 2, 81. 9, 78. 1, 73. 3 (CH2), 55. 2, 49. 9, 44. 9, 41. 4 (CH2), 39. 0 (CH2), 38. 3, 36. 6, 33. 4, 30. 8, 26. 3, 25. 9, 18. 5 (q), 18. 2 (q), 17. 8, 15. 5, 12. 9, 12. 1, 11. 0,-3. 4,-3. 7,-4. 6, -4. 7 ; high resolution mass spectrum (FAB, NBA) m/z 697. 4642 [ (M+Na) + ; calcd for C39H7005Si2Na : 697. 4659].

EXAMPLE 37 Model Olefin (+)-43.

NaHMDS (0. 6 M in PhMe, 9. 46 mL, 5. 68 mmol) was added over 10 min to a suspension of (CH3) 2CHP+Ph3 I' (2. 52 g, 5. 83 mmol) in PhMe (20 mL) at room temperature. After 15 min, the mixture was cooled to-78 °C, and aldehyde (+)-18 (1. 46 g, 3. 84 mmol) in PhMe (15 mL) was introduced via a cannula (l5mL rinse). After 20 min at-78 °C and 30 min at room temperature, the reaction was quenched with MeOH (1. 0 mL). The solution was separated, and the oil residue was extracted with hexane (3 x 30 mL). The combined organic solutions were then concentrated and, and flash chromatography (2*-. ethyl acetate/hexane) provided (+)-43 (1. 44 g, 92% yield) as a colorless oil : [o'] +8. 07° (c 2. 57, CHCl3) ; IR (CHCl3) 2960 (s), 2925 (s), 2880 (s), 2855 (s), 1610 (m), 1585 (m), 1510 (s), 1460 (s), 1375 (m), 1360 (m), 1300 (m), 1245 (s), 1172 (m), 1085 (s, br), 1035 (s), 1003 (m), 970 (m), 950 (m), 935 (m), 862 (s), 835 (s) cm~1 ; 1H NMR (500 MHZ, CDCl3) d 7. 23 (d, J = 9. 0 Hz, 2 H), 6. 85 (d, J = 8. 6 Hz, 2 H), 4. 92 (d-quintet, J = 9. 7, 1. 4 Hz, 1 H), 4. 37 (apparent s, 2 H), 3. 78 (s, 3 H), 3. 49 (dd, J = 9. 2, 4. 9 Hz, 1 H), 3. 39 (dd, J = 6. 3, 4. 5 Hz, 1 H), 3. 19 (dd, J = 9. 0, 8. 4 Hz, 1 H), 2. 49 (ddq, J = 9. 6, 6. 7, 6. 7 Hz, 1 H), 2. 00-1. 92 (m, 1 H), 1. 63 (d, J = 1. 2 Hz, 3 H), 1. 55 (d, J = 1. 3 Hz, 3 H), 0. 945 (d, J = 7. 0 Hz, 3 H), 0. 874 (d, J = 6. 7 Hz, 3 H), 0. 873 (s, 9 H), 0. 01 (apparent s, 6 H) ; 13C NMR (125 MHZ, CDCl3) 159. 0, 131. 1, 129. 7, 129. 4, 129. 1, 113. 7, 78. 6, 72. 6, 55. 3, 38. 5, 36. 0, 26. 2, 25. 8, 18. 4, 17. 9, 17. 0, 14. 8,-3. 88,-3. 95 ; high resolution mass spectrum (CI, NH3) m/z 407. 2984 [(M+H) + ; calcd for C24H4303Si : 407. 2981].

EXAMPLE 38 Alcohol (+)-44.

A mixture of olefin (+)-43 (387. 6 mg, 0. 954 mmol) in CH2C12 (10 mL) was treated with Hp (500 HL) and DDQ (320 mg, 1. 41 mmol). After 30 min at room temperature, the mixture was filtered through a short silica plug (50% ethyl acetate/hexane) and concentrated. Flash chromatography (3o ethyl

acetate/hexane) provided (+)-43 (273. 1 mg, 99t yield) as a colorless oil : [cil 23D +17. 5 (c 2. 80, CHC13) ; IR (CHCl3) 3620 (w), 3500 (m, br), 2955 (s), 2925 (s), 2880 (s), 2860 (s), 1460 (s), 1405 (m), 1375 (m), 1360 (m), 1337 (m), 1252 (s), 1070 (s), 1050 (s), 1015 (s), 1002 (s), 978 (m), 933 (m), 832 (s) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 4. 92 (apparent d quintet, J = 9. 7, 1. 4 Hz, 1 H), 3. 66 (ddd, J = 11. 0, 4. 4, 4. 4 Hz, 1 H), 3. 52 (ddd, J = 11. 0, 5. 5, 5. 5 Hz, 1 H), 3. 42 (dd, J = 6. 8, 4. 0 Hz, 1 H), 2. 57 (ddq, J = 9. 6, 6. 8, 6. 8 Hz, 1 H), 2. 45 (apparent t, J = 5. 2 Hz, 1 H), 1. 85-1. 78 (m, 1 H), 1. 65 (d, J = 1. 3 Hz, 3 H), 1. 59 (d, J = 1. 3 Hz, 3 H), 0. 98 (d, J = 7. 1 Hz, 3 H), 0. 92 (d, J = 6. 8 Hz, 3 H), 0. 90 (s, 9 H), 0. 08 (s, 3 H), 0. 05 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 130. 7, 128. 5, 81. 7, 65. 5, 38. 1, 37. 4, 26. 2, 25. 8, 18. 3, 17. 9, 17. 4, 15. 9,-3. 7,-3. 9 ; high resolution mass spectrum (CI, NH3) m/z 287. 2418 [(M+H) + ; calcd for C16H3sO2Si : 287. 2406].

EXAMPLE 39 Wittig reagent (+)-46.

Iodine (1. 08 g, 4. 24 mmol) was added to a solution of alcohol (+)-44 (810 mg, 2. 83 mmol), PPh, (1. 11 g, 4. 24 mmol) and imidazole (289 mg, 4. 24 mmol) in benzene/ether (1 : 2, 21 mL) under vigorous stirring at room temperature. After 40 min, the mixture was diluted with ether (100 mL), washed with saturated Na2S203 (50 mL), brine (100 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (hexane) provided a mixture of 45/47/48 (1. 06 g, 97% yield, 18 : 1 : 1) as a colorless oil ; This material was then treated with I-Pr2NEt (928 yL, 5. 33 mmol) and PPh3 (7. 01 g, 26. 7 mmol) then heated at 80 °C for 13 h. The mixture was extracted with hexane (3 x 100 mL). The residue was purified by flash chromatography (2W MeOH/CHCl3) providing Wittig reagent (+)-48 (207. 1 mg, 38% yield from (+)-46) as a pale yellow foam. The hexane extract was concentrated and purified by flash chromatography (hexane) affording a mixture of two cyclization products (380 mg) and further purification by preparative TLC (hexane) afforded (-)-49 and (-)-50.

Wittig reagent (+)-46 : [a] 23D +4. 8° (c 1. 23, CHCl3) ; IR (CHCl3) 2940 (s), 2860 (m), 1588 (w), 1482 (w), 1468 (m), 1460 (m), 1440 (s), 1380 (m), 1360 (w), 1310 (w), 1253 (m), 1230 (m), 1210 (m), 1110 (s), 1080 (m), 1050 (m), 1018 (m), 1000 (m), 995 (m), 860 (m), 832 (s), 800 (m), 708 (m), 680 (m), 652 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3 ; concentration dependent) d 7. 81-7. 67 (m, 15 H), 4. 92 (d, J = 9. 7 Hz, 1 H), 3. 50 (apparent t, J = 5. 3 Hz, 1 H), 3. 38 (ddd, J = 14. 9, 14. 9, 1. 5 Hz, 1 H), 3. 25 (ddd, J = 15. 6, 11. 1, 11. 1 Hz, 1 H), 2. 42 (ddq, J = 9. 7, 6. 6, 6. 6 Hz, 1 H), 2. 10-2. 00 (m, 1 H), 1. 53 (s, 3 H), 1. 43 (s, 3 H), 0. 83 (s, 9 H), 0. 81 (d, J = 6. 7 Hz, 3 H), 0. 75 (d, J = 6. 8 Hz, 3 H), 0. 03 (s, 3 H),-0. 02 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d, 135. 3 (Jcp = 2. 8 Hz), 133. 3 (J, = 9. 9 Hz), 131. 0, 130. 6 (Jp = 12. 4 Hz), 128. 0, 118. 2 (Jcp = 85. 6 Hz), 80. 4 (J, = 13. 3 Hz), 36. 0, 33. 0 (Jp = 4. 0 Hz), 26. 1, 25. 6, 25. 1 (J, p = 50. 8 Hz), 18. 3, 18. 1, 17. 9, 16. 4,-3. 3,-4. 0 ; high resolution mass spectrum (FAB, NBA) m/z 531. 3221 [(M-I) + ; calcd for C34H48OPSi : 531. 3213].

Olefin (-)-47 : Colorless oil ; [a] 23D-14° (c 0. 36, CHCl3) ; IR (CHC13) 2960 (s), 2930. (s), 2860 (s), 1470 (m), 1460, 1370 (m), 1360 (m), 1250 (m), 1206 (w), 1165 (m), 1140 (m), 1070 (s), 1020 (s), 1000 (m), 932 (w), 908 (w), 897 (w), 853 (m), 830 (s) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 3. 63 (d, br, J = 3. 6 Hz, 1 H), 2. 50 (apparent q, J = 7. 3 Hz, 1 H), 2. 28 (ddd, J = 15. 5, 7. 7, 0. 8 Hz, 1 H), 2. 13-2. 03 (m, 1 H), 1. 99-1. 91 (m, 1 H), 1. 60 (apparent br s, 3 H), 1. 57 (apparent d, J = 0. 8 Hz, 1 H), 0. 94 (d, J = 6. 7 Hz, 3 H), 0. 91 (d, J = 7. 4 Hz, 3 H), 0. 85 (s, 9 H), 0. 01 (apparent s, 6 H) ; 13C NMR (125 MHZ, CDCl3) d 138. 9 (q), 122. 0 (q), 82. 9, 46. 1, 36. 4, 35. 8 (CH2), 25. 9, 21. 2, 20. 4, 18. 3 (q), 18. 0, 14. 3,-4. 6,-4. 8 ; high resolution mass spectrum (CI, NH3) m/z 269. 2310 [ (M+H) + ; calcd for C16H33OSi : 269. 2300].

Olefin (-)-48 : Colorless oil ; [a] 23D-3. 8° (c 0. 24, CHCl3) ; IR (CHCl3) 2953 (s), 2925 (s), 2880 (m), 2855 (m), 1638 (w), 1470 (m), 1460 (m), 1385 (w), 1373 (m), 1360 (w), 1250 (m), 1135 (m), 1117 (m), 1100 (m), 1075 (m), 1028 (m), 1000 (m), 932 (w), 865 (m), 830 (s) cm-1 ; 1H NMR (500 MHZ, C6D6) d

4. 84-4. 83 (m, 1 H), 4. 79-4. 77 (m, 1 H), 3. 46 (apparent t, J = 5. 3 Hz, 1 H), 1. 94-1. 88 (m, 1 H), 1. 87-1. 78 (m, 2 H), 1. 73 (ddd, J = 12. 4, 7. 3, 7. 3 Hz, 1 H), 1. 66 (apparent dd, J = 1. 3, 0. 8 Hz, 3 H), 1. 45 (ddd, J = 12. 2, 10. 3, 8. 7 Hz, 1 H), 1. 00 (d, J = 6. 9 Hz, 3 H), 0. 99 (s, 9 H), 0. 96 (d, J = 6. 7 Hz, 3 H), 0. 06 (s, 3 H), 0. 05 (s, 3 H) ; 13C NMR (125 MHZ, C6D6) d 147. 4 (q), 110. 3 (CH2), 82. 3, 53. 1, 45. 4, 37. 5 (CH) 2, 37. 3, 26. 1, 19. 3, 18. 4 (q), 18. 0, 15. 6,-4. 4,-4. 5 ; high resolution mass spectrum (CI, NH3) m/z 269. 2315 [(M+H)+ ; calcd for C16H33OSi : 269. 2300].

EXAMPLE 40 Alcohol (+)-51.

A solution of olefin (+)-44 (70. 9 mg, 0. 28 mmol) in EtOH/EtOAc (1 : 8, 4. 5 mL) was treated with Pd/C (10*-. wet, E101 NE/W, 15. 2 mg) under H2 atmosphere for 18 h. The mixture was then filtered through a short silica pipet and concentrated.

Flash chromatography (5% ethyl acetate/hexane) provided (+)-51 (70. 8 mg, 100% yield) as a colorless oil. lul 23D +28° (c 0. 15, CHC13) ; IR (CHCl3) 3680 (w), 3620 (w), 3500 (w, br), 3010 (m), 2960 (s), 2935 (s), 2900 (m), 2885 (m), 2860 (m), 1522 (w), 1510 (w), 1470 (m), 1426 (m), 1420 (m), 1412 (m), 1387 (m), 1370 (m), 1255 (m), 1205 (m), 1070 (m), 1030 (m), 1013 (m), 1002 (m), 980 (m), 925 (m), 833 (s), 720 (m), 665 (m), 658 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 3. 60-3. 56 (m, 2 H), 3. 46 (dd, J = 5. 5, 3. 8 Hz, 1 H), 2. 46 (br s, 1 H), 1. 89-1. 81 (m, 1 H), 1. 74-1. 66 (m, 1 H), 1. 64-1. 56 (m, 1 H), 1. 21 (ddd, J = 13. 3, 8. 9, 4. 6 Hz, 1 H), 1. 09 (ddd, J = 13. 7, 9. 6, 5. 3 Hz, 1 H), 0. 94 (d, J = 7. 0 Hz, 3 H), 0. 90 (s, 9 H), 0. 88 (d, J = 6. 6 Hz, 3 H), 0. 86 (d, J = 6. 9 Hz, 3 H), 0. 83 (d, J = 6. 6 Hz, 3 H), 0. 095 (s, 3 H), 0. 07 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 81. 3, 66. 3, 42. 5, 37. 8, 35. 7, 26. 1, 25. 4, 23. 8, 21. 8, 16. 4, 15. 1,-3. 9, -4. 1 ; high resolution mass spectrum (CI, NH3) m/z 289. 2565 [(M+H) + ; calcd for C16H3., OzSi : 289. 2562].

EXAMPLE 41 Iodide (+)-52.

A solution of alcohol (+)-51 (150 mg, 0. 520 mmol), PPh3 (205 mg, 0. 780 mmol) and imidazole (53 mg, 0. 780 mmol) in benzene/ether (1 : 2 ; 6. 0 mL) was treated with iodine (198 mg, 0. 780 mmol) under vigorous stirring at room temperature. After 40 min, the mixture was diluted with ether (100 mL), washed with saturated Na2S 2° 3 (50 mL), brine (100 mL), dried over MgSO4, filtered and concentrated. Flash chromatography (hexane) provided (+)-51 (195 mg, 94W yield) as a colorless oil : [a] 23D +24-2 (c 2. 21, CHCl3) ; IR (CHCl3) 2960 (s), 2935 (s), 2900 (m), 2860 (s), 1470 (m), 1463 (m), 1425 (w), 1405 (w), 1382 (m), 1368 (m), 1360 (m), 1290 (w), 1255 (s), 1190 (m), 1170 (m), 1082 (s), 1065 (m), 1028 (m), 1003 (m), 970 (w), 932 (w), 832 (s) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 3. 41 (dd, J = 9. 6, 3. 7 Hz, 1 H), 3. 38 (dd, J = 6. 3, 2. 6 Hz, 1 H), 3. 10 (dd, J = 9. 6, 7. 5 Hz, 1 H), 1. 72-1. 56 (m, 3 H), 1. 17 (ddd, J = 13. 4, 8. 3, 5. 4 Hz, 1 H), 1. 09 (ddd, J = 13. 3, 5. 9, 2. 1 Hz, 1 H), 0. 99 (d, J = 6. 8 Hz, 3 H), 0. 89 (s, 9 H), 0. 88 (d, J = 6. 6 Hz, 3 H), 0. 84 (d, J = 6. 6 Hz, 3 H), 0. 81 (d, J = 6. 8 Hz, 3 H), 0. 09 (s, 3 H), 0. 06 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 79. 1, 43. 7, 39. 8, 33. 8, 26. 2, 25. 3, 23. 5, 22. 0, 18. 7, 18. 5, 15. 9, 14. 4, -3. 65,-3. 71 ; high resolution mass spectrum (CI, NH3) m/z 399. 1572 [(M+H)+; calcd for C16H36OISi : 399. 1580].

EXAMPLE 42 Wittig Reagent (+)-53.

A mixture of Iodide (+)-52 (195 mg, 0. 489 mmol) and benzene (100 mL) was treated with i-Pr2NEt (85 µL 0. 488 mmol) and PPh3 (1. 28 g, 4. 88 mmol), then heated at 70 °C for 24 h. The mixture was extracted with hexane (3 x 20 mL). The residue was purified by flash chromatography (3W MeOH/CHCl3) furnishing (+)-53 (303 mg, 94W yield) as a white foam ; [a] 23D +3. 3° (C 2. 14, CHCl3) ; IR (CHCl3) 2950 (s), 2930 (s), 2855 (m), 1588 (w), 1482 (w), 1463 (m), 1438 (s), 1385 (m), 1365 (w), 1253 (m), 1225 (m), 1207 (m), 1110 (s), 1080 (m), 1032 (m), 1000 (m), 832 (s), 804 (m), 708 (m), 680 (m), 653 (m) cm-1 ; 1H NMR (500 MHZ,

CDCl3) d 7. 83-7. 67 (m, 15 H), 3. 70 (ddd, J = 15. 6, 11. 0, 11. 0 Hz, 1 H), 3. 52 (dd, J = 7. 6, 1. 7 Hz, 1 H), 3. 45 (apparent t, J = 15. 4 Hz, 1 H), 2. 08-1. 97 (m, 1 H), 1. 70-1. 62 (m, 1 H), 1. 51 (9 lines, J = 6. 5 Hz, 1 H), 1. 09-0. 97 (m, 2 H), 0. 850 (s, 9 H), 0. 79 (d, J = 6. 7 Hz, 3 H), 0. 77 (d, J = 7. 9 Hz, 3 H), 0. 74 (d, J = 6. 5 Hz, 3 H), 0. 68 (d, J = 6. 8 Hz, 3 H), 0. 12 (s, 3 H), 0. 11 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 135. 2 (Jcp = 2. 7 Hz), 133. 6 (Jcp =9. 9 Hz), 130. 6 (J p = 12. 4 Hz), 118. 5 (J cp= 85. 5 Hz), 80. 1 (Jcp = 12. 9 Hz), 43. 5, 33. 6, 32. 6 (J cp= 3. 7 Hz), 26. 2, 25. 3 (Jcp = 51. 1 Hz), 25. 0, 23. 4, 21. 7, 18. 6, 18. 5, 13. 7, -2. 7,-3. 8 ; high resolution mass spectrum (FAB, NBA) m/z 533. 3369 [(M-I) + ; calcd for C34HsoOPSi : 533. 3357].

EXAMPLE 43 Olefin (-)-54.

Phosphonium salt (-)-49 was dried azeotropically with anhydrous benzene and heated at 50 °C under vacuum for 3 h before use. A solution of (-)-49 (97. 7 mg, 0. 0917 mmol) in THF (700 yL) was cooled to-78 °C and treated with NaHMDS (1. 0 M in THF, 85. 5 µL, 0. 0855 mmol). The mixture was stirred for 20 min at 0°C, recooled to-78 °C and aldehyde C (28. 0 mg, 0. 0570 mmol) in THF (300 L) was added. After 10 min at-78 °C and 2 h at room temperature, the mixture was quenched with saturated aqueous NH4Cl (1. 0 mL) and extracted with ether (30 mL). The ether solution was washed with water, brine (30 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (2o ethyl acetate/hexane) provided (-)-56 (50. 0 mg, 76% yield) as a colorless oil : [a] 23D-44. 9 (c 2. 09, CHCl3) ; IR (CHCl3) 2960 (s), 2930 (s), 2855 (s), 1615 (m), 1587 (w), 1517 (m), 1463 (s), 1380 (m), 1360 (m), 1320 (m), 1300 (m), 1250 (s), 1170 (m), 1160 (m), 1120-1000 (s, br), 990 (m), 965 (m), 935 (m), 900 (m), 835 (s), 807 (m), 670 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 35 (d, J = 8. 7 Hz, 2 H), 6. 85 (d, J = 8. 8 Hz, 2 H), 5. 37 (s, 1 H), 5. 27 (dd, J = 11. 2, 7. 8 Hz, 1 H), 5. 19 (apparent t, J = 10. 9 Hz, 1 H), 5. 08 (d, J = 10. 1 Hz, 1 H), 5. 06 (d, J = 2. 2 Hz, 1 H), 4. 68 (apparent t, J = 9. 1 Hz, 1 H), 4. 08 (dd, J = 11. 2, 4. 7 Hz, 1 H), 3. 78 (s, 3 H), 3. 68 (apparent t, J = 10. 1

Hz, 1 H), 3. 61 (dd, J = 7. 1, 1. 7 Hz, 1 H), 3. 53 (apparent t, S = 2. 6 Hz, 1 H), 3. 50 (dd, J = 9. 9, 1. 6 Hz, 1 H), 3. 46 (apparent t, J = 11. 1 Hz, 1 H), 3. 25 (apparent t, J = 5. 3 Hz, 1 H), 2. 71-2. 58 (m, 1 H), 2. 68 (dq, J = 12. 8, 7. 4 Hz, 1 H), 2. 62 (dq, J = 12. 8, 7. 4 Hz, 1 H), 2. 50 (m, 1 H), 2. 30 (apparent t, J = 12. 2 Hz, 1 H), 2. 08-2. 01 (m, 1 H), 1. 98-1. 90 (m, 1 H), 1. 88 (dqd, J = 7. 1, 7. 1, 1. 7 Hz, 1 H), 1. 82 (apparent qt, J = 7. 1, 2. 6 Hz, 1 H), 1. 65 (br d, J = 12. 4 Hz, 1 H), 1. 62-1. 57 (m, 2 H), 1. 56 (d, J = 0. 4 Hz, 3 H), 1. 38 (ddd, J = 13. 6, 10. 7, 1. 5 Hz, 1 H), 1. 29-1. 22 (apparent t, J = 7. 4 Hz, 3 H), 1. 00 (d, J = 7. 1 Hz, 3 H), 0. 94 (d, J = 7. 3 Hz, 3 H), 0. 930 (d, J = 6. 9 Hz, 3 H), 0. 925 (d, J = 7. 1 Hz, 3 H), 0. 90 (s, 18 H), 0. 89 (s, 9 H), 0. 86 (s, 9 H), 0. 74 (apparent d, J = 6. 6 Hz, 6 H), 0. 73 (d, J = 6. 1 Hz, 3 H), 0. 05 (s, 3 H), 0. 04 (s, 3 H), 0. 03 (s, 3 H), 0. 019 (s, 3 H), 0. 017 (s, 3 H), 0. 013 (s, 3 H), 0. 009 (s, 3 H), 0. 00 (s, 3 H) ; 13C NMR (125 MHZ, CDC13) d 159. 8, 134. 4, 131. 9, 131. 8, 131. 5, 131. 4, 127. 3, 113. 4, 101. 0, 83. 4, 80. 9, 80. 4, 78. 5, 76. 7, 76. 5, 74. 2, 73. 3, 65. 5, 55. 2, 42. 5, 41. 9, 38. 2, 37. 5, 37. 1, 35. 4, 34. 4, 33. 8, 26. 3, 26. 2, 26. 0, 25. 9, 25. 1, 23. 2, 18. 5, 18. 4, 18. 12, 18. 08, 17. 0, 16. 6, 15. 6, 14. 4, 12. 7, 12. 1, 11. 6, 10. 9,-2. 7,-3. 5,-3. 66,-3. 69,-4. 2,-4. 5, -4. 9,-5. 0 ; high resolution mass spectrum (FAB, NBA) m/z 1171. 7799 [(M+Na) + ; calcd for C63H120OBSSi4Na : 1171. 7781].

EXAMPLE 44 Hydroxy Diene (-)-55.

A solution of the olefin (-)-54 (49. 8 mg, 0. 0434 mmol) in CH2C12 (4. 4 mL) was cooled to-78 C and DIBAL (1. 0 M in toluene, 430 yL, 0. 430 mmol) was added over 5 min. After 10 min at-78 °C and 30 min at 0 °C, the reaction was quenched with saturated aqueous Rochelle's salt (500 UL). The mixture was diluted with ether (60 mL), washed with saturated aqueous Rochelle salt, brine (30 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (5t ethyl acetate/hexane) furnished (-)-57 (38. 0 mg, 88W yield) as a colorless oil : M'-32° (c 1. 90, CHC1,) ; IR (CHCl3) 3500 (w, br), 2960 (s), 2935 (s), 2900 (m), 2885 (m), 2860 (s), 1610

(m), 1585 (w), 1510 (m), 1470 (m), 1460 (m), 1400 (m), 1375 (m), 1360 (m), 1300 (m), 1250 (s), 1170 (m), 1095 (m), 1080 (m), 1047 (s), 1000 (m), 960 (m), 950 (m), 933 (m), 835 (s), 805 (m), 665 (m) cm-1 ; 1H NMR (500 MHZ, CDC13) d 7. 24 (d, J = 8. 6 Hz, 2 H), 6. 85 (d, J = 8. 6 Hz, 2 H), 5. 27 (dd, J = 11. 4, 7. 8 Hz, 1 H), 5. 20 (apparent t, J = 10. 3 Hz, 1 H), 5. 10 (d, J = 10. 0 Hz, 1 H), 5. 05 (d, J = 2. 2 Hz, 1 H), 4. 68 (apparent t, J = 9. 2 Hz, 1 H), 4. 49 (ABq, JAB = 10. 4 Hz, AFAF3 = 23. 4 Hz, 2 H), 3. 78 (s, 3 H), 3. 73 (ddd, J = 10. 7, 4. 0, 4. 0 Hz, 1 H), 3. 68 (apparent t, J = 10. 4 Hz, 1 H), 3. 57 (ddd, J = 10. 6, 5. 1, 5. 1 Hz, 1 H), 3. 53 (dd, J = 5. 4, 3. 4 Hz, 1 H), 3. 50 (apparent t, J = 5. 2 Hz, 1 H), 3. 35 (apparent t, J = 5. 5 Hz, 1 H), 3. 26 (apparent t, J = 5. 2 Hz, 1 H), 2. 68 (dq, J = 12. 8, 7. 4 Hz, 1 H), 2. 61 (dq, J = 12. 8, 7. 5 Hz, 1 H), 2. 71-2. 58 (m, 2 H), 2. 51-2. 44 (m, 1 H), 2. 22 (apparent t, J = 12. 4 Hz, 1 H), 1. 99-1. 86 (m, 3 H), 1. 81 (apparent qt, J = 7. 1, 2. 6 Hz, 1 H), 1. 72 (br d, J = 12. 7 Hz, 1 H), 1. 62-1. 57 (m, 1 H), 1. 61 (s, 3 H), 1. 56-1. 48 (m, 1 H), 1. 38 (ddd, J = 13. 5, 12. 3, 1. 4 Hz, 1 H), 1. 27 (apparent t, J = 7. 4 Hz, 3 H), 1. 03 (d, J = 6. 9 Hz, 3 H), 1. 02 (d, J = 6. 8 Hz, 3 H), 0. 95-0. 92 (m, 9 H), 0. 93 (s, 9 H), 0. 90 (s, 9 H), 0. 89 (s, 9 H), 0. 86 (s, 9 H), 0. 74 (d, J = 8. 0 Hz, 3 H), 0. 73 (d, J = 7. 0 Hz, 3 H), 0. 08 (s, 6 H), 0. 05 (s, 3 H), 0. 024 (s, 3 H), 0. 020 (s, 3 H), 0. 012 (s, 3 H), 0. 009 (s, 3 H), 0. 006 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 159. 4, 134. 4, 132. 3, 131. 7, 130. 9, 130. 4, 129. 3, 114. 0, 86. 3, 80. 9, 80. 4, 77. 6, 76. 5, 75. 3, 74. 2, 65. 6, 65. 5, 55. 3, 42. 6, 41. 9, 40. 0, 37. 6, 37. 0, 36. 8, 35. 9, 35. 2, 34. 5, 26. 30, 26. 27, 25. 9, 25. 8, 25. 1, 23. 2, 18. 53, 18. 47, 18. 13, 18. 07, 17. 1, 16. 6, 15. 7, 15. 6, 14. 4, 13. 6, 11. 6, 11. 4,-2. 8,-3. 2,-3. 4,-3. 6,-4. 2, -4. 5,-4. 9 ; high resolution mass spectrum (FAB, NBA) m/z 1173. 7859 [(M+Na) + ; calcd for C63H1220BSSi4Na : 1173. 7835].

EXAMPLE 45 Aldehyde (-)-56.

A solution of alcohol (-)-55 (13. 8 mg, 0. 0120 mmol) and Et3N (42 ßL, 0. 30 mmol) in CH2Cl2 (200 UL) was cooled to 0 °C and treated with SO3. pyridine (40 mg, 0. 251 mmol) in DMSO

(600 L). After 45 min at 0 °C, the mixture was diluted with ethyl acetate (30 mL), washed with aqueous NaHSO4 (1. 0 M, 30 mL), brine (2 x 30 mL), dried over MgSO4, filtered and concentrated. Pipette flash chromatography (3E ethyl acetate/hexane) afforded (-)-56 (13. 2 mg, 96h yield) as a colorless oil : [a] 23D-32. 1 (c 1. 40, CHC13) ; IR (CHCl3) 2960 (s), 2935 (s), 2880 (m), 1720 (m), 1610 (m), 1512 (m), 1470 (m), 1460 (m), 1387 (m), 1380 (m), 1360 (m), 1340 (m), 1320 (m), 1300 (m), 1250 (s), 1110 (s), 1098 (s), 1080 (s), 1048 (s), 1002 (m), 988 (m), 965 (m), 950 (m), 935 (m), 835 (s) cm~1 ; 'H NMR (500 MHZ, CDC13) d 9. 78 (d, J = 2. 5 Hz, 1 H), 7. 20 (d, J = 8. 6 Hz, 2 H), 6. 85 (d, J = 8. 7 Hz, 2 H), 5. 27 (dd, J = 11. 1, 7. 8 Hz, 1 H), 5. 19 (apparent t, J = 10. 4 Hz, 1 H), 5. 10 (d, J = 10. 0 Hz, 1 H), 5. 05 (d, J = 2. 1 Hz, 1 H), 4. 67 (apparent t, J = 8. 9 Hz, 1 H), 4. 45 (apparent s, 2 H), 3. 78 (s, 3 H), 3. 68 (apparent t, J= 10. 2 Hz, 1 H), 3. 58-3. 56 (m, 2 H), 3. 51 (apparent t, J = 2. 6 Hz, 1 H), 3. 25 (apparent t, J = 5. 2 Hz, 1 H), 2. 73 (dqd, J = 7. 1, 6. 0, 2. 6 Hz, 1 H), 2. 70-2. 57 (m, 3 H), 2. 51-2. 44 (m, 1 H), 2. 23 (apparent t, J = 12. 4 Hz, 1 H), 1. 98-1. 85 (m, 2 H), 1. 81 (apparent qt, J = 7. 1, 2. 6 Hz, 1 H), 1. 67 (br d, J = 13. 0 Hz, 1 H), 1. 60 (s, 3 H), 1. 62-1. 50 (m, 2H), 1. 37 (ddd, J = 13. 8, 10. 4, 1. 5 Hz, 1 H), 1. 26 (apparent t, J = 7. 4 Hz, 3 H), 1. 10 (d, J = 7. 0 Hz, 3 H), 1. 02 (d, J = 7. 0 Hz, 3 H), 0. 938 (d, J = 7. 1 Hz, 3 H), 0. 932 (d, J = 7. 8 Hz, 3 H), 0. 919 (s, 9 H), 0. 918 (d, J = 6. 6 Hz, 3 H), 0. 90 (s, 9 H), 0. 88 (s, 9 H), 0. 86 (s, 9 H), 0. 732 (d, J = 6. 7 Hz, 3 H), 0. 726 (d, J = 6. 8 Hz, 3 H), 0. 07 (s, 3 H), 0. 053 (s, 3 H), 0. 047 (s, 3 H), 0. 02 (s, 6 H), 0. 009 (s, 3 H), 0. 005 (s, 6 H) ; 13C NMR (125 MHZ, CDCl3) d 204. 6, 159. 3, 134. 4, 132. 3, 131. 8, 130. 8, 130. 3, 129. 1, 128. 3, 113. 8, 82. 6, 80. 9, 80. 4, 76. 5, 74. 5, 74. 2, 65. 5, 55. 3, 49. 5, 42. 5, 41. 9, 40. 3, 37. 1, 36. 8, 35. 4, 34. 9, 34. 4, 26. 3, 26. 2, 25. 9, 25. 8, 25. 1, 23. 2, 18. 49, 18. 45, 18. 12, 18. 07, 17. 0, 16. 6, 15. 6, 14. 4, 13. 3, 12. 1, 11. 6, 11. 4,-2. 8, -3. 3,-3. 4,-3. 7,-4. 2,-4. 5,-4. 9,-5. 0 ; high resolution mass spectrum (FAB, NBA) m/z 1171. 7670 [(M+Na) + ; calcd for C63H12008SSiNa : 1171. 7676].

EXAMPLE 46 Tetraene (-)-57.

A solution of Ph2PCH2CH=CH2 (40 L, 0. 19 mmol) in THF (1. 0 mL) was cooled to-78 °C and t-BuLi (1. 7 M in pentane, 72. 0 yL, 0. 122 mmol) was added. The mixture was stirred at 0 °C for 30 min, recooled to-78 °C and treated with Ti (OiPr) 4 (45 ßL, 0. 15 mmol). After 30 min, a cold (-78 °C) solution of the aldehyde (-)-56 (30. 2 mg, 0. 0262 mmol) in THF (1. 0 mL) was introduced via cannula, and the resultant mixture was stirred for 10 min at-78 °C and 1 h at 0 °C. MeI (20 UL, 0. 32 mmol) was then added, and the reaction was maintained at 0 °C for 30 min, warmed to room temperature, protected from light with aluminum foil, and stirred overnight. The reaction mixture was diluted with ether (30 mL), washed with aqueous NaHSO4 (1. 0 M), brine (30 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography (2W ethyl acetate/hexane) gave a 16 : 1 mixture of Z/E isomers (20. 0 mg, 70% yield) as an oil. Pipette flash chromatography (20% benzene/hexane) furnished the Z-olefin (-)-57 as a colorless oil : [a] 23D-57. 2° (c 2. 56, CHC13) ; IR (CHCl3) 3015 (m), 2960 (s), 2940 (s), 2900 (m), 2885 (m), 2860 (s), 1613 (w), 1515 (m), 1475 (m), 1465 (m), 1390 (w), 1380 (w), 1360 (w), 1250 (s), 1110 (m), 1100 (m), 1080 (m), 1050 (s), 1003 (m), 963 (w), 950 (w), 835 (s), 800 (m), 790 (m), 770 (m), 700 (w), 690 (w), 670 (w), 655 (w) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 7. 25 (d, J = 8. 2 Hz, 2 H), 6. 84 (d, J = 8. 7 Hz, 2 H), 6. 57 (dddd, J = 16. 8, 11. 0, 11. 0, 0. 7 Hz, 1 H), 6. 00 (apparent t, J = 11. 1 Hz, 1 H), 5. 55 (apparent t, J = 10. 5 Hz, 1 H), 5. 26 (dd, J = 11. 2, 7. 8 Hz, 1 H), 5. 20-5. 16 (m, 2 H), 5. 09 (d, J = 10. 1 Hz, 1 H), 5. 05 (d, J = 2. 2 Hz, 1 H), 5. 03 (d, J = 10. 0 Hz, 1 H), 4. 67 (apparent t, J = 9. 1 Hz, 1 H), 4. 49 (ABq, J = 10. 6 Hz, A6,, = 41. 3 Hz, 2 H), 3. 78 (s, 3 H), 3. 68 (apparent t, J = 10. 2 Hz, 1 H), 3. 52 (apparent t, J = 2. 6 Hz, 1 H), 3. 43 (dd, J = 4. 8, 3. 9 Hz, 1 H), 3. 24-3. 21 (m, 2 H), 3. 01-2. 94 (m, 1 H), 2. 67 (dq, J = 12. 8, 7. 4 Hz, 1 H), 2. 61 (dq, J = 12. 8, 7. 5 Hz, 1 H), 2. 71-2. 57 (m, 1 H), 2. 46-2. 39 (m, 1 H), 2. 00 (apparent t, J = 12. 4 Hz, 1 H), 1. 83-1. 73 (m, 3 H), 1. 64 (br d, J = 14. 0 Hz, 1 H), 1. 62-1. 52 (m, 2 H), 1. 55 (d,

J = 0. 5 Hz, 3 H), 1. 36 (ddd, J = 13. 7, 10. 8, 1. 5 Hz, 1 H), 1. 26 (d, J = 7. 4 Hz, 3 H), 1. 25 (d, J = 7. 4 Hz, 3 H), 1. 08 (d, J = 6. 8 Hz, 3 H), 0. 98 (d, J = 6. 8 Hz, 3 H), 0. 94 (d, J = 7. 1 Hz, 3 H), 0. 93 (s, 9 H), 0. 90 (s, 9 H), 0. 89 (s, 9 H), 0. 89-0. 86 (m, 3 H), 0. 86 (s, 9 H), 0. 73 (d, J = 6. 8 Hz, 3 H), 0. 70 (d, J = 6. 7 Hz, 3 H), 0. 08 (s, 6 H), 0. 05 (s, 3 H), 0. 02 (s, 3 H), 0. 013 (s, 3 H), 0. 010 (s, 6 H),-0. 02 (s, 3 H) ; 13C NMR (125 MHZ, CDC1,) d 159. 1, 134. 5, 134. 3, 132. 2, 131. 9, 131. 8, 131. 2, 129. 13, 129. 07, 117. 6, 113. 7, 84. 6, 80. 9, 80. 5, 76. 5, 75. 0, 74. 2, 65. 5, 55. 3, 42. 5, 41. 9, 40. 2, 37. 2, 36. 1, 35. 4, 35. 3, 34. 5, 29. 7, 26. 3, 26. 0, 25. 9, 25. 1, 23. 1, 18. 7, 18. 6, 18. 5, 18. 14, 18. 09, 17. 0, 16. 8, 15. 6, 14. 8, 14. 4, 11. 6, 10. 6,-2. 8, -3. 2,-3. 3,-3. 6,-4. 2,-4. 5,-4. 90,-4. 93 ; high resolution mass spectrum (FAB, NBA) m/z 1195. 8001 [(M+Na) t ; calcd for C66H12407SSi4Na : 1195. 8042].

EXAMPLE 47 Lactone (-)-58.

A solution of diene (-)-57 (7. 0 mg, 0. 00597 mmol) in THF/CH3CN (2 : 1, 1. 50 mL) was treated with pH 7. 0 phosphate buffer (500 UL) and HgCl2 (215 mg). The suspension was stirred at room temperature for 40 min, diluted with ether (30 mL), washed with brine (2 x 30 mL), dried over MgSO4, filtered and concentrated. Pipette flash chromatography (5% ethyl acetate/hexane) provided a mixture of lactols as a colorless oil which was further treated with DMSO (1. 0 mL) and Ac2O (200 mL) at room temperature for 2 days. The mixture was diluted with ether (30 mL), washed with saturated NaHCO3 (30 mL), brine (30 mL), dried over MgSO4, filtered and concentrated. Pipette flash chromatography (2o ethyl acetate/hexane) provided (-)-58 (5. 5 mg, 82-6 yield from (-)-57) as a colorless oil : [cf] -31. 6 (c 0. 23, CHC1,) ; IR (CHCl3) 3015 (m), 2960 (s), 2930 (s), 2880 (m), 2855 (m), 1725 (m), 1610 (w), 1510 (w), 1460 (m), 1385 (m), 1373 (m), 1360 (m), 1300 (w), 1250 (s), 1230 (m), 1200 (m), 1170 (m), 1120 (m), 1097 (m), 1060 (m), 1045 (s), 1020 (m), 1003 (m), 980 (w), 955 (w), 930 (w), 905 (w), 867 (m), 835 (s), 800 (m), 695 (m), 670 (m), 660 (m) cm-1 ; 1H NMR (500 MHZ,

CDCl3) d 7. 25 (d, J = 9. 0 Hz, 2 H), 6. 84 (d, J = 8. 7 Hz, 2 H), 6. 57 (ddd, J = 16. 7, 10. 6, 10. 6 Hz, 1 H), 6. 00 (apparent t, J = 11. 0 Hz, 1 H), 5. 55 (apparent t, J = 10. 5 Hz, 1 H), 5. 26 (dd, J = 11. 1, 7. 9 Hz, 1 H), 5. 19 (dd, J = 15. 4, 1. 4 Hz, 1 H), 5. 18 (apparent t J = 10. 1 Hz, 1 H), 5. 10 (d, J = 10. 2 Hz, 1 H), 5. 01 (d, J = 10. 0 Hz, 1 H), 4. 75 (apparent t, J = 9. 2 Hz, 1 H), 4. 50 (ddd, J = 10. 5, 1. 3, 1. 3 Hz, 1 H), 4. 50 (ABq, J = 10. 6 Hz, Abc = 42. 6 Hz, 2 H), 3. 78 (s, 3 H), 3. 60 (apparent t, J = 2. 4 Hz, 1 H), 3. 42 (dd, J = 5. 1, 3. 7 Hz, 1 H), 3. 23 (dd, J = 7. 5, 3. 7 Hz, 1 H), 3. 20 (apparent t, J = 5. 4 Hz, 1 H), 3. 01-2. 94 (m, 1 H), 2. 60 (qd, J = 7. 7, 2. 6 Hz, 1 H), 2. 62-2. 55 (m, 1 H), 2. 45-2. 38 (m, 1 H), 1. 98 (apparent t, J = 12. 3 Hz, 1 H), 1. 84-1. 67 (m, 3 H), 1. 63 (br d, J = 13. 2 Hz, 1H), 1. 52 (s, 3 H), 1. 55-1. 48 (m, 1 H), 1. 20 (d, J = 7. 6 Hz, 3 H), 1. 09 (d, J = 6. 8 Hz, 3 H), 0. 98 (d, J = 6. 8 Hz, 3 H), 0. 93 (apparent d, J = 6. 7 Hz, 6 H), 0. 93 (s, 9 H), 0. 89 (s, 9 H), 0. 86 (s, 9 H), 0. 85 (s, 9 H), 0. 84 (d, J = 6. 8 Hz, 3 H), 0. 69 (d, J = 6. 7 Hz, 3 H), 0. 085 (s, 3 H), 0. 079 (s, 3 H), 0. 051 (s, 3 H), 0. 046 (s, 3 H), 0. 042 (s, 3 H), 0. 029 (s, 3 H), 0. 028 (s, 3 H),-0. 02 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 173. 2, 159. 1, 134. 4, 133. 4, 132. 4, 132. 2, 131. 9., 131. 3, 131. 2, 129. 11, 129. 09, 117. 6, 113. 7, 84. 6, 80. 5, 76. 9, 75. 0, 74. 9, 64. 6, 55. 3, 44. 1, 42. 7, 40. 1, 37. 5, 36. 0, 35. 44, 35. 37, 35. 2, 34. 2, 26. 31, 26. 28, 25. 9, 25. 7, 23. 0, 18. 7, 18. 6, 18. 4, 18. 1, 18. 0, 17. 1, 16. 5, 16. 4, 14. 9, 14. 1, 10. 5,-3. 0,-3. 2,-3. 3,-4. 3,-4. 4,-4. 5,-4. 8, -4. 9 ; high resolution mass spectrum (FAB, NBA) m/z 1149. 7836 [(M+Na)+; Calcd for C64H1l808Si4Na : 1149. 7802].

EXAMPLE 48 Alcohol (-)-59.

A solution of (-)-58 (4. 0 mg, 0. 00355 mmol) in CH2Cl2 (500 UL) was treated with H20 (50 FL) and DDQ (3. 0 mg, 0. 0132 mmol) at 0 °C. After 1 h, the mixture was diluted with ethyl acetate (30 mL), washed with brine (3 x 30 mL), dried over MgSO4, filtered and concentrated. Pipette flash chromatography (2% ethyl acetate/hexane) provided (-)-59 (3. 4 mg, 95% yield) as a colorless oil : [a] 23D-20 (c 0. 34, CHCl3) ; IR (film, CHC13

on NaCl plate) 3500 (w, br), 2960 (s), 2930 (s), 2890 (s), 2855 (s), 1740 (m), 1460 (m), 1405 (m), 1380 (m), 1360 (s), 1253 (m), 1220 (m), 1120 (s), 1093 (s), 1075 (s), 1045 (s), 1022 (s), 1002 (m), 980 (m), 933 (m), 902 (m), 833 (s), 808 (m), 770 (s), 663 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 6. 61 (ddd, J = 16. 8, 10. 9, 10. 9 Hz, 1 H), 6. 13 (apparent t, J = 11. 0 Hz, 1 H), 5. 32 (apparent t, J = 10. 5 Hz, 1 H), 5. 28 (dd, J = 11. 1, 7. 9 Hz, 1 H), 5. 24-5. 21 (m, 1 H), 5. 19 (apparent t, J = 10. 3 Hz, 1 H), 5. 14 (d, J = 10. 2 Hz, 1 H), 5. 06 (d, J = 10. 0 Hz, 1 H), 4. 76 (apparent t, J = 9. 3 Hz, 1 H), 4. 50 (apparent t, J = 9. 9 Hz, 1 H), 3. 62 (apparent t, J = 2. 4 Hz, 1 H), 3. 60 (dd, J = 5. 5, 3. 4 Hz, 1 H), 3. 32 (br d, J = 5. 3 Hz, 1 H), 3. 24 (apparent t, J = 5. 1 Hz, 1 H), 2. 79 (ddq, J = 9. 9, 6. 7, 6. 7 Hz, 1 H), 2. 60 (qd, J = 7. 6, 2. 7 Hz, 1 H), 2. 63-2. 57 (m, 1 H), 2. 50-2. 45 (m, 1 H), 2. 16 (apparent t, J = 12. 3 Hz, 1 H), 1. 90-1. 77 (m, 3 H), 1. 75-1. 69 (m, 2 H), 1. 57 (s, 3 H), 1. 60-1. 50 (m, 1 H), 1. 20 (d, J = 7. 6 Hz, 3 H), 0. 96 (d, J = 6. 8 Hz, 3 H), 0. 95 (d, J = , Hz, 3 H), 0. 95-0. 93 (m, 6 H), 0. 91 (s, 9 H), 0. 89 (s, 9 H), 0. 89-0. 84 (m, 3 H), 0. 87 (s, 9 H), 0. 85 (s, 9 H), 0. 73 (d, J = 6. 8 Hz, 3 H), 0. 07 (apparent s, 6 H), 0. 052 (s, 3 H), 0. 051 (s, 3 H), 0. 04 (apparent s, 6 H), 0. 03 (s, 3 H),-0. 01 (s, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 173. 3, 134. 7, 133. 5, 132. 5, 132. 1, 132. 0, 131. 5, 131. 0, 118. 4, 80. 5, 78. 8, 76. 4, 74. 9, 64. 7, 44. 1, 42. 7, 38. 0, 37. 4, 36. 3, 36. 1, 35. 2, 35. 1, 34. 2, 26. 3, 26. 2, 25. 9, 25. 7, 23. 2, 18. 5, 18. 1, 18. 0, 17. 3, 17. 2, 16. 4, 16. 1, 14. 1, 13. 7, 9. 4,-3. 0,-3. 3,-3. 6,-4. 34,-4. 36,-4. 5,-4. 8 ; high resolution mass spectrum (FAB, NBA) m/z 1029. 7273 [ (M+Na) + ; calcd for Cs6H1l007Si4Na : 1029. 7226].

EXAMPLE 49 Carbamate (-)-60.

A solution of alcohol (-)-59 (2. 2 mg, 0. 00219 mmol) in CH2C12 (500 ßL) was treated with C13CON=C=O (20 UL, 0. 168 mmol) at room temperature. After 30 min, the mixture was diluted with regular CH2Cl2 (2. 0 mL) and treated with neutral Al2O3 (500 mg). The mixture was stirred at room temperature for 2 h, filtered through a short silica plug, and concentrated.

Pipette flash chromatography (lao ethyl acetate/hexane) provided (-)-60 (1. 9 mg, 83W yield) as a colorless oil : []o -37° (c 0. 19, CHC1,) ; IR (film, CHC13 on NaCl plate) 3510 (m), 3360 (m, br), 3180 (m), 2960 (s), 2930 (s), 2880 (s), 2855 (s), 1730 (s, br), 1596 (m), 1460 (s), 1385 (s), 1362 (s), 1325 (m), 1255 (s), 1220 (m), 1100 (s), 1043 (s), 983 (m), 937 (m), 904 (m), 832 (s), 770 (s), 663 (m) cm-1 ; 1H NMR (500 MHZ, CDCl3) d 6. 58 (dddd, J = 16. 8, 10. 6, 10. 6, 0. 7 Hz, 1 H), 6. 01 (apparent t, J = 11. 0 Hz, 1 H), 5. 36 (apparent t, J = 10. 4 Hz, 1 H), 5. 27 (dd, J = 11. 1, 7. 9 Hz, 1 H), 5. 22-5. 16 (m, 2 H), 5. 12 (d, J = 10. 1 Hz, 1 H), 5. 03 (d, J = 10. 0 Hz, 1 H), 4. 76 (apparent t, J = 9. 2 Hz, 1 H), 4. 71 (apparent t, J = 6. 1 Hz, 1 H), 4. 50 (ddd, J = 10. 5, 10. 5, 1. 3 Hz, 1 H), 4. 44 (br s, 2 H), 3. 62 (apparent t, J = 2. 4 Hz, 1 H), 3. 42 (apparent t, J = 4. 5 Hz, 1 H), 3. 22 (apparent t, J = 5. 3 Hz, 1 H), 2. 98 (ddq, J = 10. 1, 6. 6, 6. 6 Hz, 1 H), 2. 60 (qd, J = 7. 6, 2. 7 Hz, 1 H), 2. 63-2. 55 (m, 1 H), 2. 48-2. 41 (m, 1 H), 2. 09 (apparent t, J = 12. 4 Hz, 1 H), 1. 93-1. 88 (m, 1 H), 1. 87-1. 77 (m, 2 H), 1. 71 (ddd, J = 14. 1, 10. 8, 1. 6 Hz, 1 H), 1. 67 (br d, J = 13. 7 Hz, 1 H), 1. 56 (apparent s, 3 H), 1. 55-1. 50 (m, 1 H), 1. 21 (d, J = 7. 6 Hz, 3 H), 0. 98 (d, J = 6. 8 Hz, 3 H), 0. 95 (d, J = 7. 0 Hz, 3 H), 0. 94 (d, J = 7. 5 Hz, 3 H), 0. 918 (d, J = 6. 8 Hz, 3 H), 0. 915 (s, 9 H), 0. 89 (s, 9 H), 0. 86 (s, 9 H), 0. 853 (d, J = 6. 4 Hz, 3 H), 0. 847 (s, 9 H), 0. 70 (d, J = 6. 8 Hz, 3 H), 0. 09 (s, 3 H), 0. 07 (s, 3 H), 0. 053 (s, 3 H), 0. 051 (s, 3 H), 0. 040 (s, 3 H), 0. 037 (s, 3 H), 0. 03 (s, 3 H),-0. 02 (s, 3 H) ; 13C NMR (125 MHZ, CDC1,) d 173. 3, 156. 9, 133. 6, 133. 5, 132. 4, 132. 1, 131. 9, 131. 4, 129. 8, 118. 0, 80. 5, 78. 9, 74. 9, 64. 6, 44. 2, 42. 7, 37. 8, 37. 4, 36. 0, 35. 3, 35. 2, 34. 5, 34. 2, 26. 3, 26. 2, 25. 9, 25. 7, 23. 0, 18. 5, 18. 4, 18. 1, 18. 0, 17. 5, 17. 1, 16. 44, 16. 38, 14. 1, 13. 7, 10. 1,-3. 0,-3. 4,-3. 6,-4. 4,-4. 5,-4. 8 ; high resolution mass spectrum (FAB, NBA) m/z 1072. 7264 [(M+Na) + ; calcd for Cs7H1llNO8Si4Na : 1072. 7283].

EXAMPLE 50 Discodermolide A solution of olefin (-)-60 (5. 8 mg, 5. 5 mmol) in 48% HF-CH3CN (1 : 9, 1. 0 mL) was stirred at room temperature for 12 h, then quenched with saturated aqueous NaHCO3 (5. 0 mL). The mixture was extracted with ethyl acetate (3 x 10 mL). The combined organic extracts were washed with brine (5. 0 mL), dried over MgSO4, filtered and concentrated. Pipette flash chromatography (gradient elution, 1 : 30 to 1 : 6 MeOH/CHCl3) provided (-)-1 (2. 0 mg, 60% yield) as a white amorphous solid : [a] 23D-16 (c 0. 03, MeOH) ; IR (CHC13) 3690 (w), 3620 (w), 3540 (w), 3430 (w), 3020 (s), 2975 (m), 2935 (m), 1740 (m), 1590 (w), 1540 (w), 1520 (w), 1467 (w), 1430 (w), 1385 (m), 1330 (w), 1233 (s), 1210 (s), 1100 (w), 1045 (m), 1033 (m), 975 (w), 930 (m), 910 (w), 793 (m), 777 (m), 765 (m), 750 (m), 705 (m), 687 (m), 670 (m), 660 (m), 625 (w) cm'' ;'H NMR (500 MHZ, CDC1,) d 6. 60 (dddd, J = 16. 8, 8. 4, 8. 4, 0. 8 Hz, 1 H), 6. 02 (apparent t, J = 11. 1 Hz, 1 H), 5. 51 (dd, J = 11. 2, 7. 9 Hz, 1 H), 5. 42 (ddd, J = 10. 6, 10. 6, 0. 6 Hz, 1 H), 5. 34 (apparent t, J = 10. 4 Hz, 1 H), 5. 20 (dd, J = 16. 9, 1. 9 Hz, 1 H), 5. 16 (d, J = 10. 0 Hz, 1 H), 5. 11 (d, J = 10. 1 Hz, 1 H), 4. 77-4. 69 (m, 1 H), 4. 70 (dd, J = 7. 3, 4. 2 Hz, 1 H), 4. 60 (ddd, J = 10. 0, 10. 0, 2. 4 Hz, 1 H), 4. 56 (br s, 2 H), 3. 73 (m, 1 H), 3. 28 (m, 1 H), 3. 18 (dd, J = 6. 8, 4. 8 Hz, 1 H), 2. 98 (ddq, J = 10. 1, 6. 9, 6. 9 Hz, 1 H), 2. 78 (ddq, J = 9. 8, 6. 8, 6. 8 Hz, 1 H), 2. 66 (qd, J = 7. 3, 4. 6 Hz, 1 H), 2. 60-2. 55 (m, 1 H), 2. 10-1. 80 (m, 10 H), 1. 69 (ddd, J = 14. 4, 10. 3, 3. 1 Hz, 1 H), 1. 64 (d, J = 1. 3 Hz, 3 H), 1. 30 (d, J = 7. 4 Hz, 3 H), 1. 06 (d, J = 6. 9 Hz, 3 H), 1. 00 (d, J = 6. 8 Hz, 3 H), 0. 99 (d, J = 6. 7 Hz, 3 H), 0. 97 (d, J = 6. 8 Hz, 3 H), 0. 94 (d, J = 6. 8 Hz, 3 H), 0. 82 (d, J = 6. 3 Hz, 3 H) ; 13C NMR (125 MHZ, CDCl3) d 173. 6, 157. 0, 134. 4, 133. 7, 133. 4, 132. 9, 132. 2, 129. 9, 129. 8, 117. 9, 79. 1, 78. 9, 77. 9, 75. 7, 73. 2, 64. 4, 43. 1, 41. 0, 37. 4, 36. 1, 36. 0, 35. 8, 35. 3, 34. 8, 33. 1, 23. 3, 18. 4, 17. 4, 15. 6, 15. 5, 13. 7, 12. 5, 9. 0 ; high resolution mass spectrum (FAB, NBA) m/z 616. 3840 [(M+Na) + ; calcd for C33HSSNOgNa : 616. 3826].

EXAMPLE 51 (Figures 16 and 17) A. Tosylate 101 A solution of diene 16 (see, Smith, et al., J. Am.

Chem. Soc. 1995, 117, 12011) (1. 15 g, 1. 0 mmol) in anhydrous pyridine (10 mL) at 0 °C is treated with p-toluenesulfonyl chloride (286 mg, 1. 5 mmol). The mixture is allowed to warm to room temperature for 4-6 h. The pyridine is removed in vacuo and the residue is purified by flash chromatography to afford tosylate 101.

B. Arene 102 Phenyllithium (2. 7 mL, 1. 8 M in cyclohexane-ether (70 : 30)) is added dropwise to a solution of copper (I) iodide (460 mg, 2. 4 mmol) in anhydrous diethyl ether (5 mL) at 0 °C.

To the resultant mixture is added a solution of tosylate 101 (780 mg, 0. 6 mmol) in ether (5 mL) and the resultant mixture is warmed to room temperature with stirring. After 4 h, saturated aqueous ammonium chloride (20 mL) is added. The layers are separated and the aqueous layer is extracted with ethyl acetate. The combined organics are dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 102.

C. Lactol 103.

To a solution of 102 (120 mg, 0. 1 mmol) in tetrahydrofuran-acetonitrile (15 mL, 2 : 1) is added phosphate buffer (pH 7, 5 mL) and mercury (II) chloride (272 mg, 1. 0 mmol). The resultant mixture is stirred 1 h at room temperature. The reaction mixture is diluted with ether (100 mL) and washed with saturated aqueous brine (2 x 50 mL), dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 103 as a mixture of a and anomers.

D. Lactone 104.

To a solution of 103 (84 mg, 0. 070 mmol) in dimethyl sulfoxide (10 mL) is added acetic anhydride (2 mL). After 2 days at room temperature, the mixture is diluted with ether (100 mL) and washed with saturated aqueous sodium bicarbonate (50 mL), saturated aqueous brine (50 mL), dried over magnesium

sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 104.

E. Alcohol 105.

To a solution of 104 (56 mg, 0. 050 mmol) in dichloromethane (3 mL) at 0 °C is added water (50 mL) and 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone (52 mg, 0. 018 mmol).

After 1 h, the reaction mixture is diluted with ethyl acetate (50 mL), washed with saturated aqueous brine (3 x 25 mL), dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 105.

F. Carbamate 106.

To a solution of 105 (10 mg, 0. 010 mmol) in dichloromethane (2 mL) is added trichloroacetyl isocyanate (0. 12 mL, 1. 00 mmol). After 30 min, the reaction mixture is diluted with dichloromethane (4 mL) and neutral alumina (1 g) is added. The resultant suspension is stirred an additional 4 h. The reaction mixture is filtered and the concentrated filtrate is chromatographed on silica gel to afford 106.

G. Tetrol 107.

A solution of 106 (10 mg, 0. 0096 mmol) in 48% hydrofluoric acid-acetonitrile (1 : 9, 2 mL) is stirred at ambient temperature. After 12 h, saturated aqueous sodium bicarbonate (25 mL) is added and the mixture is extracted with ethyl acetate (3 x 20 mL). The combined organics are dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 107.

EXAMPLE 52 (Figures 18-20) A. Alcohol 203.

To a slurry of powdered 4-A molecular sieves (2. 0 g) in 100 mL of anhydrous toluene is added boronate 202 (see, Roush, et al., J. Am. Chem. Soc. 1990, 112, 6348) (170 mL, 1. 0 M in toluene). The resultant solution is stirred 10 min at room temperature and then cooled to-78 °C. A solution of aldehyde 201 (see, Solladie, et al., Tetrahedron Lett. 1987, 28, 797) (113 mmol) in toluene (100 mL) is added over a 2 h period, after which the reaction is maintained at-78 °C for 10

h. Excess ethanolic sodium borohydride (ca. 0. 75 g/10 mL) is added and the reaction mixture is warmed to 0 °C. Aqueous 1 N sodium hydroxide (300 mL) is added and the mixture is stirred vigorously for 2 h. The layers are separated and the aqueous layer is extracted with ether (5 x 300 mL). The combined organics are dried over potassium carbonate and concentrated in vacuo. The residue is purified by flash chromatography to afford 203.

B. Bis-silyl ether 204 A solution of 203 (75 mmol) in dimethylformamide (150 mL) is cooled to 0 °C and treated with imidazole (150 mmol) and tert-butyldimethylsilyl chloride (100 mmol). The resultant solution is warmed to room temperature. After 12 h, the reaction mixture is poured into 1500 mL of water and extracted with ether (3 x 200 mL). The ethereal extracts are washed with water (2 x 50 mL) and saturated aqueous brine (50 mL), dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 204.

C. Alcohol 205.

A solution of 204 (20 mmol) in 500 mL of methanol is cooled to-78 °C and treated with a stream of ozone and oxygen until the colorless solution is converted into a steel blue one. The crude reaction mixture is cautiously quenched with sodium borohydride (100 mmol) and the resultant solution is warmed to room temperature. After 3 h, the excess sodium borohydride is destroyed by the cautious addition of water.

The methanol is removed in vacuo and the residue is partitioned between saturated aqueous ammonium chloride (200 mL) and ethyl acetate (200 mL). The layers are separated and the aqueous layer is further extracted with ethyl acetate (2 x 100 mL).

The combined organics are dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 205.

D. Triethylsilyl ether 206.

A solution of 205 (15 mmol) in dimethylformamide (30 mL) is cooled to 0 °C and treated with imidazole (30 mmol) and triethylsilyl chloride (20 mmol). The resultant solution is

warmed to room temperature. After 12 h, the reaction mixture is poured into 300 mL of water and extracted with ether (3 x 40 mL). The ethereal extracts are washed with water (2 x 25 mL) and saturated aqueous brine (25 mL), dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 206.

E. Alcohol 207.

To a solution of 206 (6 mmol) in ethyl acetate-ethanol (8 : 1, 90 mL) is added palladium on carbon (10W wet, 500 mg).

The mixture is stirred under hydrogen atmosphere for 3-6 h, then filtered and concentrated in vacuo. The residue is purified by flash chromatography to afford 207.

F. Aldehyde 208.

To a-10 °C solution of 207 (13 mmol) and triethylamine (50 mmol) in dichloromethane (26 mL) is added a solution of sulfur trioxide-pyridine (39 mmol) in dimethyl sulfoxide (50 mL). The mixture is stirred 1 h at room temperature and diluted with ether (150 mL). The organic phase is washed with aqueous sodium bisulfate (1 M, 100 mL), saturated aqueous brine (4 x 100 mL), dried over magnesium sulfate, and concentrated in vacuo. The residue is purified by flash chromatography to afford 208.

G. Wittig product 209.

Phosphonium salt 15 (see, Smith, et al., J. Am. Chem.

Soc. 1995, 117, 12011) (0. 2 mmol) is dissolved in anhydrous tetrahydrofuran (2 mL) and chilled to 0 °C. A solution of sodium bis (trimethylsilyl) amide (0. 2 mmol, 1. 0 M in tetrahydrofuran) is added and the reaction mixture is stirred 30 min at 0 °C. After cooling to-78 °C, a solution of aldehyde 208 (0. 1 mmol) in tetrahydrofuran (2 mL) is added and the mixture is stirred 10 min at-78 °C and 2 h at room temperature. Saturated aqueous ammonium chloride (2 mL) is added and the resultant mixture is extracted with ether (3 x 20 mL). The ethereal layer is washed with water (2 x 25 mL) and saturated aqueous brine (25 mL), dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 209.

H. Hydroxy diene 210.

A-78 °C solution of 209 (0. 05 mmol) in CH2Cl2 (5 mL) is treated with diisobutylaluminum hydride (0. 5 mL, 1. 0 M in toluene). The resultant solution is stirred 10 min at-78 °C and 30 min at 0 °C. The reaction is quenched with a saturated solution of sodium potassium tartrate (50 mL) and the mixture is diluted with ether (60 mL). The organic layer is separated, dried over magnesium sulfate, and concentrated in vacuo. The residue is purified by flash chromatography to afford 210.

I. Aldehyde 211.

To a-10 °C solution of 207 (1. 3 mmol) and triethylamine (5. 0 mmol) in dichloromethane (3 mL) is added a solution of sulfur trioxide-pyridine (3. 9 mmol) in dimethyl sulfoxide (5 mL). The mixture is stirred 1 h at room temperature and diluted with ether (15 mL). The organic phase is washed with aqueous sodium bisulfate (1 M, 10 mL), saturated aqueous brine (4 x 10 mL), dried over magnesium sulfate, and concentrated in vacuo. The residue is purified by flash chromatography to afford 211.

J. Tetraene 212.

A solution of diphenylallylphosphine (0. 08 mL, 0. 38 mmol) in tetrahydrofuran (2 mL) is cooled to-78 °C and tert-butyllithium (0. 14 mL, 1. 7 M in pentane) is added. The mixture is warmed to 0 °C for 30 min, then recooled to-78 °C and treated with titanium (IV) isopropoxide (0. 30 mmol). After 30 min, aldehyde 211 (0. 30 mmol) is introduced as a solution in tetrahydrofuran (2 mL). The resultant solution is stirred at -78 °C for 15 min and at 0 °C for 1 h. Methyl iodide (0. 64 mmol) is added, and the reaction is warmed to room temperature for 12 h. The reaction mixture is diluted with ether (60 mL), washed with aqueous sodium bisulfate (30 mL, 1. 0 M), saturated aqueous brine (30 mL), and is dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 212.

K. Aldehyde 213.

Oxalyl chloride (1. 5 mmol) is added dropwise to a-78 °C solution of dimethyl sulfoxide (3 mmol) in dichloromethane

(4 mL). After 15 min, a-78 °C solution of 212 (1 mmol) in dichloromethane (2 mL) is added via canula. After an additional 15 min, diisopropylethylamine (4. 5 mmol) is added and the reaction is gradually warmed to room temperature over 1 h and quenched with aqueous sodium bisulfate. The mixture is diluted with ether (50 mL) and is washed with water (2 x 30 mL), saturated aqueous brine (2 x 30 mL), is dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 213.

L. Ester 214.

To a-78 °C solution of (F3CCH2O) 2POCH2CO2Et (2 mmol) and 18-crown-6 (2. 4 mmol) in tetrahydrofuran (5 mL) is added potassium bis (trimethylsilyl) amide (2 mmol) in tetrahydrofuran (2 mL). The resultant solution is stirred 10 min at-78 °C and then treated with aldehyde 213 (1. 2 mmol) in 4 mL of tetrahydrofuran. The reaction mixture is warmed to 0 °C for 6-8 h and then quenched with saturated aqueous ammonium chloride (10 mL). The aqueous layer is separated and extracted with hexane (2 x 25 mL). The combined organics are dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 214.

M. Alcohol 215.

To a solution of 214 (0. 050 mmol) in dichloromethane (3 mL) at 0 °C is added water (50 mL) and 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone (0. 018 mmol). After 1 h, the reaction mixture is diluted with ethyl acetate (50 mL), washed with saturated aqueous brine (3 x 25 mL), dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 215.

N. Carbamate 216.

To a solution of 215 (0. 010 mmol) in dichloromethane (2 mL) is added trichloroacetyl isocyanate (1. 00 mmol). After 30 min, the reaction mixture is diluted with dichloromethane (4 mL) and neutral alumina (1 g) is added. The resultant suspension is stirred an additional 4 h. The reaction mixture is filtered and the concentrated filtrate is chromatographed on silica gel to afford 216.

0. Triol 217.

A solution of 216 (0. 010 mmol) in 48° hydrofluoric acid-acetonitrile (1 : 9, 2 mL) is stirred at ambient temperature. After 12 h, saturated aqueous sodium bicarbonate (25 mL) is added and the mixture is extracted with ethyl acetate (3 x 20 mL). The combined organics are dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 217.

EXAMPLE 53 (Figures 21 and 22) A. Hydroxy-oxazole 302.

A solution of oxazole (3 mmol) in tetrahydrofuran (15 mL) is cooled to-78 °C and treated with n-BuLi (3 mmol) in hexane. (see, Hodges, et al., J. Org. Chem. 1991, 56, 449).

After 30 min at-78 °C, previously prepared (see, Smith, et al., J. Am. Chem. Soc. 1995, 117, 12011) aldehyde 301 (2 mmol) is added in tetrahydrofuran (10 mL) and the reaction mixture is gradually allowed to warm to room temperature. After 18-24 h, the reaction is quenched by addition of saturated aqueous ammonium chloride (25 mL). The aqueous layer is separated and extracted with ether (3 x 25 mL). The combined organics are dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 302.

B. Tosylate 303.

A solution of 302 (1. 0 mmol) in anhydrous pyridine (10 mL) at 0 °C is treated with p-toluenesulfonyl chloride (286 mg, 1. 5 mmol). The mixture is allowed to warm to room temperature for 4-6 h. The pyridine is removed in vacuo and the residue is purified by flash chromatography to afford tosylate 303.

C. Reduction product 304.

To a 0 °C solution of tosylate 303 (0. 5 mmol) in tetrahydrofuran (2 mL) is added lithium triethylborohydride (2 mmol) as a solution in tetrahydrofuran (1. 0 M). The resultant solution is warmed to room temperature for 2-4 h and then quenched with water (1 mL) and diluted with ether (25 mL). The ethereal layer is washed with saturated aqueous brine (2 x 10

mL), dried over magnesium sulfate, and concentrated in vacuo.

The residue is purified by flash chromatography to afford 304.

D. Lactol 305.

To a solution of 304 (0. 1 mmol) in tetrahydrofuran-acetonitrile (15 mL, 2 : 1) is added phosphate buffer (pH 7, 5 mL) and mercury (II) chloride (1. 0 mol). The resultant mixture is stirred 1 h at room temperature. The reaction mixture is diluted with ether (100 mL) and washed with saturated aqueous brine (2 x 50 mL), dried over magnesium sulfate and concentrated in vacuo. The residue is purified by <BR> <BR> <BR> flash chromatography to afford 305 as a mixture of a and anomers.

E. Lactone 306.

To a solution of 305 (0. 070 mmol) in dimethyl sulfoxide (10 mL) is added acetic anhydride (2 mL). After 2 days at room temperature, the mixture is diluted with ether (100 mL) and washed with saturated aqueous sodium bicarbonate (50 mL), saturated aqueous brine (50 mL), dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 306.

F. Alcohol 307.

To a solution of 306 (0. 050 mmol) in dichloromethane (3 mL) at 0 °C is added water (50 mL) and 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone (0. 018 mmol). After 1 h, the reaction mixture is diluted with ethyl acetate (50 mL), washed with saturated aqueous brine (3 x 25 mL), dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 307.

G. Carbamate 308.

To a solution of 307 (0. 010 mmol) in dichloromethane (2 mL) is added trichloroacetyl isocyanate (1. 00 mmol). After 30 min, the reaction mixture is diluted with dichloromethane (4 mL) and neutral alumina (1 g) is added. The resultant suspension is stirred an additional 4 h. The reaction mixture is filtered and the concentrated filtrate is chromatographed on silica gel to afford 308.

H. Tetrol 309.

A solution of 308 (0. 010 mmol) in 48t hydrofluoric acid-acetonitrile (1 : 9, 2 mL) is stirred at ambient temperature. After 12 h, saturated aqueous sodium bicarbonate (25 mL) is added and the mixture is extracted with ethyl acetate (3 x 20 mL). The combined organics are dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 309.

EXAMPLE 54 As shown in Figure 23, a solution of 402 (10. 5 mg, 10. 4 mmol) in 48k HF-CH3CN (1 : 9, 1. 0 mL) is stirred at room temperature for 12 hr. The reaction is quenched by saturated NaHCO3 (5. 0 mL). The mixture is extracted with ethyl acetate (3 x 10 mL). The combined organic phase is then washed with brine (5. 0 mL), dried over MgSO4, concentrated in vacuo. The residue is purified by flash chromatography to afford 401.

EXAMPLE 55 (Figure 24) A. PMB-ether 503 ZnCl2 (1. 32 g, 9. 69 mmol) is dried at 160°C under vacuum overnight and then treated with a solution of iodide 502 (2. 46 g, 9. 59 mmol) in dry Et2O (50 mL). The mixture is stirred at room temperature until most of the ZnCl2 is dissolved and then cooled to-78°C. t-BuLi (1. 7M in pentane, 17. 0 mL) is added over 30 min, and the resultant solution is stirred an additional 15 min, warmed to room temperature, and stirred for lhr. The solution is added by cannula to a mixture of iodoolefin B (see, Smith, et al., J. Am. Chem. Soc. 1995, 117, 12011) (3. 21 g, 6. 19 mmol) and Pd (PPh3) 4 (364. 2 mg, 0. 315 mmol). The mixture is covered with aluminum foil, stirred overnight, and then diluted with ethyl acetate (100 mL), washed with brine (2 X 100 mL), dried over MgSO4, filtered and concentrated in vacuo. The residue is purified by flash chromatography to afford 503.

B. Phosphonium salt 504 A solution of alcohol 503 (1. 70 g, 3. 26 mmol) in CH2Cl2 (28 mL) is cooled to 0 °C and treated with water (1. 3 mL) and 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone (774 mg, 3. 41 mmol). The mixture is stirred at 0°C for 5 hr, diluted with CH2Cl2 (20 mL), dried over MgSO4, and filtered through a column of silica gel. Following concentration in vacuo, the residue is dissolved in ethanol (50 mL) at room temperature, and excess sodium borohydride is added. After 30 min, the reaction is cooled to 0°C, quenched with saturated aqueous NH4Cl (50 mL), and concentrated. The residue is then dissolved in CH2Cl2 (90 mL), and the solution is washed with water, dried over MgSO4, filtered and concentrated in vacuo. The residue is purified by flash chromatography to afford an alcohol A solution of this alcohol (400 mg, 1. 0 mmol) in dry benzene/ether (1 : 2, 50 mL) is treated with triphenylphosphine (923 mg, 3. 6 mmol) and imidazole (273 mg, 4. 0 mmol). After all of the imidazole dissolved, iodine (761 mg, 3. 0 mmol) is added with vigorous stirring of the reaction mixture. The mixture is stirred 2 h further and then treated with triethylamine (4 mL).

The resultant solution is diluted with CH2Cl2 (50 mL) and washed with saturated aqueous Na2S203 (100 mL), saturated aqueous NaHCO3 (100 mL), and brine (2 x 100 mL). The organic phase is dried over MgSO4, filtered and concentrated in vacuo.

Filtration though silica gel to remove triphenylphosphine oxide, affords an iodide. The iodide was mixed with diisopropylethylamine (0. 6 mL, 3. 44 mmol) and triphenylphosphine (4. 94 g, 18. 8 mmol). The mixture is heated at 80 °C for 24 hr, cooled to room temperature, and washed with hexane (2 x 50 mL). The product is isolated by flash chromatography to afford 504.

C. Coupled product 505.

Phosphonium salt 504 (386 mg, 0. 5 mmol) is dried azeotropically with dry benzene and heated at 50°C under vacuum for 3 hr before use. It is then dissolved in tetrahydrofuran (3. 0 mL). Sodium bis (trimethylsilyl) amide (1. 0 M in tetrahydrofuran, 0. 48 mL, 0. 48 mmol) is added at-78°C, and the

mixture is stirred for 25 min and then recooled to-78°C. A solution of aldehyde C (see, Smith, et al., J. Am. Chem. Soc.

1995, 117, 12011) (147 mg, 0. 30 mmol) in tetrahydrofuran (1. 5 mL) is added, and the mixture is stirred for 10 min at-78°C, and 2 hr at room temperature. The reaction is quenched with saturated aqueous NH4C1 (4. 0 mL), the resultant mixture is extracted with ether (120 mL), and the ether layer is washed with water (100 mL) and brine (100 mL), dried over MgSO4, filtered and concentrated in vacuo. Flash chromatography provides olefin 505.

D. Lactone 506.

To a solution of 505 (200 mg, 0. 23 mmol) in tetrahydrofuran-acetonitrile (10 mL, 2 : 1) is added a phosphate buffer solution (pH = 7. 0, 3. 3 mL), and HgCl, (1. 3 g). The suspension is stirred at room temperature for 40 min, then diluted with ether (150 mL), washed with brine (2 x 70 mL), dried over MgSO4, and concentrated in vacuo. Flash chromatography provides a mixture of lactols as ulo anomers.

This material is used directly in the next oxidation : Under argon, to a solution of lactols in dimethylsulfoxide (5. 0 mL) is added acetic anhydride (1. 0 mL). After 2 days at room temperature, the mixture is diluted with ether (150 mL), washed with saturated NaHCO3 (150 mL), brine (150 mL), dried over MgSO4, and concentrated in vacuo. Flash chromatography affords a lactone. A solution of the lactone (160 mg, 0. 20 mmol) in methanol (4 mL) is treated with pyridinium p-toluenesulfonate (10 mg) and stirred at 40°C for 30 min. The mixture is diluted with ether (80 mL) and washed successively with saturated aqueous NaHCO3 solution (90 mL) and brine (40 mL), and then dried over MgSO4. The organic solution is concentrated in vacuo, and the residue is passed through a column of silica gel to provide alcohol 506.

E. Acid 507.

To a solution of alcohol 506 (140 mg, 0. 19 mmol) in dimethylformamide (5. 0 mL), is added pyridinium dichromate (210 mg, 0. 55 mmol). The reaction mixture is stirred at room temperature for 5 hr, and diluted with water (120 mL). The

mixture is extracted with ether (3 x 15 mL). The organic solutions are combined and washed with brine (40 mL), and dried over MgSO4. Then it is concentrated in vacuo to give a residue, which is purified by flash chromatography to afford carboxylic acid 507.

F. Amino-amide 508.

To a solution of 507 (60. 0 mg, 78. 1 mmol) and D-leucine hydrochloride (26. 0 mg, 0. 16 mmol) in CH2Cl2 (3 mL) is added 1- (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC, 23 mg, 0. 12 mmol) and 1-hydroxybenzotriazole (21. 0 mg, 0. 14 mmol), followed by diisopropylamine (40 mL, 0. 23 mmol). The mixture is stirred at room temperature overnight before addition of 5t KHSO4 solution. The resulting mixture is extracted with ethyl acetate (30 mL). The organic layer is washed with brine (20 mL) and dried over MgSO4, and then concentrated in vacuo. The residue is purified by column chromatography to afford 508.

G. Analog 501.

A solution of 508 (52 mg, 59 mmol) in 48% HF-acetonitrile (1 : 9, 1. 0 mL) is stirred at room temperature for 12 hr. The reaction is quenched by saturated NaHCO3 (5. OmL).

The mixture is extracted with ethyl acetate (3 x 10 mL). The combined organic phase is then washed with brine (5. 0 mL), dried over MgSO4, and concentrated in vacuo. Flash chromatography provides 501.

EXAMPLE 56 (Figure 25) A. Diene 603.

Phosphonium salt 15 (98. 0 mg, 0. 092 mmol) is dried azeotropically with dry benzene and heated at 50°C under vacuum for 3 hr before use. It is then dissolved in tetrahydrofuran (0. 7 mL). Sodium bis (trimethylsilyl) amide (1. 0 M in tetrahydrofuran, 86 mL, 0. 0855 mmol) is added at-78°C, and the mixture is stirred for 20 min and then recooled to-78°C. A solution of aldehyde 602 (13 mg, 60 mmol) in tetrahydrofuran (300 mL) is added, and the mixture is stirred for 10 min at -78°C, and 2 hr at room temperature. The reaction is quenched

with saturated aqueous NH4Cl (1. 0 mL). The resultant mixture is extracted with ether (30 mL), and the ether layer is washed with water (30 mL) and brine (30 mL), dried over MgSO4, filtered and concentrated in vacuo. Flash chromatography provides the coupled product.

A solution of the olefin (39 mg, 44 mmol) in CH, ci, is cooled to-78°C, diisobutylaluminum hydride (1. 0 M in toluene, 440 mL, 0. 40 mmol) is added dropwise over 5 min, and the resultant solution is stirred for 10 min at-78°C and 30 min at 0°C. The reaction is quenched with a saturated solution of Rochelle's salt, and the mixture is diluted with ether (60 mL), washed with Rochelle solution, and brine (30 mL each), dried over MgSO4, filtered and concentrated in vacuo. Flash chromatography provides alcohol 603.

B. Alkane 604.

To a solution of alcohol 603 (82 mg, 0. 93 mmol) in pyridine (1. 5 mL) at 0°C is added p-toluenesulfonyl chloride (26. 6 mg, 0. 14 mmol) with stirring. After 3 hr, the reaction mixture is concentrated in vacuo. The residue is purified by column chromatography to give a tosylate. To a solution of this tosylate (94 mg, 0. 91 mmol) in ether (5 mL) is added lithium diisopropylcuprate (Pr2CuLi) (ca. 0. 5 M in ether, 10 mL, excess. The resultant solution is stirred for 8 hr and then quenched with saturated aqueous solution of NH4Cl (50 mL).

Stirring is continued for an additional 2 h. The organic phase is separated and washed with NH4Cl solution (20 mL), dried over MgSO4, and concentrated in vacuo. Flash chromatography provides 604.

C. Enone 605.

A solution of 604 (75 mg, 83 mmol) in methanol (2 mL) is treated with pyridinium p-toluenesulfonate (ca. 4 mg) and stirred at 40°C for 30 min. The mixture is diluted with ether (20 mL) and washed successively with saturated aqueous NaHCO3 solution (25 mL) and brine (10 mL), and then dried over MgSO4.

The organic solution is concentrated in vacuo, and the residue is passed through a column of silica gel to provide an alcohol.

To a solution of the alcohol (62. 0 mg, 68. 2 mmol) in benzene

(2. 0 mL) is added manganese (IV) oxide (100 mg, 1. 15 mmol).

After stirring for 8 h at room temperature, the reaction mixture is filtered through a pad of celite. The filtrate is concentrated in vacuo. Flash chromatography of the residue affords a, a-unsaturated ketone 605.

D. Triol 606.

A solution of the 0',/3-unsaturated ketone 605 (45 mg, 56 mmol) in CH2Cl2 (2 mL) is cooled to 0 °C and treated with water (0. 1 mL) and 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone (15 mg, 66 mmol). The mixture is stirred at 0 °C for 5 hr, diluted with CH2C12 (15 mL), dried over MgSO4, and filtered through a column of silica gel. Following concentration in vacuo, the residue is used for next step without further purification. A solution of the crude alcohol in 480 HF-acetonitrile (1 : 9, 1. 0 mL) is stirred at room temperature for 12 hr. The reaction is quenched by saturated NaHCO3 (5. OmL).

The mixture is extracted with ethyl acetate (3 x 10 mL). The combined organic phase is then washed with brine (5. 0 mL), dried over MgSO4, concentrated in vacuo. The residue is purified by flash chromatography to afford 601.

EXAMPLE 57 (Figure 26) A. Alkane 702 To a solution of iodide A (300 mg, 0. 54 mmol) in ether (5 mL) is added lithium dibutylcuprate (Bu2CuLi) (ca. 0. 5 M in ether, 5. 4 mL, excess) at-25°C. The resultant solution is stirred for 8 hr and then quenched with saturated aqueous NH4Cl (50 mL). Stirring is continued for another 2 hr and the organic phase is separated. The organic solution is washed with NH4Cl solution (20 mL) and dried over MgSO, and concentrated in vacuo. Flash chromatography provides 702.

B. Alcohol 703.

A solution of 702 (240 mg, 0. 50 mmol) in CHIC'2 (6. 0 mL) is cooled to-78°C. Diisobutylaluminum hydride (1. 0 M in toluene, 1. 50 mL, 1. 50 mmol) is added dropwise over 5 min, and the resultant solution is stirred for 10 min at-78°C and 30 min at 0°C. The reaction is quenched with a saturated solution

of Rochelle's salt, and the mixture is diluted with ether (60 mL), washed with Rochelle solution, and brine (30 mL each), dried over MgSO4, filtered and concentrated in vacuo. Flash chromatography provides alcohol 703.

C. Iodide 704 A solution of alcohol 703 (210 mg, 0. 44 mmol) in dry benzene/ether (1 : 2, 5 mL) is treated with triphenylphosphine (420 mg, 1. 6 mmol) and imidazole (123 mg, 1. 8 mmol). After all of the imidazole dissolved, iodine (335 mg, 1. 32 mmol) is added with vigorous stirring. The mixture is stirred for 2 h and then treated with triethylamine (1. 8 mL). The resultant solution is diluted with CH2C12 (22 mL) and washed with saturated aqueous Na2S203 (40 mL), saturated aqueous NaHCO3 (40 mL), and brine (2 x 40 mL). The organic phase is dried over MgSO4, filtered and concentrated in vacuo. The residue is purified by flash chromatography to afford iodide 704.

D. Phosphonium salt 705.

The iodide 704 is mixed with triphenylphosphine (2. 17 g, 8. 27 mmol) and the mixture is heated at 80°C for 24 hr, cooled to room temperature, and washed with hexane (2 x 20 mL).

Flash chromatography provides phosphonium salt 705.

E. Alkene 707.

A solution of 705 (260 mg, 0. 30 mmol) in tetrahydrofuran (6. 0 mL) is cooled to-10°C and a solution of n-butyl lithium (1. 0 M in hexane, 0. 29 mL, 0. 29 mmol) is introduced dropwise over 5 min. The resultant solution is stirred for 50 min at room temperature and then the mixture is recooled to-78°C and aldehyde 706 (39 mg, 0. 3 mmol) is added a solution in tetrahydrofuran (1. 5 mL). The mixture is stirred for 10 min at-78°C, and 1 hr at 0 °C. The reaction is quenched with saturated aqueous NH4Cl (1. 0 mL) and the resultant mixture is extracted with ether (30 mL). The ether layer is washed with water (30 mL) and brine (30 mL), dried over MgSO4, filtered and concentrated in vacuo. The residue is purified by flash chromatography to afford olefin 707 (149 mg, 85% yield).

F. Diol 708.

Acetonide 707 (147 mg, 0. 25 mmol) is dissolved in 800 aqueous acetic acid (2. 5 mL) at room temperature. The reaction mixture is stirred for 4 hr at room temperature and then diluted with water (20 mL). The mixture is extracted with ethyl acetate (2 x 5 mL). The combined organic layers are washed with saturated NaHCO3 solution, and brine (10 mL each), and then dried over MgSO4. The organic solution is concentrated in vacuo, and the residue is flash chromatogaraphed over silica gel to afford diol 708.

G. Tosylate 709.

To a solution of diol 708 (134 mg, 0. 25 mmol) in pyridine (2 mL) is added p-toluenesulfonyl chloride (52 mg, 0. 27 mmol). After 3 hr, the reaction mixture is diluted with ether (30 mL), and washed with ice cold 1 M hydrochloric acid (60 mL), saturated NaHCO3 solution (20 mL), and brine (20 mL) and then concentrated in vacuo. The residue is purified by column chromatography to give a monotosylate 709.

H. Epoxide 710.

A solution of tosylate 709 (145 mg, 0. 21 mmol) in methanol (3. 0 mL) is added potassium carbonate (10 mg) at room temperature. The mixture is stirred for 20 min, and then diluted with water (60 mL) and extracted with ethyl acetate (2 x 20 mL). The combined organic layers are washed with brine and concentrated in vacuo. Flash chromatography provides epoxide 710.

I. Alcohol 711.

To a solution of 710 (41 mg, 79 mmol) in CHOC12 (3. 0 mL) at 0°C is added water (0. 15 mL) and 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone (60 mg, 0. 26 mmol).

The mixture is stirred at 0°C for 5 hr, diluted with CH2Cl2 (15 mL), dried over MgSO4, and filtered through a column of silica gel. Following concentration in vacuo, the crude 711 is used without further purification.

J. Carbamate 712.

To a solution of 711 (8. 7 mg, 22 mmol) in CHzCl2 (1. 0 mL) is added trichloroacetyl isocyanate (0. 20 mL, 1. 7 mmol) at

room temperature. After 30 min, the mixture is diluted with CH2C12 (20 mL), and some neutral Al 2° (500 mg) is added. The mixture is then stirred at room temperature for 2 hr, then filtered though a short column of silica gel, and concentrated in vacuo. The residue is purified by flash chromatography to afford 712.

K. Hydroxy-urethane 701.

A solution of 712 (6. 0 mg, 14 mmol) in 48% HF-acetonitrile (1 : 9, 1. 0 mL) is stirred at room temperature for 12 hr. The reaction is quenched by saturated NaHCO3 (5. 0 mL). The mixture is extracted with ethyl acetate (3 x 10 mL).

The combined organic phase is then washed with brine (5. 0 mL), dried over MgSO4, and concentrated in vacuo. The residue is purified by flash chromatography afford 701.

EXAMPLE 58 (Figures 27 and 28) A. Iodide 802.

A solution of alcohol 16 (see, Smith, et al., J. Am.

Chem. Soc. 1995, 117, 12011) (410 mg, 0. 360 mmol) in dry benzene/ether (1 : 2, 10 mL) is treated with triphenylphosphine (378 mg, 1. 44 mmol) and imidazole (111 mg, 1. 62 mmol). After complete dissolution of the imidazole, iodine (301 mg, 1. 19 mmol) is added with vigorous stirring. The reaction mixture is stirred 2 h and then treated with triethylamine (1. 7 mL). The resultant solution is diluted with CH2C12 (30 mL) and washed with saturated aqueous Na2S203 (40 mL), saturated aqueous NaHCO3 (40 mL), and brine (2 x 40 mL). The organic phase is dried over MgSO4, filtered and concentrated in vacuo. Purification of the residue by flash chromatography affords iodide 802.

B. Phosphonium salt 803.

To a solution of iodide 802 (410 mg, 0. 325 mmol) in benzene (20 mL) is added triphenylphosphine (1. 00 g, 3. 81 mmol).

The mixture is heated at 80°C for 24 hr, cooled to room temperature, and concentrated in vacuo. The residue is washed with hexane (2 x 20 mL). Flash chromatography affords phosphonium salt 803.

C. Alkene 805 A solution of 803 (460 mg, 0. 30 mmol) in tetrahydrofuran (9. 0 mL) is cooled to-10°C. A solution of n-butyl lithium (1. 0 M in hexane, 0. 29 mL, 0. 29 mmol) is added dropwise over 5 min, and the resultant solution is stirred for 50 min at room temperature. Then the mixture is recooled to -78°C and a solution of aldehyde 804 (39 mg, 0. 3 mmol) in tetrahydrofuran (1. 5 mL) is added. The mixture is stirred for 10 min at-78°C, and 1 hr at 0 °C. The reaction is quenched with saturated aqueous NH4Cl (20 mL), the resultant mixture is extracted with ether (40 mL), and the ether layer is washed with water (30 mL) and brine (30 mL), dried over MgSO4, filtered and concentrated in vacuo. Flash chromatography of the residue affords 805.

D. Diol 806 Acetonide 805 (280 mg, 0. 22 mmol) is dissolved in 80% aqueous acetic acid (3. 5 mL) at room temperature. The reaction mixture is stirred for 4 hr at room temperature and then diluted with water (40 mL). The mixture is extracted with ethyl acetate (2 x 10 mL). The combined organic layers are washed with saturated NaHCO3 solution, and brine (10 mL each), and then dried over MgSO4. The organic solution is concentrated in vacuo, and the residue is flash chromatogaraphed over silica gel to afford diol 806.

E. Tosylate 807.

To a solution of diol 806 (235 mg, 0. 19 mmol) in pyridine (2 mL) at 0 °C is added p-toluenesulfonyl chloride (45 mg, 0. 23 mmol). After 3 hr, the reaction mixture is diluted with ether (30 mL), and washed with ice cold 1 M hydrochloric acid (30 mL), saturated NaHCO3 solution (20 mL), and brine (20 mL) and then concentrated in vacuo. The residue is purified by column chromatography to give a monotosylate 807.

F. Epoxide 808.

To a solution of tosylate 807 (187 mg, 0. 21 mmol) in methanol (3. 0 mL) is added potassium carbonate (10 mg) at room temperature. The mixture is stirred for 20 min, and then diluted with water (60 mL) and extracted with ethyl acetate (2

x 20 mL). The combined organic layers were washed with brine and concentrated in vacuo. Flash chromatography provides epoxide 808.

G. Lactone 809.

To a solution of 808 (110 mg, 93 mmol) in tetrahydrofuran-acetonitrile (10 mL, 2 : 1) is added a phosphate buffer solution (pH = 7. 0, 3. 5 mL), and HgCl2 (2. 3 g). The suspension is stirred at room temperature for 40 min, then diluted with ether (30 mL), washed with brine (2 x 30 mL), dried over MgSO4, and concentrated in vacuo. Flash chromatography affords the lactol as an a/ (3 anomeric mixture. This material is used directly in the next oxidation : Under argon atmosphere, a solution of the lactols in dimethylsulfoxide (3. 0 mL) is treated with acetic anhydride (0. 60 mL). After 2 days at room temperature, the mixture is diluted with ether (50 mL), washed with saturated NaHCO3 (30 mL), brine (30 mL), dried over MgSO4, and concentrated in vacuo. Flash chromatography provides 809.

H. Alcohol 810.

To a solution of 809 (90 mg, 79 mmol) in CHOC12 (3. 0 mL) at 0°C is added water (0. 15 mL) and 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone (60 mg, 0. 26 mmol). The mixture is stirred at 0°C for 5 hr, diluted with CH2C12 (15 mL), dried over MgSO4, and filtered through a column of silica gel. Following concentration in vacuo, the crude 810 is used in the next reaction without further purification.

I. Carbamate 811 To a solution of 810 (22 mg, 22 mmol) in CH2C12 (1. 0 mL) is added trichloroacetyl isocyanate (0. 20 mL, 1. 7 mmol) at room temperature. After 30 min, the mixture is diluted with CH2C12 (20 mL), and some neutral Al203 (500 mg) is added. The mixture is then stirred at room temperature for 2hr, then filtered though a short column of silica gel, and concentrated in vacuo. Flash chromatography affords 811.

J. Epoxide analog 812.

A solution of 811 (15 mg, 14 mmol) in tetrahydrofuran (1. 0 mL) is cooled to 0°C, and treated with a

1. 0 M solution of tetrabutylammonium fluoride in tetrahydrofuran (0. 14 mL, 0. 14 mmol). The reaction mixture is stirred for 2 hr, and diluted with water (20 mL). The mixture is extracted with ethyl acetate (3 x 10 mL). The combined organic phase is then washed with brine (10 mL), dried over MgSO4, concentrated in vacuo. Flash chromatography affords 801.

EXAMPLE 59 (Figure 29) A. Alcohol 903.

Phosphonium salt 15 (98. 0 mg, 0. 092 mmol) is dried azeotropically with dry benzene and heated at 50°C under vacuum for 3 hr before use. It is then dissolved in tetrahydrofuran (0. 7 mL). Sodium bis (trimethylsilyl) amide (1. 0 M in tetrahydrofuran, 86 mL, 0. 0855 mmol) is added at-78°C, and the mixture is stirred for 20 min and then recooled to-78°C. A solution of aldehyde 902 (60 mmol) in tetrahydrofuran (300 mL) is added, and the mixture is stirred for 10 min at-78°C, and 2 hr at room temperature. The reaction is quenched with saturated aqueous NH4Cl (1. 0 mL). The resultant mixture is extracted with ether (30 mL), and the ether layer is washed with water (30 mL) and brine (30 mL), dried over MgSO4, filtered and concentrated in vacuo. Flash chromatography provides an olefin. A solution of the olefin (44 mmol) in CH, ci, is cooled to-78°C. Diisobutylaluminum hydride (1. 0 M in toluene, 440 mL, 0. 40 mmol) is added dropwise over 5 min, and the resultant solution is stirred for 10 min at-78 °C and 30 min at 0 °C. The reaction is quenched with a saturated solution of Rochelle's salt, and the mixture is diluted with ether (60 mL), washed with Rochelle solution, and brine (30 mL each), dried over MgSO4, filtered and concentrated in vacuo.

Flash chromatography provides alcohol 903.

B. Diene 905.

A solution of 903 (0. 012 mmol) and Et3N (42 mL, 0. 30 mmol) in CHIC'2 (2. 0 mL) is cooled to 0°C and a solution of SO3-pyridine complex (40 mg, 0. 251 mmol) in dimethylsulfoxide (0. 6 mL) is added. The mixture is stirred at 0°C for 45 min

and then diluted with ethyl acetate (30 mL), washed with aqueous NaHSO4 (1. 0 M, 30 mL) and brine (2 x 30 mL), dried over MgSO, and concentrated in vacuo. Flash chromatography affords an aldehyde. A solution of allyldiphenylphosphine 904 (0. 19 mmol) in tetrahydrofuran (1. 0 mL) is cooled to-78°C and t-butyl lithium (1. 7 M in pentane, 0. 122 mmol) is added. The mixture is stirred at 0°C for 30 min, recooled to-78°C and treated titanium tetra-i-propoxide (0. 15 mmol). After 30 min, a cold (-78°C) solution of the aldehyde (0. 26 mmol) in tetrahydrofuran (1. 0 mL) is introduced via cannula, and the mixture is stirred 10 min further at-78°C and at 0°C for 1 hr.

Iodomethane (0. 32 mmol) is added, and the reaction is maintained at 0°C for 30 min, warmed to room temperature, protected from light, and stirred overnight. The reaction mixture is diluted with ether (30 mL), washed with 1. 0 M aqueous NaHSO4 and brine (30 mL each), dried over MgSO, 4 concentrated in vacuo. Flash chromatography affords diene 905.

C. Glycoside 908.

A solution of 905 (83 mmol) in methanol (2 mL) is treated with pyridinium p-toluenesulfonate (ca. 4 mg) and stirred at 40°C for 30 min. The mixture is diluted with ether (20 mL) and washed successively with saturated aqueous NaHCO3 solution (25 mL) and brine (10 mL), and then dried over MgSO4.

The organic solution is concentrated in vacuo, and the residue is passed through a column of silica gel to give an alcohol.

To a solution of glycosyl bromide 906 (75 mmol) in CHIC'2 (2. 0 mL) is added HgBr2 (7 mmol) and powdered molecular sieves (4A, 50 mg) and stirred for 60 min at room temperature.

The mixture is then cooled to 0°C, and the alcohol (74 mmol) prepared above is added in CH2C12 (0. 7 mL). The resultant mixture is stirred 6 hr at 0°C and then warmed to room temperature and diluted with CH2C12 (10 mL), and filtered through a pad of celite. The filtrate is washed with aqueous KI solution, and dried over MgSO4. The organic solution is concentrated in vacuo, and the residue is passed through a column of silica gel to give an anomeric mixture of glycosides 908.

D. Triol 901.

To a solution of 908 (79 mmol) in CH2Cl2 (3. 0 mL) at 0°C is added water (0. 15 mL) and 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone (60 mg, 0. 26 mmol). The mixture is stirred at 0°C for 5 hr, diluted with CH2C12 (15 mL), dried over MgSO4, and filtered through a column of silica gel. Following concentration in vacuo, the crude alcohol is used for next step without further purification. To a solution of the alcohol (22 mmol) in CH2C12 (1. 0 mL) is added trichloroacetyl isocyanate (0. 20 mL, 1. 7 mmol) at room temperature. After 30 min, the mixture is diluted with CH2C12 (20 mL), and some neutral A1203 (500 mg) is added. The mixture is then stirred at room temperature for 2 hr, then filtered though a short column of silica gel, and concentrated in vacuo. Flash chromatography affords a carbamate. A solution of the carbamate (14 mmol) in 48t HF-acetonitrile (1 : 9, 1. 0 mL) is stirred at room temperature for 12 hr. The reaction is quenched by saturated NaHCO3 (5. 0 mL). The mixture is extracted with ethyl acetate (3 x 10 mL). The combined organic phase is then washed with brine (5. 0 mL), dried over MgSO4, concentrated in vacuo. Flash chromatography affords 901.

EXAMPLE 60 (Figure 30) A. Olefin 1001 A solution of model phosphonium salt (0. 0917 mmol) in THF (700 mL) is cooled to-78 °C and treated with NaHMDS (1. 0 M in THF, 85. 5 mL, 0. 0855 mmol). The mixture is stirred for 20 min at 0 °C, recooled to-78 °C and aldehyde C (0. 0570 mmol) in THF (300 mL) is added. After 10 min at-78 °C and 2 h at room temperature, the mixture is quenched with saturated aqueous NH4Cl (1. 0 mL) and extracted with ether (30 mL). The ether solution is washed with water, brine (30 mL each), dried over MgSO4, filtered and concentrated. Flash chromatography provides olefin 1001.

B. Lactone 1002 A solution of olefin 1001 (0. 00597 mmol) in THF/CH3CN (2 : 1, 1. 50 mL) is treated with pH 7. 0 phosphate buffer (500 mL)

and HgCl2 (215 mg). The suspension is stirred at room temperature for 40 min, diluted with ether (30 mL), washed with brine (2 x 30 mL), dried over MgSO4, filtered and concentrated.

Pipette flash chromatography (5'-o ethyl acetate/hexane) provides a mixture of lactols as a colorless oil which is further treated with DMSO (1. 0 mL) and Ac2O (200 mL) at room temperature for 2 days. The mixture is diluted with ether (30 mL), washed with saturated NaHCO3 (30 mL), brine (30 mL), dried over MgSO4, filtered and concentrated. Flash chromatography provides lactone 1002.

C. Model Compound 1003 A solution of olefin 1002 (5. 5 mmol) in 48W HF-CH3CN (1 : 9, 1. 0 mL) is stirred at room temperature for 12 h, then quenched with saturated aqueous NaHCO3 (5. 0 mL). The mixture is extracted with ethyl acetate (3 x 10 mL). The combined organic extracts are washed with brine (5. 0 mL), dried over MgSO4, filtered and concentrated. Pipette flash chromatography (gradient elution, 1 : 30 to 1 : 6 MeOH/CHC13) provides 1003.

EXAMPLE 61 (Figures 31 and 32) I. General procedure for synthesis of hydroxy aldehydes 1104.

A. TBS ether 1102a A solution of bromide 1101a (see, Jacquesy, et al., Tetrahedron 1981, 37, 747) (20 mmol) in ether (40 mL) is added slowly to a-78 °C solution of tert-butyllitium (40 mmol, 1. 7 M in pentane). After 1 h at-78 °C, the cold solution is transferred to a suspension of copper (I) iodide (10 mmol) in ether at 0 °C. After an additional 30 min at 0 °C, a solution of benzyl (S)- (+)-glycidyl ether (9 mmol) in ether (20 mL) is added and the reaction is allowed to warm to room temperature.

After 18-24 h, the reaction is quenched by the addition of tert-butyldimethylsilyl triflate (10 mmol). The reaction mixture is poured into saturated aqueous sodium bicarbonate (100 mL). The aqueous layer is separated and extracted with ether (2 x 50 mL). The combined organics are washed with saturated aqueous brine (50 mL), dried over magnesium sulfate

and concentrated in vacuo. The residue is purified by flash chromatography to afford 1102a.

B. Alcohol 1103a.

To a solution of 1102a (6 mmol) in ethyl acetate-ethanol (8 : 1, 90 mL) is added palladium on carbon (10% wet, 500 mg). The mixture is stirred under hydrogen atmosphere for 3-6 h, then filtered and concentrated in vacuo. The residue is purified by flash chromatography to afford 1103a.

C. Aldehyde 1104a.

Oxalyl chloride (1. 5 mmol) is added dropwise to a-78 °C solution of dimethyl sulfoxide (3 mmol) in dichloromethane (4 mL). After 15 min, a-78 °C solution of 1103a (1 mmol) in dichloromethane (2 mL) is added via canula. After an additional 15 min, diisopropylethylamine (4. 5 mmol) is added and the reaction is gradually warmed to room temperature over 1 h and quenched with aqueous sodium bisulfate. The mixture is diluted with ether (50 mL) and is washed with water (2 x 30 mL), saturated aqueous brine (2 x 30 mL), is dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 1104a.

II. General procedure for the conversion of 1104 to arene analog 1111 : A. Diene 1105.

Phosphonium salt 15 (see, Smith, et al., J. Am. Chem.

Soc. 1995, 117, 12011) (0. 2 mmol) is dissolved in anhydrous tetrahydrofuran (2 mL) and chilled to 0 °C. A solution of sodium bis (trimethylsilyl) amide (0. 2 mmol, 1. 0 M in tetrahydrofuran) is added and the reaction mixture is stirred 30 min at 0 °C. After cooling to-78 °C, a solution of aldehyde 1104 (0. 1 mmol) in tetrahydrofuran (2 mL) is added and the mixture is stirred 10 min at-78 °C and 2 h at room temperature. Saturated aqueous ammonium chloride (2 mL) is added and the resultant mixture is extracted with ether (3 x 20 mL). The ethereal layer is washed with water (2 x 25 mL) and saturated aqueous brine (25 mL), dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 1105.

B. Hydroxy diene 1106.

A-78 °C solution of 1105 (0. 05 mmol) in CH, Cl2 (5 mL) is treated with diisobutylaluminum hydride (0. 5 mL, 1. 0 M in toluene). The resultant solution is stirred 10 min at-78 °C and 30 min at 0 °C. The reaction is quenched with a saturated solution of sodium potassium tartrate (50 mL) and the mixture is diluted with ether (60 mL). The organic layer is separated, dried over magnesium sulfate, and concentrated in vacuo. The residue is purified by flash chromatography to afford 1106.

C. Aldehyde 1107.

Oxalyl chloride (1. 5 mmol) is added dropwise to a-78 °C solution of dimethyl sulfoxide (3 mmol) in dichloromethane (4 mL). After 15 min, a-78 °C solution of 1106 (1 mmol) in dichloromethane (2 mL) is added via canula. After an additional 15 min, diisopropylethylamine (4. 5 mmol) is added and the reaction is gradually warmed to room temperature over 1 h and quenched with aqueous sodium bisulfate. The mixture is diluted with ether (50 mL) and is washed with water (2 x 30 mL), saturated aqueous brine (2 x 30 mL), is dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 1107.

D. Tetraene 1108.

A solution of diphenylallylphosphine (0. 08 mL, 0. 38 mmol) in tetrahydrofuran (2 mL) is cooled to-78 °C and tert-butyllithium (0. 14 mL, 1. 7 M in pentane) is added. The mixture is warmed to 0 °C for 30 min, then recooled to-78 °C and treated with titanium (IV) isopropoxide (0. 30 mmol). After 30 min, aldehyde 1107 (0. 30 mmol) is introduced as a solution in tetrahydrofuran (2 mL). The resultant solution is stirred at-78 °C for 15 min and at 0 °C for 1 h. Methyl iodide (0. 64 mmol) is added, and the reaction is warmed to room temperature for 12 h. The reaction mixture is diluted with ether (60 mL), washed with aqueous sodium bisulfate (30 mL, 1. 0 M), saturated aqueous brine (30 mL), and is dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 1108.

E. Alcohol 1109.

To a solution of 1108 (0. 050 mmol) in dichloromethane (3 mL) at 0 °C is added water (50 mL) and 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone (0. 018 mmol). After 1 h, the reaction mixture is diluted with ethyl acetate (50 mL), washed with saturated aqueous brine (3 x 25 mL), dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 1109.

F. Carbamate 1110.

To a solution of 1109 (0. 010 mmol) in dichloromethane (2 mL) is added trichloroacetyl isocyanate (1. 00 mmol). After 30 min, the reaction mixture is diluted with dichloromethane (4 mL) and neutral alumina (1 g) is added. The resultant suspension is stirred an additional 4 h. The reaction mixture is filtered and the concentrated filtrate is chromatographed on silica gel to afford 1110.

G. Arene analog 1111.

A solution of 1110 (0. 010 mmol) in 48W hydrofluoric acid-acetonitrile (1 : 9, 2 mL) is stirred at ambient temperature. After 12 h, saturated aqueous sodium bicarbonate (25 mL) is added and the mixture is extracted with ethyl acetate (3 x 20 mL). The combined organics are dried over magnesium sulfate and concentrated in vacuo. The residue is purified by flash chromatography to afford 1111.

Those skilled in the art will appreciate that numerous changes and modifications may be made to the preferred embodiments of the invention and that such changes and modifications may be made without departing from the spirit of the invention. It is therefore intended that the appended claims cover all equivalent variations as fall within the true spirit and scope of the invention.